case_id1,gender,vital_status,year_of_birth,ajcc_pathologic_stage,primary_diagnosis,treatment_type,year_of_diagnosis,Location,latitude,longitude,city,state,zip
bb026999-0aab-4232-96d7-2c93b6c9691d,female,Alive,1963,Stage IIIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
a32cb96a-78bf-456e-a6ab-2d47b2c67ad4,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
97943d87-fed7-4f14-a0a7-c5bfee64c392,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
bdd08ec8-8892-4273-8f21-6fde0f23c52d,female,Alive,1937,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
20e8106b-1290-4735-abe4-7621e08e3dc8,female,Alive,1971,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
2e538802-2a31-4774-89a8-c6e4381a887d,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
dcd5e079-813a-4c1a-b320-0931468d2bbc,female,Alive,1931,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
1549dc64-3dab-43fc-96e9-b07d520957e1,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
a2453bcb-90f2-4505-949d-a89cf4bfc9b8,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
5fe3c51f-65e2-4da6-8924-a6fae17c022d,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
97677fd7-8523-48c5-a8ce-614fd4010551,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
74f31744-0aed-4633-beec-4e203315f0b7,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
65cac997-4d39-4501-85ec-4fcb328a8eb5,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
e783e518-c1e5-4eac-8eaf-e2d65ccd9692,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
a947a945-4721-45cc-bc45-13b8ea41c10e,female,Alive,1956,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
a2db9dd1-44d5-48b5-817c-a21a85fadb21,female,Alive,1967,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
241fffc8-4250-4cfa-b2e7-e68c33ae07dc,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
972447aa-4332-47e7-bddd-2eb699dbb664,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
f39edd06-1016-4e8e-a42e-12f7e699ddc5,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
9f6be944-83de-42ab-8738-f0022f475e61,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
f2da1d3f-f226-4c99-a97e-9b26f67d7a5d,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
f30eb65f-fb44-4062-ac39-a38d072f655f,female,Alive,1930,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1998,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
b205c89f-af62-4186-acad-ed23d243fa98,female,Alive,1962,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
dd43ffd9-da18-4ad3-abe7-6f443c76a717,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
86b7b206-8e69-432d-acc9-bccce710955e,female,Alive,1973,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
626b4ff0-2188-4a14-aac8-6703c624917f,female,Alive,1934,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
a272171b-44f5-47a5-89be-7520413c01ad,female,Alive,1923,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
4da999a0-ef41-4a0b-b1d1-446b39cc855a,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
02f5ae33-a563-4ecb-9e33-dfa500a44931,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
c0892598-1f7b-4f23-9cd8-731f797753d5,female,Alive,1946,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
9e894662-b718-40f8-8899-b5e036cfbd76,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
5c9d8163-a68e-43ce-9cba-effb7405761e,female,Alive,1922,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
6f959c92-b79f-4f84-9ee5-d07d3212d52d,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
75b5529b-565a-4eba-918a-910b2f441d32,female,Alive,1925,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
ed2617c3-5d3b-4688-9283-0f8a10e0b10d,female,Alive,1971,Stage IIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2012,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
389e5b18-8f89-41a9-9fa5-efd4172836e2,female,Alive,1959,Stage IIIB,"Medullary carcinoma, NOS","Radiation Therapy, NOS",2013,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
6f89509c-f802-482e-b4da-94553aa76fe9,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2001,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
7e1673f8-5758-4963-8804-d5e39f06205b,female,Alive,1955,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
0807435a-e75e-4e04-8e45-ed0cd49a841a,female,Alive,1941,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",1992,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
9f93ea0a-1687-44e0-9e8a-eeb4097d471c,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
b0bcb829-cee0-4247-bb75-093a5bea89ee,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
81e32f39-3aa0-468b-87ed-dd2eb6165ddf,female,Alive,1953,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
3886b4fb-ba22-4a50-b11a-a6893951f170,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
e17c565c-9857-4df3-a352-903b53093c85,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
993103b1-e5a1-4c33-8629-be53ebc41d64,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
f3b86c02-09a5-4e97-aa7a-86f13f7cda4b,female,Alive,1955,Stage IIA,Intraductal micropapillary carcinoma,"Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
f357fe19-5359-4662-8ce9-aa996132283b,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
753d5d49-3b40-4737-9d4c-b1ec29cc2692,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
e3c336f5-c32f-4c5d-81fb-e2408ae145b2,female,Alive,1931,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
495f9eda-b9be-4eef-bae1-766a4bfbd68e,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
34d5a193-85e5-4399-8a9b-e92858eafdfe,female,Alive,1943,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
8db69f1d-72e2-40ba-ad8a-cf228499840d,female,Alive,1954,Stage IIIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2013,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
b6b932ce-6856-4d94-9e6c-16dfbe51906f,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
cd3faa15-743c-476f-ab0d-f205b14126b6,female,Alive,1954,Stage IIIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",1996,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d3b9d925-ae04-4721-8bfc-50b41225bc74,female,Alive,1927,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
38a4e9bd-93e9-432d-a756-3b1055b823bd,female,Alive,1934,Stage IIIC,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2013,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
ed6cef77-1bd9-4e3b-b576-550a91e4253a,female,Alive,1972,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
ce887e90-0660-4f44-a3a4-b3b894cb7eda,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
491b6364-1223-474f-816f-e248c8c841e2,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
6cb6f179-defd-4661-af0a-c353b74c0c49,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
5580b21a-2cdb-4777-ad79-6e06654144f5,female,Alive,1971,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
ec461eaf-f5cb-4225-a9a0-59d8e6c17ea6,female,Alive,1984,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
3ca67cd0-81da-4f68-a9fa-f1a8c013c28d,female,Alive,1966,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
d8f8064f-02ef-4fed-942b-714cbe5e8455,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
aa30ac3d-4216-45dd-a314-1ae192fafcb2,female,Alive,1967,Stage IIIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2005,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
a947a945-4721-45cc-bc45-13b8ea41c10e,female,Alive,1956,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
02bbb632-0f7f-439d-b8f0-c86a06237424,female,Alive,1944,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
a721dac6-0126-476c-b2d4-2dbf7406454b,female,Alive,1930,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
ba39bfbc-5cac-4f6c-b55c-4eee3466ee93,female,Alive,1943,Stage IIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
4ac693e9-10f3-46b3-9d46-df3af7b0d259,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
75113445-d2d6-44a0-866c-c9175e6d214b,female,Alive,1972,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
a0963e93-b63e-4de2-86c1-81302e271d3e,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
dd0f8e5a-383d-4f03-bb71-0e115d4e442c,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
d8f8064f-02ef-4fed-942b-714cbe5e8455,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
995fdab7-7284-4d33-befa-ec22aa7c6479,female,Alive,1952,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
55262fcb-1b01-4480-b322-36570430c917,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
0b172e29-6166-4863-803d-a0a010887c11,female,Alive,1922,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1993,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
e7a00d67-2c26-4d1f-bd17-35f659e88bc1,female,Alive,1951,Stage II,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
05af737d-89aa-49b6-97b2-28b8ac8bd2cf,female,Alive,1933,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
03ab1e9f-4918-404d-b178-3a4fd929c5e8,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
05506f4c-e701-4a9d-ae06-97f066aade43,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
01eef340-598c-4205-a990-cec190ac2ca5,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1996,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
539bbbed-43fb-4fef-9c67-6406f58b186a,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2005,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
c8f39325-5382-447c-9291-a6915fc978b8,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
89e867de-d30e-4bfc-a453-0a76309dabd5,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
01674b2c-5cf2-478f-84a1-f69c39f47bd4,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
2fe854b4-bac9-4801-9a1c-ee99388e8082,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a2efe7e1-aca3-440f-825f-ed621edca69f,female,Alive,1972,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
115bc72c-116f-40c1-be9b-e3dd7650efae,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
3e9f93c0-aa79-4b4c-bd6c-b3325912362a,female,Alive,1969,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
7875018b-91dc-4ab1-83b0-ee3883e2816e,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
3b01d064-8c00-4972-9f07-407eac8e7534,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
08de63a2-7b76-43c3-80dc-df748b1d81bc,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
f130f376-5801-40f9-975d-a7e2f7b5670d,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
632984bd-dc81-42b6-b024-476cfd0bb2ae,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
9ced0c70-c46c-4f98-8f48-840defe4b8b1,female,Alive,1950,--,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
6397d7bc-9cb1-4a84-81ad-76954e0a8cee,female,Alive,1940,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
97943d87-fed7-4f14-a0a7-c5bfee64c392,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
9536bec0-dae0-4d63-a1b3-956741835243,female,Alive,1938,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0a229f95-0ea1-4d63-953e-74f5ec2f3028,female,Alive,1946,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
2fe854b4-bac9-4801-9a1c-ee99388e8082,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
ccb22ecc-6e18-44b8-ad48-6ab51314b16e,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
3aaabc62-f5a4-4025-9b29-5adf82c86c84,female,Alive,1926,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde,female,Alive,1922,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
54883111-d475-4515-ba3f-fece8a71e79e,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
3f56d67f-5a9c-4353-9408-e7f60eb6477b,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
7f97971b-2818-4e4b-9c9e-7c0246f9484c,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
3c612e12-6de8-44fa-a095-805c45474821,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
a8f5c479-8685-4e2d-bb60-63f1cc651083,female,Alive,1942,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
97b5f490-1cd9-4833-b903-5f4c6e45670d,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
5ed024e8-d05e-4c65-9441-eda9930ccc82,female,Alive,1960,Stage IIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
88cd6ccc-70f7-436e-a99c-039b9d31e335,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
dfe6db17-cf45-488e-bd3c-b8433d7343ca,female,Alive,1971,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
c85f080a-1075-41df-959f-1b514a11b3c4,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
f31c21b6-0f7f-435b-9e24-97c909755c36,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
c70ee5e1-4703-4996-bb5c-f4cca0fb53ba,female,Alive,1973,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2002,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
5d8ed961-a012-4b6b-bffb-9468d3953646,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
2192c1db-4718-4254-ba42-3ae7f30ad5a8,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
077506ea-8f11-405d-bb8e-3c9924fe54d0,female,Alive,1944,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
281f70c5-876f-44b3-84fb-f2302f85e74c,female,Alive,1944,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
49a2fd48-744d-4d88-b9b4-8c778d4f48fd,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
c65b835a-2d38-4250-a173-0780d2c2cf58,female,Alive,1960,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
0e1d0d46-7a7b-4538-95dd-b9fc20a15aec,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
f51af6db-2655-47fb-9ffc-83a503a728ea,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
66072c06-f251-4f0b-b6ae-12b407c52cc6,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
491b6364-1223-474f-816f-e248c8c841e2,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
0d146997-cfdc-4587-888c-e876fc455c80,female,Alive,1962,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
241fffc8-4250-4cfa-b2e7-e68c33ae07dc,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
1174f6e4-ffbe-4e59-a000-8d861c968369,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
c0f88fc5-56b0-4255-bbd1-9a21ced8b37b,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
00a2d166-78c9-4687-a195-3d6315c27574,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
53d0af48-d7ea-42c9-8695-c614b89b415b,female,Alive,1933,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
18eb4dfc-556f-4bf3-a411-4780209ed1e0,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
8c09f413-e938-4f2e-a414-84f0e7fcfe41,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
03c143e0-d8a1-4d60-a4a3-df0501fc6b6e,female,Alive,1940,Stage IIIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
530ad151-703d-4638-851f-0b5111ff318b,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
5e2cbc56-97f9-4b94-ade2-a3f739bcc7be,female,Alive,1930,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
33919e92-4ea9-47e5-a6f4-36e51845d50f,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
2e243f0e-9d7d-4cb0-9678-70607f90430a,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
cffe832c-8a81-4cdb-8b25-df7f35afafdc,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
e828455d-4680-41b2-8a1c-1582e3790d62,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4,female,Alive,1960,Stage IIA,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
a9bb8159-32f0-454c-a946-b3286a52b9d5,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
cffe832c-8a81-4cdb-8b25-df7f35afafdc,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
43b3bf47-7313-4dfb-952a-ec0b9d48e16c,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
76bd9bb9-9a8b-4a90-bb7c-eafe76472ee4,female,Alive,,Stage IB,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2012,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
b26d41cd-393b-4cd4-8925-a9488f7de576,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
530ad151-703d-4638-851f-0b5111ff318b,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
ca20249f-b7ea-4fd9-9ecb-34f74755ae35,female,Alive,1945,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
9857be0c-aeca-4a43-90b1-0535bd08e086,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",1998,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
dc15a8ae-991e-421c-bc70-70e94f79dd17,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
9ba11ea8-97d3-464a-90a4-ec1151be9088,female,Alive,1983,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
a076f135-be82-40fa-8516-285ed355c965,female,Alive,1945,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
853456d8-2367-404e-abc9-020fe8bbd209,female,Alive,1927,Stage X,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
33cea538-4c3f-470a-972d-257c43241ab4,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
f801aeed-dc43-49d7-a319-84c8851979d9,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
14267783-5624-4fe5-ba81-9d67f1017474,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
f947d67f-4aa2-4eb9-977e-21a5ae563613,female,Alive,1938,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
4b54e06e-a280-4981-a4e1-9aea154341b4,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
08740d7f-5a5e-4dfa-bd48-7fbf228a7a28,female,Alive,1946,Stage II,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1996,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
e9002f4e-ba0b-4738-9368-dd9614a5da8a,female,Alive,1952,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
441919eb-8c9f-478c-bda3-8de4f8295e8a,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
271e8024-a008-4bf0-9f6e-177f60096b1b,female,Alive,1933,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
ef4cbd38-bc79-4d60-a715-647edd2ebe9e,female,Alive,1960,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
5a53ec47-e63f-44a2-8078-87659544fb04,female,Alive,1966,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
e3935ce4-64d3-4a66-ba11-d308b844b410,female,Alive,1947,Stage IIB,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2012,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
3144f1fb-4342-4079-bfe8-940da4bfd88e,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
8159ff7b-89f4-411a-9b9c-491f1cb3eb34,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
124b693c-77dc-4fa8-b703-54e8b5054a92,female,Alive,,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
3c612e12-6de8-44fa-a095-805c45474821,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9,female,Alive,1926,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
3b1f7e48-216d-47de-ba79-db350f52bff0,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
e112b452-8850-4353-bfed-0dbdc243290b,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
67c73260-a242-4bba-87c5-d2302556dff7,female,Alive,1961,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
c364e81c-eb1e-4870-ab37-9c661f5f2e3d,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
f0d8a1fe-e313-44f1-99cc-b965cbeeff0e,female,Alive,1963,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
de531604-bd1a-49df-96c2-6de3ae703f1d,female,Alive,1924,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb,female,Alive,1946,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
f9eb88f7-9293-46bf-ace4-a746e4ff80dc,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a,female,Alive,1962,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
a0963e93-b63e-4de2-86c1-81302e271d3e,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
fb3607eb-858e-4ecd-8477-95140658c6d2,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
3e25056d-d137-49f5-abaa-f68509426600,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
324bcba2-f6a4-45a6-807c-215bdffcca21,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
0dca98b0-f43e-45b6-9a02-00092c78678c,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
c8f39325-5382-447c-9291-a6915fc978b8,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
c25898b4-eb33-42f4-bf3f-bf532a929e7d,female,Alive,1962,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
a1872011-b928-4189-ac02-e87506c20bca,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
04af44fc-c487-4005-b3cb-cb64815824a2,female,Alive,1935,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2001,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
a06ff6ae-b0dd-4516-a75c-0db71694b46b,female,Alive,1961,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
d5d8e76e-2f2a-49bc-ba0a-d51283611b16,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
b094e8b2-8ece-4b36-8025-18073a8b873c,female,Alive,1964,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2002,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
1549dc64-3dab-43fc-96e9-b07d520957e1,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
b5b99291-507e-4b68-a039-9a0f571f55df,female,Alive,1939,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
76bd9bb9-9a8b-4a90-bb7c-eafe76472ee4,female,Alive,,Stage IB,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2012,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
7e1673f8-5758-4963-8804-d5e39f06205b,female,Alive,1955,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
83f26720-007c-42c9-a7de-7484bf8afa89,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
a991644b-3ee6-4cda-acf0-e37de48a49fc,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
2c6adb12-380d-4710-a7e6-93d5a0e53289,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
1f99e4d4-4e8b-4cc1-a129-227a2a82780e,female,Alive,1946,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
78582fbc-dcc7-48ae-9f95-5271c9bc5b72,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2001,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
31427699-e27a-4035-8925-6d8d6900d097,female,Alive,1968,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
016caf42-4e19-4444-ab5d-6cf1e76c4afa,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2002,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
6af6d256-a753-46d2-b611-e4094ff265aa,female,Alive,1944,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9,female,Alive,1926,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
9ce7ce09-4409-4fa3-9f78-b2b24716f860,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
6f18f96e-c0c9-4cc4-9fb2-cba8949d5402,female,Alive,1923,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
6f4c8d30-47fb-47df-9eb7-4e5881e3711e,female,Alive,1932,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
49717f75-0f2d-4e1c-9a12-f1cd7877b80a,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
2cf68894-168b-458b-af4f-53cad72989a8,female,Alive,1966,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
e1119732-3e97-4259-bc69-dc4269d9496d,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
6f6afd31-b5dd-48ab-b18f-6390ba18a5f0,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
53d0af48-d7ea-42c9-8695-c614b89b415b,female,Alive,1933,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
42378dbc-a123-4cf9-8502-165e89fda271,female,Alive,1980,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
0ed9ad26-7fdc-4d75-93f9-d029eee94993,female,Alive,1945,Stage IIB,Intraductal micropapillary carcinoma,"Radiation Therapy, NOS",2006,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
9e894662-b718-40f8-8899-b5e036cfbd76,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
73ccc949-01b7-48d3-a7c4-c4bcd261672a,female,Alive,1964,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
f39edd06-1016-4e8e-a42e-12f7e699ddc5,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
d7808cbc-4b8c-467b-b2c3-f48d05b9ecab,female,Alive,1928,--,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
71f97b63-c970-44ee-98c2-e02e663d5a40,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
60df7543-6da5-4c75-943b-5800c1e08234,female,Alive,1954,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
4bf50455-9ab7-4521-a791-089f66d3b877,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1996,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
82ec33dd-e783-4c74-9a87-797a699e11df,female,Alive,1961,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
fb57c598-b45b-478a-9d34-ca1f050d5b7c,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
6e7d5ec6-a469-467c-b748-237353c23416,female,Alive,1949,Stage X,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2004,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
910655da-2c12-4572-96b7-ded616e69b4b,female,Alive,1968,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
5e670fec-8992-44bf-8657-f7f9a272306b,female,Alive,1933,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
6f4c8d30-47fb-47df-9eb7-4e5881e3711e,female,Alive,1932,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
37242f5a-25ae-4b1f-9ce6-09ce1dc92539,female,Alive,1945,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b,female,Alive,1970,--,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
dc11b1c7-1f00-4813-b4b5-ecf776b2eb37,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
c0b7b798-3383-4a45-a455-9eca5810739e,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
43d5632e-7272-4aad-9496-7f5a99671223,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
89a8da07-4487-47c6-8d3c-442a87e4f632,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
70f34c5c-3671-44c8-9469-99f9786efec1,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
b58ad350-5140-4fa8-bc2c-24bca8395f3a,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
518f231c-f5f9-4a39-a97b-7fd5666d3e50,female,Alive,1961,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
84b7ccf2-8ab3-4b21-96de-800d231bc072,female,Alive,1960,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
441919eb-8c9f-478c-bda3-8de4f8295e8a,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
03ab1e9f-4918-404d-b178-3a4fd929c5e8,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
b0bcb829-cee0-4247-bb75-093a5bea89ee,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
3efa245d-177d-4ef9-94f7-f554c54e345e,female,Alive,1925,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
0dc337fa-da8b-42c4-b9a7-fb76d81c161f,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
dbcad60f-86c7-41e3-b0ae-baa39c9f83dd,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
189e1f27-7738-413a-a4d4-97d41d592a13,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
3a711140-1b89-4611-9992-3861e3d0e01a,female,Alive,1943,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
31c31cce-1b4d-4f12-922f-84f389403170,female,Alive,1938,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
01f50abf-fc15-446e-9d07-edeecc545a32,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
36fe6152-f61e-4948-9ccc-23ac01a9d77d,female,Alive,1952,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
6fa2a667-9c36-4526-8a58-1975e863a806,female,Alive,1928,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
f45aa0b2-f3de-4db5-9730-e5c6c4e2ed3a,female,Alive,1972,Stage IIIC,Intraductal micropapillary carcinoma,"Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
5d8ed961-a012-4b6b-bffb-9468d3953646,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
e1786e78-ac46-46fd-8ce0-8f7456e46082,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
56033839-35d5-4d72-8b8c-400cb345263d,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
d9627184-b972-4e00-8c11-b0b946ac357a,female,Alive,1938,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
32efa6e8-6b19-480a-9d04-ace02e93318a,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
0bf6e772-1aa1-4f54-9a50-c1414e2f22f3,female,Alive,1958,Stage II,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
56bbd282-b88d-4730-9242-ab97d08dc83a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
6f18f96e-c0c9-4cc4-9fb2-cba8949d5402,female,Alive,1923,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
a45d296e-efc0-479e-b2f6-bad834668cdf,female,Alive,1938,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
f06f09f3-8133-4a92-ac86-fbe64295e0d8,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
84b7ccf2-8ab3-4b21-96de-800d231bc072,female,Alive,1960,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
599c3701-df7a-4a75-a347-fa9b510dd242,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
becedbfd-b2aa-4dde-b7f4-29e6f59ec32c,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
09c2bc35-c21f-4aa4-ac30-0d8db02ad811,female,Alive,1925,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
34a74805-300c-4773-ab59-2085fcc2e6cc,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
dfaabd03-2d40-4422-b210-caf112ff4229,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
f81ac8a2-4ce6-439e-b027-1c0bfc88ceaa,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
ac68d219-5670-4ddd-8df6-8aa7ad59e5c7,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
89414e79-7f89-42d9-8228-101b5bf2f31f,female,Alive,1963,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
9c55032f-4db7-4026-ae83-8d060dd8e3fe,female,Alive,1952,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
18eb4dfc-556f-4bf3-a411-4780209ed1e0,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
0f64edec-0f1f-4025-8a53-75f9534f7828,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
27ba717a-5cd8-440a-9345-4ae086f6efca,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
c65b835a-2d38-4250-a173-0780d2c2cf58,female,Alive,1960,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
99927651-34be-4795-893a-128d8a1fdb30,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
8631969d-4ac6-4fe1-9db3-d47db604494a,female,Alive,1960,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
c0f88fc5-56b0-4255-bbd1-9a21ced8b37b,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
6014a582-d22e-46e1-9000-c8e2fbad7acf,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
c462e422-eb8d-4daf-9897-2a9c6cbd783a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
aaea5f9c-b35b-47f8-93cb-bdc7b81844ff,female,Alive,1959,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
a1da9db1-db11-4f4d-a249-c738db81b87e,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
515b1400-e896-4f2a-81bd-70895441a0bd,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
c836951b-3ffb-4e20-8504-0eccb7d50dd4,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
9848307d-1bd5-40c1-b655-a33297aaf74f,female,Alive,1958,Stage IIA,"Medullary carcinoma, NOS","Radiation Therapy, NOS",2005,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
9435447e-d65f-408b-863b-6576b1d652dd,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
00807dae-9f4a-4fd1-aac2-82eb11bf2afb,female,Alive,1955,Stage IIB,Apocrine adenocarcinoma,"Radiation Therapy, NOS",2005,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
6951fe6a-d7d1-4f41-85af-76655b5d1f62,female,Alive,1960,Stage IIB,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2013,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
9676e46b-8f29-43cd-ab65-eb6a535cced4,female,Alive,1979,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
f55dd73d-8c36-440b-84e5-9aae53107775,female,Alive,1951,Stage IIA,"Basal cell carcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
39de7761-e762-4811-b95c-8216b79ae06b,female,Alive,1974,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
ebd1512a-4865-4193-97b3-f599d555759a,female,Alive,1954,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
4cf0f639-7940-48b6-8ea1-2a3494097cdb,female,Alive,1950,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
d3b9d925-ae04-4721-8bfc-50b41225bc74,female,Alive,1927,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
bfd55808-dddd-44c3-97d7-41600497b992,female,Alive,1948,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1992,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
44bec761-b603-49c0-8634-f6bfe0319bb1,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
fd0b1b8b-1a76-480a-b61c-d176e4e02c6b,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2005,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
d69e59a8-b10b-46f5-b859-b6c178d90506,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
c5f00132-1c6b-4337-af6f-596c652665cc,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0ec70e40-07df-461d-8ff9-351240a0d454,female,Alive,1950,Stage IIA,"Carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
6cb6f179-defd-4661-af0a-c353b74c0c49,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
515b1400-e896-4f2a-81bd-70895441a0bd,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
02bf5203-f9cd-4c5a-97b4-e5584dc22325,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
2a84997d-ccee-4f46-bea2-752534f26416,female,Alive,1935,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
281f70c5-876f-44b3-84fb-f2302f85e74c,female,Alive,1944,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
3b01d064-8c00-4972-9f07-407eac8e7534,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
b26d41cd-393b-4cd4-8925-a9488f7de576,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
dc696e3c-f448-468f-a576-f4429be0338a,female,Alive,1945,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
7b605fb6-d077-401e-b870-b87ddf505f82,female,Alive,1929,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
da9c10ea-c13f-4d88-8b94-a0cbc106d036,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
521e2140-ae5b-456f-8699-97398d009687,female,Alive,1966,Stage IIA,"Medullary carcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
f81ac8a2-4ce6-439e-b027-1c0bfc88ceaa,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
6ddaee34-46eb-490c-bd13-f0ab963c4322,female,Alive,1940,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2003,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
53ff5893-7d5e-4bcb-be9c-665fa34b7824,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
a12fd22a-7f84-4b6e-b6d8-012e38eb73d7,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
3f56d67f-5a9c-4353-9408-e7f60eb6477b,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
38a8b734-9acc-42f9-b5b7-e51b0dfc6504,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
58c56d4b-3f85-4aad-a779-5f9e1791677d,female,Alive,1931,Stage IIA,Pleomorphic carcinoma,"Radiation Therapy, NOS",2006,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
5c8983f2-9788-4dfa-971c-3ec457b6166e,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
8f34cb4c-5798-47a0-89a1-f0ee26a8ae93,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
f83b866b-0b2e-4bba-9367-be6dccf56232,female,Alive,1934,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
f89588e9-ca73-4465-a7fb-7246edb45e3a,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
6f6e7356-3521-4674-8eec-ad01340d4b8e,female,Alive,1935,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
86cf879e-3b40-44dd-aaa7-6f49f54a15d9,female,Alive,1946,Stage IIA,"Papillary carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
843c8f16-5e59-40d4-9ecc-8a75375156f6,female,Alive,1946,Stage IIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
1174f6e4-ffbe-4e59-a000-8d861c968369,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
96f23d8a-be0f-4925-ba00-805dc293414c,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
9f6be944-83de-42ab-8738-f0022f475e61,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
e9a12df9-024e-4cbc-b6bf-e4e87485fa90,female,Alive,1924,Stage IIIB,Paget disease and infiltrating duct carcinoma of breast,"Pharmaceutical Therapy, NOS",2012,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
1d75e89d-4b01-443c-be54-749c7a667bf4,female,Alive,1948,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
bfd49783-1767-469b-9d79-7822301c5efc,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
2cf68894-168b-458b-af4f-53cad72989a8,female,Alive,1966,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
8b525ec6-d24b-49d4-bfcb-b354de4dae7c,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
56230e4a-29ca-4f37-a0f9-730dbdfb6fa2,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
738e1acc-1f0c-4a96-9c8a-222727ef5af8,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
2021ed1f-dc75-4701-b8b8-1386466e4802,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
33919e92-4ea9-47e5-a6f4-36e51845d50f,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
1f8f87cb-8a0b-474c-97fb-c71b4fd88d97,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a412b374-4d25-491f-b76f-ddaa989acf59,female,Alive,1949,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Pharmaceutical Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
71229981-97c2-4ae1-a130-fe5de336b37d,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
9ac44381-5d43-4f63-aa3f-7703bfc923c9,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
9de678e5-67ed-4453-a98b-7ac351d5d0f1,female,Alive,1930,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
dddd8e2f-e540-418a-b02e-698d18a12c14,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
327a2395-85c8-42e1-9638-8e037a1723ed,female,Alive,1947,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
1c40b84e-a0e3-429f-a48c-21566cf881c0,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
0bc5744c-5fa3-45bb-87d0-70a02068b392,female,Alive,1977,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
b0f8d698-a30e-4d8d-b0a2-a5a01fac8406,female,Alive,1947,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
7875018b-91dc-4ab1-83b0-ee3883e2816e,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
8e11c5ec-c15a-48d4-85ac-b7b08a9ed827,female,Alive,1965,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2012,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
39cde586-df95-435f-b9a6-73b0c0ee5e92,female,Alive,1942,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
994ca1f5-ad10-44ec-aa21-71fc2940653b,female,Alive,1953,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
08da7c4c-3067-4bcf-9d7a-78566df72e69,female,Alive,1928,Stage X,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1989,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
09d6e904-7184-4788-8a19-04f8c46cb13f,female,Alive,1960,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
0807435a-e75e-4e04-8e45-ed0cd49a841a,female,Alive,1941,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",1992,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
57cf380d-ab52-467f-b9ae-740b2f84c820,female,Alive,1971,Stage IB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
0adf59c6-581a-475d-a2f4-40aa40060b5b,female,Alive,1941,--,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
2fd36838-5a83-433e-ac80-b1f77448e5aa,female,Alive,1961,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2013,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
b8a44fdf-9cb9-4123-9ab0-4bc198921fee,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
17baef7c-d97d-4b98-ab53-503ef856523d,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
2b36853f-34d3-47c5-ba6a-e5a93233d2b1,female,Alive,1957,Stage IIB,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
43029932-feb0-4658-97fa-645c1e775009,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
27dfb9d4-3a2c-44bc-9acf-8f638d3f3004,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
7451af3c-acc0-4d79-8429-6b8be96911d8,female,Alive,1933,Stage IIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
e3b555aa-7f0a-49c6-9b13-182c61a144c1,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
bfd55808-dddd-44c3-97d7-41600497b992,female,Alive,1948,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1992,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
1502c7d7-1535-4e56-9f34-30623acd50d5,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
5fc7ff35-d3f7-4687-8759-3542bd58e988,female,Alive,1966,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
49a2fd48-744d-4d88-b9b4-8c778d4f48fd,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
59d60247-e549-4326-a672-50b05c13a291,female,Alive,1958,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
5f5964a8-8e07-4620-98f0-93d162dbc31e,female,Alive,1963,Stage IV,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
dbf6f981-15cc-40ad-91ac-a66360405fbd,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
029ce650-5e5a-4100-8596-cd94300e7ef5,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
b205bba0-1870-4458-9088-8817e20389fe,female,Alive,1969,Stage X,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
ef1b3332-cd7f-41bb-a2d3-2538e7becc5c,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
623befd6-0ca4-4a6c-9cf5-d9385c3b718f,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
b6633c36-7ce4-4b69-9bf6-30b64d46c66f,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
b95eef8a-205f-4cf8-9d3c-ae51d406e1e0,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
e7bae6e7-f779-449d-92b9-66996041e00d,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
31427699-e27a-4035-8925-6d8d6900d097,female,Alive,1968,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
757df7b0-4774-4493-98bf-999ded9ac86e,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
8c51bbcb-7c8d-47ad-9193-70ca157c6900,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
b95eef8a-205f-4cf8-9d3c-ae51d406e1e0,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
6f0fd68f-ed6a-4c9e-be02-c97ba4950f76,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
cf0e7e4e-b857-4db5-9ae2-551a899f77be,female,Alive,1941,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
1be375fe-5ae5-4e75-a729-69f86a661d9a,female,Alive,1960,Stage IIA,Tubular adenocarcinoma,"Pharmaceutical Therapy, NOS",2013,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
9938ce5c-e74e-446e-a932-f096f85cc3b1,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
5cdae21d-eee5-478f-932a-0f51fcf5f031,female,Alive,1951,Stage IIIC,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2007,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
02bed00f-bef7-4fb7-b243-540354990e45,female,Alive,1954,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
6f89509c-f802-482e-b4da-94553aa76fe9,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
1d75e89d-4b01-443c-be54-749c7a667bf4,female,Alive,1948,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
b7f74ae1-6f58-447c-be50-a7666eb19d9a,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
c744fc13-3aca-4245-9e24-abd368cc8bef,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
546248b0-22a0-4b70-a437-76fb0a238a0d,female,Alive,1951,Stage IV,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
89414e79-7f89-42d9-8228-101b5bf2f31f,female,Alive,1963,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
01eef340-598c-4205-a990-cec190ac2ca5,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1996,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
2779fa01-ac93-4e80-a997-3385f72172c3,female,Alive,1937,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
3efa245d-177d-4ef9-94f7-f554c54e345e,female,Alive,1925,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
9536bec0-dae0-4d63-a1b3-956741835243,female,Alive,1938,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2009,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
910655da-2c12-4572-96b7-ded616e69b4b,female,Alive,1968,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
0c23c380-363c-474d-b64c-b47f612a8225,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
b094e8b2-8ece-4b36-8025-18073a8b873c,female,Alive,1964,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2002,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
e5aae05a-478e-4a55-a27c-12b2b4be302a,female,Alive,1972,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
88cd6ccc-70f7-436e-a99c-039b9d31e335,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
89c128b9-1c6b-4c04-a4af-7066772e783c,female,Alive,1966,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
a4903de8-6cf5-4541-8ec7-065beace8b44,female,Alive,1946,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
298d33da-15af-48cb-b30f-eaf54e7baa43,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
b205c89f-af62-4186-acad-ed23d243fa98,female,Alive,1962,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
a2434f47-2168-47d0-9bbb-981071597843,female,Alive,1962,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
ac6d3ba9-f84f-4657-aa85-4d66fb7c09da,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
b5b99291-507e-4b68-a039-9a0f571f55df,female,Alive,1939,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
a2db9dd1-44d5-48b5-817c-a21a85fadb21,female,Alive,1967,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
0a017f15-1c6b-45e7-8d55-e0a71df1b2e8,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
02e6f999-24f2-4ad2-9b92-df3ee2b082e5,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
33fe5833-d7a0-43d7-a03d-56985ea448a6,female,Alive,1941,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
92654f8d-5137-4ffd-aaa3-5ae38eb88226,female,Alive,1958,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
71f97b63-c970-44ee-98c2-e02e663d5a40,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
15ff4b02-bb69-4d24-8a07-b82f428e428d,female,Alive,1949,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
271404de-24e8-43f6-806b-fb510c1124c4,female,Alive,1941,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1998,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
e0929c47-cff3-4518-a188-8764af01073a,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
6ddaee34-46eb-490c-bd13-f0ab963c4322,female,Alive,1940,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
7e9c8d3c-790c-46ad-8f31-b557b7c26f69,female,Alive,1967,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
ef1b3332-cd7f-41bb-a2d3-2538e7becc5c,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
ff0f875f-113a-4c0f-8c0a-4259cd496e6d,female,Alive,1952,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
f2622cdb-ac92-42b3-a1ca-67e133c3dd4a,female,Alive,1943,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
e36e985d-2c44-4e14-854a-7dbca4bb0304,female,Alive,1933,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
0b0f9938-ce1e-4814-8821-0132d137eb9e,female,Alive,1959,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2013,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
378778d2-b331-4867-a93b-c64028c8b4c7,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
24334ac1-28a3-4b61-b590-3f51e375b247,female,Alive,1929,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
b379bfb8-284e-4300-8325-85cfd6809cb8,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
31c31cce-1b4d-4f12-922f-84f389403170,female,Alive,1938,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
9d876f05-5080-4c4e-9bf5-45f631d381e5,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
fb3607eb-858e-4ecd-8477-95140658c6d2,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
0b0f9938-ce1e-4814-8821-0132d137eb9e,female,Alive,1959,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2013,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
b304302a-f2b9-4cd7-ab14-c21edf7778ea,female,Alive,1952,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
33cea538-4c3f-470a-972d-257c43241ab4,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
2dc1cec9-925a-417f-9e21-3c2143e711b4,female,Alive,1924,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2004,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
bfa3dbc0-361c-400e-8c10-0aca7049fce9,female,Alive,1956,Stage IIIB,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
dc696e3c-f448-468f-a576-f4429be0338a,female,Alive,1945,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
f3ba71f9-25f3-4784-bf2d-3aa522a0cba8,female,Alive,1938,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
ba39bfbc-5cac-4f6c-b55c-4eee3466ee93,female,Alive,1943,Stage IIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
4229e432-6ac5-49d2-b58a-e8713ddb79bd,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
14267783-5624-4fe5-ba81-9d67f1017474,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
1557183c-aedd-4df6-b98a-3654667f7b69,female,Alive,1924,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
b6c286c6-2755-419b-87d3-59c7feda9653,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
dc15a8ae-991e-421c-bc70-70e94f79dd17,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
e9f4f373-37a5-48ad-a1a0-b0d47820111a,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
d48e9f25-f083-4f88-a92d-c12d9f765ba6,female,Alive,1962,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
28e9048a-e540-42de-a1f4-4ef894fccc4c,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
7e9c8d3c-790c-46ad-8f31-b557b7c26f69,female,Alive,1967,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
43b3bf47-7313-4dfb-952a-ec0b9d48e16c,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
9c55032f-4db7-4026-ae83-8d060dd8e3fe,female,Alive,1952,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
2c86c3ea-d926-4d39-a5ae-39ece4774287,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1995,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
4da7abaf-ac7a-41c0-8033-5780a398545c,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
995fdab7-7284-4d33-befa-ec22aa7c6479,female,Alive,1952,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
de531604-bd1a-49df-96c2-6de3ae703f1d,female,Alive,1924,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
6412854a-f874-469e-9d1f-8bd3ae5bd41d,female,Alive,1956,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
97677fd7-8523-48c5-a8ce-614fd4010551,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d5e655fe-3fbc-47b0-ba23-1d1dd01d591c,female,Alive,1942,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
214a4507-d974-4b3e-8525-7408fccc6a0f,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
2779fa01-ac93-4e80-a997-3385f72172c3,female,Alive,1937,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
4229e432-6ac5-49d2-b58a-e8713ddb79bd,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
58090433-d8d1-4499-a235-810c3e9d5b74,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
2dc1cec9-925a-417f-9e21-3c2143e711b4,female,Alive,1924,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
887b9e5b-99db-44ac-9c30-c0dc6877b41c,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
e68ebfd4-3688-4caa-9e38-7764f9258c30,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
b2ecbc0f-2c30-4200-8d5e-7b95424bcadb,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
d111c4ab-b39a-4a7c-8d8e-cb342bc10627,female,Alive,1945,Stage IIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
abdc76db-f85e-4337-a57e-6d098789da03,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
b8b6cebc-26dc-43ae-a94a-20da6018f7ae,female,Alive,1945,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
807b62ed-d3f7-4211-83be-754386ff2c96,female,Alive,1962,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
7acf33e7-c386-45fd-8c9a-469600378687,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
606fbc6a-b41b-441d-9401-51e54912bf5e,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
2cb8c866-9296-4c70-a3ea-f9a9b707895c,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
e17c565c-9857-4df3-a352-903b53093c85,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
3558dec7-eae3-4a41-a217-266c6a4535fb,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
2399caeb-ead2-4003-af38-809db4ac2e2b,female,Alive,1923,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
298a1710-deb4-4064-a0f2-da32d43aa217,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
843c8f16-5e59-40d4-9ecc-8a75375156f6,female,Alive,1946,Stage IIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2012,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
5a5f0f48-2b13-4e78-b130-901b85d9a7f3,female,Alive,1981,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
478eb8aa-50b8-4ce5-98e4-d518ede4b174,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
0cf0d67c-2f7f-42a6-94f3-407d0ec46c88,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
8cf54607-01ce-42b0-9bd9-8627edd9f3b7,female,Alive,1958,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
9d8702e1-1a36-4bca-85ab-5f11d58d7953,female,Alive,1963,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
8332806e-f547-4aae-89af-6d5bec831fd2,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
d7195183-9fe4-4b17-bcfd-9367d2e539ce,female,Alive,1934,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1995,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
67c8dc41-edcb-4563-96b3-3f93f9edcbe9,female,Alive,1948,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
43cc074d-b85a-4b0b-8feb-833094ffc565,female,Alive,1951,Stage IIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2012,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
6b923e30-2ddc-407f-91b1-c202f1373fbb,female,Alive,1930,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
42e47f3a-dff7-41e4-8f84-146d97e8ab72,female,Alive,1930,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
02bbb632-0f7f-439d-b8f0-c86a06237424,female,Alive,1944,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
c5f00132-1c6b-4337-af6f-596c652665cc,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
f45210d3-9e66-4f5e-bef1-5ee5547cc893,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
ac6d3ba9-f84f-4657-aa85-4d66fb7c09da,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
6014a582-d22e-46e1-9000-c8e2fbad7acf,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
753d5d49-3b40-4737-9d4c-b1ec29cc2692,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
6a186809-3422-41d0-83d2-867145830936,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
8f912a40-3251-4e1f-ae65-1f93d71f9881,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
17baef7c-d97d-4b98-ab53-503ef856523d,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
43d5632e-7272-4aad-9496-7f5a99671223,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
2c90d5e3-ac8c-4c86-a06f-42ccc064eb49,female,Alive,1929,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
8e159b50-8136-42d4-b9c7-d579a74e4931,female,Alive,1961,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
f5d4c2d3-cc69-4b38-8551-0917e3622a68,female,Alive,1940,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2005,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
e98b69bc-766a-485f-b5e8-9166b8d457b3,female,Alive,1933,Stage X,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
69a68fbc-e43d-4652-85ee-693211bded47,female,Alive,1969,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
bfd49783-1767-469b-9d79-7822301c5efc,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
f5d4c2d3-cc69-4b38-8551-0917e3622a68,female,Alive,1940,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
baf5e81f-2322-41ec-9053-b9559a7993bc,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
d6f7afc0-1558-43ad-acb1-2b5311ed2264,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
00807dae-9f4a-4fd1-aac2-82eb11bf2afb,female,Alive,1955,Stage IIB,Apocrine adenocarcinoma,"Pharmaceutical Therapy, NOS",2005,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
478eb8aa-50b8-4ce5-98e4-d518ede4b174,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
2680da86-c977-4611-b75f-df015283c023,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
8c51bbcb-7c8d-47ad-9193-70ca157c6900,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
0d146997-cfdc-4587-888c-e876fc455c80,female,Alive,1962,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
db62d9c7-8343-4771-84fc-146d2e307bb8,female,Alive,1961,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
57af5c72-0d60-4a6b-b1b4-ec6dab90f80f,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
048549cf-d0a5-4743-a0a1-2004f7cc2b08,female,Alive,1965,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
eb93df3d-9e25-4e4c-9a5d-350f296e5acf,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
ab89bb2e-da84-4116-a8cd-49aad7bbfd4d,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
9d8702e1-1a36-4bca-85ab-5f11d58d7953,female,Alive,1963,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
16fc3677-0393-4ed1-ad3f-c8355f056369,female,Alive,1947,Stage IV,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
cdab777e-62de-4d51-92af-b6eb089c111f,female,Alive,1970,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Pharmaceutical Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
a45d296e-efc0-479e-b2f6-bad834668cdf,female,Alive,1938,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
2e82e576-3095-4aee-9853-65f676647c34,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
86cf879e-3b40-44dd-aaa7-6f49f54a15d9,female,Alive,1946,Stage IIA,"Papillary carcinoma, NOS","Radiation Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
791c5768-f0f5-4ab6-86eb-998e5c4b49e3,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
cf0e7e4e-b857-4db5-9ae2-551a899f77be,female,Alive,1941,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
dcd5860c-7e3a-44f3-a732-fe92fe3fe300,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
ce9e0309-9756-42d2-ae94-d91264a79498,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
99e32c59-aa73-43fa-88c9-399ddadb2c72,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
f954de05-1b44-4087-8933-6cc72d81028d,female,Alive,1965,Stage IIB,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
8e11c5ec-c15a-48d4-85ac-b7b08a9ed827,female,Alive,1965,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2012,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
bef7b135-a727-45e8-850a-cc4cd56c49aa,female,Alive,1952,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
1557183c-aedd-4df6-b98a-3654667f7b69,female,Alive,1924,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
626b4ff0-2188-4a14-aac8-6703c624917f,female,Alive,1934,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
a6a863d9-b39d-4965-b47f-79a1bcf3c976,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
16368c32-2118-4fcf-8693-6c89995e49d8,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
058dcb78-bed1-40c3-a6c2-a0cc40065531,female,Alive,1972,Stage IB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea,female,Alive,1935,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
9964f447-92ad-4d1e-af20-11cf84fab7b0,female,Alive,1953,Stage IIIC,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2008,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
dfaabd03-2d40-4422-b210-caf112ff4229,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a06ff6ae-b0dd-4516-a75c-0db71694b46b,female,Alive,1961,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
57cf380d-ab52-467f-b9ae-740b2f84c820,female,Alive,1971,Stage IB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
161917b8-88ad-407b-ade6-d6b98478b359,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
33b7bf50-53f4-4839-aa83-9665f85671d8,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
fe2cd610-aa52-4789-ac62-7683281bb22f,female,Alive,1978,Stage IV,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
f55dd73d-8c36-440b-84e5-9aae53107775,female,Alive,1951,Stage IIA,"Basal cell carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
2d29a4ac-98e7-4663-9dd6-5681bc32ac2e,female,Alive,1956,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
dd3bfb26-b534-4917-9c4d-9fe7b6477762,female,Alive,1968,Stage IIIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
cdd8c046-fd97-482a-a11f-2217b321c4d1,female,Alive,1964,Stage IB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
4d51159f-ab2f-40e3-a363-847c3654431e,female,Alive,1920,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
3aaabc62-f5a4-4025-9b29-5adf82c86c84,female,Alive,1926,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
83f943c7-3975-4b4f-985d-9c057741793b,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
f0d8a1fe-e313-44f1-99cc-b965cbeeff0e,female,Alive,1963,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
7861a5f2-8910-4bcb-9c34-f79c5acd6e21,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
64089c20-939f-48b4-ae8b-904ad0597145,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
2bcacfd1-6a45-4b96-9b80-2ad569b1ab45,female,Alive,1931,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
444374f8-9282-439c-af00-0f828edcbff3,female,Alive,1970,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
c4699748-f01d-4b30-9c74-1ca77fb84ac1,female,Alive,1974,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
38dc3e09-0b0e-4a29-b318-cc0352013dae,female,Alive,1968,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
fb356957-f620-4d99-b675-1355a1d9f932,female,Alive,1932,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
4e509f73-99c7-48eb-a3a4-d34e3bface33,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
04af44fc-c487-4005-b3cb-cb64815824a2,female,Alive,1935,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
2e8e70f2-c781-44c2-8f12-1f8c2f536aa3,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
01263518-5f7c-49dc-8d7e-84b0c03a6a63,female,Alive,1933,Stage IV,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
58959e88-54e2-4558-9664-2effda7403dc,female,Alive,1960,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
2b36853f-34d3-47c5-ba6a-e5a93233d2b1,female,Alive,1957,Stage IIB,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
d5be2ab3-f748-480d-954b-385cf01b4c81,female,Alive,1975,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
f4b69043-4a67-48e3-a4d1-72a21ae2d175,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
4da999a0-ef41-4a0b-b1d1-446b39cc855a,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
ba89cb4f-cd63-47b1-9550-76fdaff89f2e,female,Alive,1970,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
2192c1db-4718-4254-ba42-3ae7f30ad5a8,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
2e538802-2a31-4774-89a8-c6e4381a887d,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
9d876f05-5080-4c4e-9bf5-45f631d381e5,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
35bd694d-1dd2-466f-ab27-03320614b40e,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
e0b1bcd2-1139-44b9-98b3-67bcf92bcc39,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
a82d0a57-4383-473d-b334-d13b278404b1,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
427d0648-3f77-4ffc-b52c-89855426d647,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
28911b97-42bf-4189-9961-522fc0aeebc6,female,Alive,1930,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
dbf6f981-15cc-40ad-91ac-a66360405fbd,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
d7cac141-9269-4733-83ce-e1bc0b503254,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
2e82e576-3095-4aee-9853-65f676647c34,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
2481a671-760b-428c-968d-42e25fd42ac5,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
5b2a4f11-ca46-4974-9420-59b4820920bf,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
0dd8dbc1-c48b-4e7c-b401-57101f724967,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
5fe3c51f-65e2-4da6-8924-a6fae17c022d,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
9ddc014d-9a8b-407b-845f-452a73f08e5e,female,Alive,1950,Stage IIIA,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2012,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
ced2c048-b047-43ff-b0e7-cd7ad480850c,female,Alive,1945,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
4d120899-9a80-4736-b097-285e9e261bcb,female,Alive,1926,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
67c5f371-3fa9-47c5-8b15-c2dd9acc8519,female,Alive,1953,Stage IIB,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2011,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
c49e3b18-fd88-48f4-8b01-300692ceb367,female,Alive,1928,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
8ace3b8c-f23e-48a9-a137-9e046bd9549b,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
02f5ae33-a563-4ecb-9e33-dfa500a44931,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
60df7543-6da5-4c75-943b-5800c1e08234,female,Alive,1954,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
f3ba71f9-25f3-4784-bf2d-3aa522a0cba8,female,Alive,1938,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
af97e043-88cb-4f99-8f8b-9bcbcccdf842,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
c2aeee6c-ba10-4cf9-b560-c739580f7bf3,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
011b9b2d-ebe5-42bf-9662-d922faccc7a1,female,Alive,1939,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
13b860c3-8048-4dc9-9eb0-7480bc660837,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
2399caeb-ead2-4003-af38-809db4ac2e2b,female,Alive,1923,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
59d60247-e549-4326-a672-50b05c13a291,female,Alive,1958,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
65cac997-4d39-4501-85ec-4fcb328a8eb5,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
abdc76db-f85e-4337-a57e-6d098789da03,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
6020d1b4-ee20-4cc9-82a3-340b5e3122f1,female,Alive,1962,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
125b0a9a-6cbe-4207-9178-e7ff03487e87,female,Alive,1962,Stage IIIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2005,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
e36e985d-2c44-4e14-854a-7dbca4bb0304,female,Alive,1933,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
d34471a1-b367-4f8a-b35a-c5901c4f5503,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
ad7fcc89-82a3-48aa-8461-581c1a857677,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
e3c336f5-c32f-4c5d-81fb-e2408ae145b2,female,Alive,1931,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
f3cb557d-23e4-4fd1-81ca-db1a3f56d56e,female,Alive,1978,Stage IIA,"Medullary carcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
b8a44fdf-9cb9-4123-9ab0-4bc198921fee,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
44bec761-b603-49c0-8634-f6bfe0319bb1,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
6ffd1b8c-6f0b-456a-9160-e0c8021e5897,female,Alive,1946,Stage IIB,"Phyllodes tumor, malignant","Pharmaceutical Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
084c6aec-94f7-4090-8f3f-59fa9e89721a,female,Alive,1932,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
b35fbe19-0e6d-427e-b9be-ee3527b5fca6,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
6ffd1b8c-6f0b-456a-9160-e0c8021e5897,female,Alive,1946,Stage IIB,"Phyllodes tumor, malignant","Radiation Therapy, NOS",2013,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
0c23c380-363c-474d-b64c-b47f612a8225,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
56203436-8634-4fd0-96b5-ba6be9d87857,female,Alive,1920,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
96f02be7-f2df-483c-8968-a5bd2d887206,female,Alive,1924,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
d8d7a6c2-6427-4f47-968c-6c3affba4617,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
316625b8-a217-4829-90d1-dfd9cb7e4bc3,female,Alive,1974,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
a412b374-4d25-491f-b76f-ddaa989acf59,female,Alive,1949,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Radiation Therapy, NOS",2012,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
3886b4fb-ba22-4a50-b11a-a6893951f170,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
cc0902fd-a2fc-4327-929e-d4219e32e1d7,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2002,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
32861b48-83f5-43a3-bb54-45215ad2c5d6,female,Alive,1964,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
ebd1512a-4865-4193-97b3-f599d555759a,female,Alive,1954,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
4842bac3-abaa-4900-871f-f2c3ba6457f5,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
539bbbed-43fb-4fef-9c67-6406f58b186a,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
6644fd4e-d2fe-4785-a73c-0f36fcc740e2,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
02e6f999-24f2-4ad2-9b92-df3ee2b082e5,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
d67cd793-2931-429a-9084-2f3c4c8be7ad,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
3b1f7e48-216d-47de-ba79-db350f52bff0,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
444374f8-9282-439c-af00-0f828edcbff3,female,Alive,1970,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
6f6e7356-3521-4674-8eec-ad01340d4b8e,female,Alive,1935,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b,female,Alive,1970,--,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
9e3de467-fb0d-4021-89f8-b34968a7c7bc,female,Alive,1960,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
dddd8e2f-e540-418a-b02e-698d18a12c14,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
88db1340-e4bf-451a-87c0-6e9168296f5e,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
92b842c5-f71b-4ef7-ba86-358d28e0966f,female,Alive,1936,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
24046547-d038-4616-b190-52ac93f4965f,female,Alive,1937,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
f83b866b-0b2e-4bba-9367-be6dccf56232,female,Alive,1934,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
5dc1bee9-c44d-4fdc-9ae5-83426c4d6880,female,Alive,1979,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
80f3f48a-cc21-415c-b181-c77e7ba1c563,female,Alive,1940,Stage X,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
733a2a0f-b37a-4b81-b49e-3c0f30d1eb37,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c,female,Alive,1944,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
fa176764-a76f-44c7-b97a-cd6d21e052be,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
0130d616-885e-4a6c-9d03-2f17dd692a05,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
2a84997d-ccee-4f46-bea2-752534f26416,female,Alive,1935,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
79126e88-9cf8-45ff-bf91-a98da3b304d7,female,Alive,1961,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
d5d8e76e-2f2a-49bc-ba0a-d51283611b16,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
cd781589-3820-45a2-906b-8d60cd02f3ef,female,Alive,1940,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
62d70067-ff77-4f95-8b69-f537abaf74ce,female,Alive,1933,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
796b593f-5886-4a27-bf94-7ea8df325e1a,female,Alive,1971,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
9fefbe7c-f66a-4940-843e-285cb7b392c1,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
be9bf36a-12e1-4386-addf-1686dc8b49de,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
9ce7ce09-4409-4fa3-9f78-b2b24716f860,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
a9bb8159-32f0-454c-a946-b3286a52b9d5,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
67eef990-5ff4-45d1-843d-d22d7848f130,female,Alive,1932,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
e7a00d67-2c26-4d1f-bd17-35f659e88bc1,female,Alive,1951,Stage II,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
a4c59287-1ad5-46a5-8040-e591e6ce064f,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
f2da1d3f-f226-4c99-a97e-9b26f67d7a5d,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
7eea2b6e-771f-44c0-9350-38f45c8dbe87,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
48ff0420-0f19-4e9d-a75d-6c54949a461a,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
eebad74f-5961-4e91-b0eb-157a2f6f952b,female,Alive,1956,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
a45833e1-7cc9-4273-b408-620f74679a12,female,Alive,1973,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
c57835be-77ab-4cf5-9b23-62c11a7b2eaf,female,Alive,1935,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
12d31787-e54d-4729-ace8-9141043c92b8,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
65077db7-dd59-4362-9d28-d5a9154e9be0,female,Alive,1949,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
ad6d26ab-6568-40db-bfb0-394d40e801cf,female,Alive,1949,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
e7db08a7-b439-4230-8dc4-1b54af4736c4,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
af97e043-88cb-4f99-8f8b-9bcbcccdf842,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
d7808cbc-4b8c-467b-b2c3-f48d05b9ecab,female,Alive,1928,--,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
f062cbd0-2426-40ac-a4be-e74ac61fa2a7,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
8cccf160-93e9-48a5-9b8b-54aa50153142,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
64975923-d032-4182-8565-59fc37127d8d,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
4b0d295c-e185-4b52-9752-178e5bc1d47d,female,Alive,1945,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
c7d7a770-23c0-4310-ab48-1f6152dc2849,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
0b23b5fe-6c7e-4297-bc55-f93fcb830ac4,female,Alive,1970,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
b205bba0-1870-4458-9088-8817e20389fe,female,Alive,1969,Stage X,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
23c31c2e-336c-4878-a476-cf8d811b4875,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
d69e59a8-b10b-46f5-b859-b6c178d90506,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
d2694b09-7844-4496-865c-5d3d8cd03330,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
7f2a63e6-64d5-4be1-9814-e8416fc9e688,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
cd3faa15-743c-476f-ab0d-f205b14126b6,female,Alive,1954,Stage IIIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",1996,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
5ed024e8-d05e-4c65-9441-eda9930ccc82,female,Alive,1960,Stage IIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
17d9e646-6ab3-40b3-a0bc-2c834d3c3213,female,Alive,1968,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
016caf42-4e19-4444-ab5d-6cf1e76c4afa,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2002,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
2c04a2f5-321e-4dea-8e00-268325da65cb,female,Alive,1932,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
6e6b7742-a562-490b-bb72-04a5653852e4,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
f0787165-6f58-4d67-b510-928eea2c4882,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
73ccc949-01b7-48d3-a7c4-c4bcd261672a,female,Alive,1964,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
bac4b268-c781-4408-96d8-43a48fec7418,female,Alive,1966,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
ac18b3a3-8d52-4e35-8625-673171a7fd92,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
81b70c58-4a12-448c-a594-2ade44f6a0ae,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
1d38d356-d126-4476-94d0-26616b9375b1,female,Alive,1968,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
e74aea7c-ca14-49df-b5cf-dacb839ac27a,female,Alive,1950,Stage IIB,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
6cd9baf5-bbe0-4c1e-a87f-c53b3af22890,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
bdd08ec8-8892-4273-8f21-6fde0f23c52d,female,Alive,1937,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
8744733a-7b46-43aa-bdef-64876816adbb,female,Alive,1949,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
6fa2a667-9c36-4526-8a58-1975e863a806,female,Alive,1928,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
e4fc0909-f284-4471-866d-d8967b6adcbc,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
d34471a1-b367-4f8a-b35a-c5901c4f5503,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
b7f74ae1-6f58-447c-be50-a7666eb19d9a,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
6cd9baf5-bbe0-4c1e-a87f-c53b3af22890,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
1a18974d-967c-4727-b42e-12ae7be66589,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1988,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
96b9c7db-1be1-4b60-b47c-26b654c3d64c,female,Alive,1953,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
1be375fe-5ae5-4e75-a729-69f86a661d9a,female,Alive,1960,Stage IIA,Tubular adenocarcinoma,"Radiation Therapy, NOS",2013,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
cf9db1af-17f0-490e-8139-142bd704763a,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
cd0c96a4-6414-4efb-879b-7408b62ed5b6,female,Alive,1936,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
17c1d42c-cb84-4655-a4cd-b54bae17ecaf,female,Alive,1952,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
9c895825-d6f6-4d14-a662-23212200f6e5,female,Alive,1946,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
aa4244a8-0454-4247-a1c3-357fd51746fa,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
70fc011c-0f22-4026-9d72-87351126203a,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
97b5f490-1cd9-4833-b903-5f4c6e45670d,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
bd5374c9-7f36-457f-b66b-7cc7ff64224e,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
a4903de8-6cf5-4541-8ec7-065beace8b44,female,Alive,1946,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
752ad011-79e0-494f-9868-98bf6feb28f8,female,Alive,1970,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
dbcad60f-86c7-41e3-b0ae-baa39c9f83dd,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
418c11e8-2670-48d5-bbf5-95b46bff1201,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
7b605fb6-d077-401e-b870-b87ddf505f82,female,Alive,1929,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
09a5e9fd-d816-4f8c-baa9-0e40ba607b16,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
dc11b1c7-1f00-4813-b4b5-ecf776b2eb37,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
96312510-c126-485d-8109-ed81844a1dc3,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
67eef990-5ff4-45d1-843d-d22d7848f130,female,Alive,1932,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
3b963d72-ba5c-467b-83c9-fbdb462510a3,female,Alive,1920,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
d9dc3b59-613d-469e-8b4f-6c5a557eb26a,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
f51af6db-2655-47fb-9ffc-83a503a728ea,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
16368c32-2118-4fcf-8693-6c89995e49d8,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
4b620966-b4c7-4615-bf58-ca9d3226b9bd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
09d6e904-7184-4788-8a19-04f8c46cb13f,female,Alive,1960,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
c25898b4-eb33-42f4-bf3f-bf532a929e7d,female,Alive,1962,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
f9eb88f7-9293-46bf-ace4-a746e4ff80dc,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
87e09544-eddb-473b-8617-212407ce644e,female,Alive,1972,Stage IB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
49dc3e68-6206-4f16-969f-a758cc7be8ed,female,Alive,1955,Stage IIIC,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2006,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
c5891c7a-fd24-4891-8f51-373967e4a6dd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
dd96a9c7-899c-47cd-a0f9-b149ed07a5d6,female,Alive,1956,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
af577366-0258-49e7-b6af-e70056c081a4,female,Alive,1953,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
4842bac3-abaa-4900-871f-f2c3ba6457f5,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
67c73260-a242-4bba-87c5-d2302556dff7,female,Alive,1961,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
75b5529b-565a-4eba-918a-910b2f441d32,female,Alive,1925,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
5dc1bee9-c44d-4fdc-9ae5-83426c4d6880,female,Alive,1979,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
b0700958-5f90-4546-b35f-635cd506889b,female,Alive,1942,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
5e4187c9-98f8-4bdb-a8da-6a914e96f47a,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
65077db7-dd59-4362-9d28-d5a9154e9be0,female,Alive,1949,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
e7db08a7-b439-4230-8dc4-1b54af4736c4,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
e89a9deb-6321-4e61-b412-b4993d4277dd,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
a0576d44-9add-429b-9eeb-f7b234b7385f,female,Alive,1974,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
327a2395-85c8-42e1-9638-8e037a1723ed,female,Alive,1947,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
58c56d4b-3f85-4aad-a779-5f9e1791677d,female,Alive,1931,Stage IIA,Pleomorphic carcinoma,"Pharmaceutical Therapy, NOS",2006,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
2c86c3ea-d926-4d39-a5ae-39ece4774287,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1995,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
89a8da07-4487-47c6-8d3c-442a87e4f632,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
91b09291-5944-4691-a0d8-7d1ccc649b9b,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
8240c4ae-f878-4882-aa07-7857c7ac52cf,female,Alive,1965,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
91da548b-5c64-49c3-a44a-1ef115f53311,female,Alive,1928,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
71229981-97c2-4ae1-a130-fe5de336b37d,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
c02699b5-580a-4d55-971e-f4692b2cce57,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
dcb68327-1537-4ca6-81de-3910d0663cb8,female,Alive,1964,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
3afa1e93-1df8-4e4c-aaa4-557463f4bb77,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
65cde5d5-1efc-4e30-b1bd-a93598794f2c,female,Alive,1948,Stage IIB,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
2e32f31f-9817-4935-b259-96c59936ee33,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
80f3f48a-cc21-415c-b181-c77e7ba1c563,female,Alive,1940,Stage X,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
81e32f39-3aa0-468b-87ed-dd2eb6165ddf,female,Alive,1953,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
96f23d8a-be0f-4925-ba00-805dc293414c,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
e828455d-4680-41b2-8a1c-1582e3790d62,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
408cb583-6dc3-4698-8bd2-e284042bd5ef,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
55262fcb-1b01-4480-b322-36570430c917,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
1ff85ada-3cdd-4afb-b311-2c7befb52702,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
a0576d44-9add-429b-9eeb-f7b234b7385f,female,Alive,1974,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
324bcba2-f6a4-45a6-807c-215bdffcca21,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
36220587-1c1c-4f92-b177-3b2155e7e273,female,Alive,1968,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
733a2a0f-b37a-4b81-b49e-3c0f30d1eb37,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
36d77496-99f8-4911-ba7c-89fae32662aa,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
378778d2-b331-4867-a93b-c64028c8b4c7,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
2481a671-760b-428c-968d-42e25fd42ac5,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
a855c228-a263-44df-87a0-cbc32187e3f5,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
a1da9db1-db11-4f4d-a249-c738db81b87e,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
2585edbd-3488-4100-a4ab-a161252a31ee,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
8a0ef221-8070-43fc-9d98-def90abe4871,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
521e2140-ae5b-456f-8699-97398d009687,female,Alive,1966,Stage IIA,"Medullary carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
e7bae6e7-f779-449d-92b9-66996041e00d,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
726c6892-0dce-4869-a7a7-cc44c26fe843,female,Alive,1964,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2013,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
a2934508-3daf-49e2-b14f-ed9b7693f96f,female,Alive,1956,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
389e5b18-8f89-41a9-9fa5-efd4172836e2,female,Alive,1959,Stage IIIB,"Medullary carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
2c04a2f5-321e-4dea-8e00-268325da65cb,female,Alive,1932,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
4e3699da-4367-4a43-9d66-a117d3ad460d,female,Alive,1942,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
5ea18514-51ad-4844-abea-15e82f0b10c9,female,Alive,1969,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
59bf0ce4-715a-4017-bccb-c59916e78324,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
d7195183-9fe4-4b17-bcfd-9367d2e539ce,female,Alive,1934,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1995,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
64d4dfae-8d91-464b-adc3-80ba7caf54ae,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
c694615c-b1c6-499c-8058-995633ebf948,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
2b22db1d-54a1-4b9e-a86e-a174cf51d95c,female,Alive,1952,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
9ced0c70-c46c-4f98-8f48-840defe4b8b1,female,Alive,1950,--,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
33b7bf50-53f4-4839-aa83-9665f85671d8,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
5e2cbc56-97f9-4b94-ade2-a3f739bcc7be,female,Alive,1930,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
a6502f17-6bee-4d5a-8520-06364593d39c,female,Alive,1961,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
a32cb96a-78bf-456e-a6ab-2d47b2c67ad4,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
ba89cb4f-cd63-47b1-9550-76fdaff89f2e,female,Alive,1970,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
38a8b734-9acc-42f9-b5b7-e51b0dfc6504,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
06ef6e83-5583-45b9-a0bd-edea68943083,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
13ca97a1-75bb-4a49-b8c3-181e5b2c9e86,female,Alive,1953,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
b58ad350-5140-4fa8-bc2c-24bca8395f3a,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
22b35927-1c3f-4f98-ba42-deafc56b677a,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde,female,Alive,1922,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
7f2a63e6-64d5-4be1-9814-e8416fc9e688,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
eb93df3d-9e25-4e4c-9a5d-350f296e5acf,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
8a0ef221-8070-43fc-9d98-def90abe4871,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
54883111-d475-4515-ba3f-fece8a71e79e,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
e783e518-c1e5-4eac-8eaf-e2d65ccd9692,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
2021ed1f-dc75-4701-b8b8-1386466e4802,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
8744733a-7b46-43aa-bdef-64876816adbb,female,Alive,1949,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
d81594d9-dd6a-45c3-8bad-61960611d78d,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
ed6cef77-1bd9-4e3b-b576-550a91e4253a,female,Alive,1972,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
9da462b0-93c2-4305-89f6-7199a30399a7,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
b2ecbc0f-2c30-4200-8d5e-7b95424bcadb,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
70ab4f23-23c4-409f-a5cc-18a010c3a24e,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
ac075bc0-1b59-4557-beea-541694faee03,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
4f321d41-3255-46a4-ae0d-1cf39699e624,female,Alive,1938,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
3a711140-1b89-4611-9992-3861e3d0e01a,female,Alive,1943,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
d7308344-5bab-4073-bb4f-4d8cd8d7bd17,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
81b70c58-4a12-448c-a594-2ade44f6a0ae,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
1285eb55-415c-494a-aa58-936f0427cdd0,female,Alive,1934,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
e0b1bcd2-1139-44b9-98b3-67bcf92bcc39,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
a8a33ba9-0976-4e19-b0e9-fa5ba4d4eaa8,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
22eaba28-be67-4730-9846-860bc1fca29a,female,Alive,1955,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
7486a2b3-b09f-4e9c-9864-8b51b58d9fb3,female,Alive,1964,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
f4b69043-4a67-48e3-a4d1-72a21ae2d175,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
b3354b72-2637-4edc-9a95-e55801d3ac13,female,Alive,1976,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
2e32f31f-9817-4935-b259-96c59936ee33,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
2c90d5e3-ac8c-4c86-a06f-42ccc064eb49,female,Alive,1929,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
77e25ae8-82ec-4dea-8e62-1176f27e47ba,female,Alive,1957,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
7d681cc6-689d-41c8-9e84-e13733089ec9,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
dd96a9c7-899c-47cd-a0f9-b149ed07a5d6,female,Alive,1956,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
b4e4fea2-b802-4a86-923e-3fcbd3c708fe,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
c632675e-e8af-43cd-8744-5be3754c1c14,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
6623fc5e-00be-4476-967a-cbd55f676ea6,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
64d4dfae-8d91-464b-adc3-80ba7caf54ae,female,Alive,1955,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
c0b7b798-3383-4a45-a455-9eca5810739e,female,Alive,1951,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
7f97971b-2818-4e4b-9c9e-7c0246f9484c,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
8360cec6-daf6-41c9-9a4f-7fc03c958dcc,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
bfa3dbc0-361c-400e-8c10-0aca7049fce9,female,Alive,1956,Stage IIIB,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5a17dcd9-5ced-4a69-8069-23c7fd0649d1,female,Alive,1959,--,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
dcd5e079-813a-4c1a-b320-0931468d2bbc,female,Alive,1931,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
f2e28af9-c40e-41c4-9e82-205cca38f26a,female,Alive,1940,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
8cccf160-93e9-48a5-9b8b-54aa50153142,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
b379bfb8-284e-4300-8325-85cfd6809cb8,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
83f26720-007c-42c9-a7de-7484bf8afa89,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
fb57c598-b45b-478a-9d34-ca1f050d5b7c,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
9f93ea0a-1687-44e0-9e8a-eeb4097d471c,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
34a74805-300c-4773-ab59-2085fcc2e6cc,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
3d676bba-154b-4d22-ab59-d4d4da051b94,female,Alive,1983,Stage IIB,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d9dc3b59-613d-469e-8b4f-6c5a557eb26a,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
b2aac45b-2073-4c7a-adb9-769a4fdcc111,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
09a5e9fd-d816-4f8c-baa9-0e40ba607b16,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
cb0a2055-2168-4454-8755-47dd613db36f,female,Alive,1927,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
a6e11b30-3ae8-4dd1-b04c-a730c6a79746,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
9b13927c-7357-44fd-8385-92ae6a656b7d,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1991,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
ad0fa961-c085-4f38-b3db-5fc0cbf6b64f,female,Alive,1964,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
64975923-d032-4182-8565-59fc37127d8d,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
fd0b1b8b-1a76-480a-b61c-d176e4e02c6b,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
c72cb184-462d-4009-9cdb-848782ff8a76,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
011b9b2d-ebe5-42bf-9662-d922faccc7a1,female,Alive,1939,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
6e7d5ec6-a469-467c-b748-237353c23416,female,Alive,1949,Stage X,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ad6d26ab-6568-40db-bfb0-394d40e801cf,female,Alive,1949,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
cdab777e-62de-4d51-92af-b6eb089c111f,female,Alive,1970,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Radiation Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
6adca853-1b09-47ff-814c-47b732a76d96,female,Alive,1961,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
ac075bc0-1b59-4557-beea-541694faee03,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
fe2cd610-aa52-4789-ac62-7683281bb22f,female,Alive,1978,Stage IV,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
6d24e675-2fa4-4102-861f-7516650b3049,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
a2934508-3daf-49e2-b14f-ed9b7693f96f,female,Alive,1956,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
6644fd4e-d2fe-4785-a73c-0f36fcc740e2,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
4d51159f-ab2f-40e3-a363-847c3654431e,female,Alive,1920,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
cf0a3f38-5850-44e1-8574-808bd37d84a3,female,Alive,1973,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a381275f-8858-4793-a8a2-0ca9db7274c8,female,Alive,1960,--,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
db8d38ab-cc61-49ee-863d-40060112f2af,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
4f321d41-3255-46a4-ae0d-1cf39699e624,female,Alive,1938,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
a8f5c479-8685-4e2d-bb60-63f1cc651083,female,Alive,1942,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
7f0bbba1-9bc3-45db-bdda-eb3319bb15d2,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
43cc074d-b85a-4b0b-8feb-833094ffc565,female,Alive,1951,Stage IIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
82ec33dd-e783-4c74-9a87-797a699e11df,female,Alive,1961,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
d48e9f25-f083-4f88-a92d-c12d9f765ba6,female,Alive,1962,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
e3b555aa-7f0a-49c6-9b13-182c61a144c1,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
3ca67cd0-81da-4f68-a9fa-f1a8c013c28d,female,Alive,1966,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
87f03d04-e651-4a6e-aea6-1c946aa46202,female,Alive,1928,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
0130d616-885e-4a6c-9d03-2f17dd692a05,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
fec0da58-1047-44d2-b6d1-c18cceed43dc,female,Alive,1940,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
01674b2c-5cf2-478f-84a1-f69c39f47bd4,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
0930e97a-72ea-4bd5-b2f0-50c76af695f3,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
89128dba-403f-4a96-bb3b-23ed0d5e2147,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
566792ae-f853-4a47-856d-f02cdcfcb18a,female,Alive,1940,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
887b9e5b-99db-44ac-9c30-c0dc6877b41c,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
0dca98b0-f43e-45b6-9a02-00092c78678c,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
7acf33e7-c386-45fd-8c9a-469600378687,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
92b842c5-f71b-4ef7-ba86-358d28e0966f,female,Alive,1936,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
95e949d3-b1f3-46c6-9451-8fe92c99e4cf,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
35bd694d-1dd2-466f-ab27-03320614b40e,female,Alive,1972,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
65cde5d5-1efc-4e30-b1bd-a93598794f2c,female,Alive,1948,Stage IIB,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
e37ae674-a107-4eb3-94d8-b86b0035a9f7,female,Alive,1924,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
03c143e0-d8a1-4d60-a4a3-df0501fc6b6e,female,Alive,1940,Stage IIIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
a8a199c9-d781-4e6c-af8c-c85d60c7cd40,female,Alive,1972,Stage IIIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
9964f447-92ad-4d1e-af20-11cf84fab7b0,female,Alive,1953,Stage IIIC,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2008,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
e8ea576b-eb16-44f7-b241-daefc1375388,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
f45aa0b2-f3de-4db5-9730-e5c6c4e2ed3a,female,Alive,1972,Stage IIIC,Intraductal micropapillary carcinoma,"Pharmaceutical Therapy, NOS",2011,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
d5be2ab3-f748-480d-954b-385cf01b4c81,female,Alive,1975,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
271404de-24e8-43f6-806b-fb510c1124c4,female,Alive,1941,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1998,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
0772cdbe-8b0d-452b-8df1-bd70d1306363,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
97862b8e-9f76-4b19-a865-156a9c00fb1e,female,Alive,1952,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
f357fe19-5359-4662-8ce9-aa996132283b,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
4c313e5b-4dc3-408e-8e92-22427f74743e,female,Alive,1946,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
ca20249f-b7ea-4fd9-9ecb-34f74755ae35,female,Alive,1945,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
f062cbd0-2426-40ac-a4be-e74ac61fa2a7,female,Alive,1928,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
03565036-b6d3-432f-8d9a-7099818e0788,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
70fc011c-0f22-4026-9d72-87351126203a,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
baf2afc8-f16c-488f-947c-efc9083c6bef,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
623befd6-0ca4-4a6c-9cf5-d9385c3b718f,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
0e1d0d46-7a7b-4538-95dd-b9fc20a15aec,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
49dc3e68-6206-4f16-969f-a758cc7be8ed,female,Alive,1955,Stage IIIC,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2006,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
7d9d3522-ec3b-4efe-8c8e-c0e675276ef5,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
20e8106b-1290-4735-abe4-7621e08e3dc8,female,Alive,1971,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
23dabeef-8e3c-44bc-9a12-a9522d17be5c,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
9848307d-1bd5-40c1-b655-a33297aaf74f,female,Alive,1958,Stage IIA,"Medullary carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
7486a2b3-b09f-4e9c-9864-8b51b58d9fb3,female,Alive,1964,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
a1872011-b928-4189-ac02-e87506c20bca,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
ff0f875f-113a-4c0f-8c0a-4259cd496e6d,female,Alive,1952,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
7d681cc6-689d-41c8-9e84-e13733089ec9,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
2bcacfd1-6a45-4b96-9b80-2ad569b1ab45,female,Alive,1931,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
88db1340-e4bf-451a-87c0-6e9168296f5e,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
4c313e5b-4dc3-408e-8e92-22427f74743e,female,Alive,1946,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
56230e4a-29ca-4f37-a0f9-730dbdfb6fa2,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
2e1e3bf0-1708-4b65-936c-48b89eb8966a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
7451af3c-acc0-4d79-8429-6b8be96911d8,female,Alive,1933,Stage IIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2012,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
c02699b5-580a-4d55-971e-f4692b2cce57,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
c49e3b18-fd88-48f4-8b01-300692ceb367,female,Alive,1928,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
b0700958-5f90-4546-b35f-635cd506889b,female,Alive,1942,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
1347c23d-8d6e-4c15-9461-640249838c96,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
c836951b-3ffb-4e20-8504-0eccb7d50dd4,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
99e32c59-aa73-43fa-88c9-399ddadb2c72,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
5b2a4f11-ca46-4974-9420-59b4820920bf,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
f7ab565c-83b5-4988-b9be-8a46f65dca8c,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
afb9418e-91eb-4db1-aacf-12bd946c9ba0,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
2585edbd-3488-4100-a4ab-a161252a31ee,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
ced2c048-b047-43ff-b0e7-cd7ad480850c,female,Alive,1945,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
8ace3b8c-f23e-48a9-a137-9e046bd9549b,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
408cb583-6dc3-4698-8bd2-e284042bd5ef,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
a20fa2c4-a502-47e3-bfaa-2ec4cce3a859,female,Alive,1936,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
91b09291-5944-4691-a0d8-7d1ccc649b9b,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
dfe6db17-cf45-488e-bd3c-b8433d7343ca,female,Alive,1971,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
2680da86-c977-4611-b75f-df015283c023,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
baf1207d-7d1a-4cad-ba58-62c26be2415e,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
791c5768-f0f5-4ab6-86eb-998e5c4b49e3,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
42378dbc-a123-4cf9-8502-165e89fda271,female,Alive,1980,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
62d70067-ff77-4f95-8b69-f537abaf74ce,female,Alive,1933,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
d5e655fe-3fbc-47b0-ba23-1d1dd01d591c,female,Alive,1942,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
5d688049-f271-40ef-813a-d37240ffe21c,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
67526f5a-3a30-45b2-aeab-2b21a855063e,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
8b525ec6-d24b-49d4-bfcb-b354de4dae7c,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
bd5374c9-7f36-457f-b66b-7cc7ff64224e,female,Alive,1937,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
76ace6aa-0505-442c-978a-f889cf2d44bb,female,Alive,1953,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
a6e5f869-1182-4f81-b4bb-cf55261c8f3f,female,Alive,1955,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
6f0fd68f-ed6a-4c9e-be02-c97ba4950f76,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
d9a1c06f-7b50-46b0-878e-89e8c31863ae,female,Alive,1965,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
cd781589-3820-45a2-906b-8d60cd02f3ef,female,Alive,1940,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
e6f527a2-38eb-457e-bb39-3c5b9c0bcbec,female,Alive,1959,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Pharmaceutical Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
95c53f69-0f05-4348-822a-571f3d757001,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
d2694b09-7844-4496-865c-5d3d8cd03330,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
52c35691-efca-42f5-a03e-02c9f872275c,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
1a679332-30a3-4495-a2e5-39d299e14333,female,Alive,1942,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
271e8024-a008-4bf0-9f6e-177f60096b1b,female,Alive,1933,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
03da7a65-fa2f-42cb-a709-5fe8736f21d3,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
5a53ec47-e63f-44a2-8078-87659544fb04,female,Alive,1966,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
599c3701-df7a-4a75-a347-fa9b510dd242,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
83f943c7-3975-4b4f-985d-9c057741793b,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
87f03d04-e651-4a6e-aea6-1c946aa46202,female,Alive,1928,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
eff2360e-399a-4167-ab2b-798e27bef739,female,Alive,1954,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
b8b6cebc-26dc-43ae-a94a-20da6018f7ae,female,Alive,1945,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
eadf8482-e60e-4307-adb7-d5c3b9fa6cae,female,Alive,1971,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
316e021c-5175-4ab3-bdb6-2bf9683f657a,female,Alive,1981,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
3b963d72-ba5c-467b-83c9-fbdb462510a3,female,Alive,1920,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
ed2617c3-5d3b-4688-9283-0f8a10e0b10d,female,Alive,1971,Stage IIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2012,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
9646160a-f1f9-437b-8c7d-efb0b57bfb97,female,Alive,1931,Stage IIB,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
4649dee3-b668-44cd-ab97-3834de3ef8f8,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
0a017f15-1c6b-45e7-8d55-e0a71df1b2e8,female,Alive,1949,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
a6a863d9-b39d-4965-b47f-79a1bcf3c976,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
dd0f8e5a-383d-4f03-bb71-0e115d4e442c,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
f5539207-6534-4edc-a5a5-7666b5d16ba4,female,Alive,1964,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
7455d832-ad66-40df-85d7-3a7051c4498d,female,Alive,1942,Stage IB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
a8a199c9-d781-4e6c-af8c-c85d60c7cd40,female,Alive,1972,Stage IIIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
6951fe6a-d7d1-4f41-85af-76655b5d1f62,female,Alive,1960,Stage IIB,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2013,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
37242f5a-25ae-4b1f-9ce6-09ce1dc92539,female,Alive,1945,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
994ca1f5-ad10-44ec-aa21-71fc2940653b,female,Alive,1953,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
dfd0b7ba-c7d3-498e-b455-346301865452,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
b8a615f9-d19b-4b09-8ec8-0674e5c648cd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
00a2d166-78c9-4687-a195-3d6315c27574,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
972447aa-4332-47e7-bddd-2eb699dbb664,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
06ef6e83-5583-45b9-a0bd-edea68943083,female,Alive,1939,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
996bd3f0-d767-4eff-9c82-99fcb5a3006a,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
6d24e675-2fa4-4102-861f-7516650b3049,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
077506ea-8f11-405d-bb8e-3c9924fe54d0,female,Alive,1944,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
87b85935-a058-44ad-8fb6-8511130eaffe,female,Alive,1926,Stage IIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
e4fc0909-f284-4471-866d-d8967b6adcbc,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
67c5f371-3fa9-47c5-8b15-c2dd9acc8519,female,Alive,1953,Stage IIB,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
9676e46b-8f29-43cd-ab65-eb6a535cced4,female,Alive,1979,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
8f34cb4c-5798-47a0-89a1-f0ee26a8ae93,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
a45833e1-7cc9-4273-b408-620f74679a12,female,Alive,1973,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
c5891c7a-fd24-4891-8f51-373967e4a6dd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
719082cc-1ebe-4a51-a659-85a59db1d77d,female,Alive,1968,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
87b85935-a058-44ad-8fb6-8511130eaffe,female,Alive,1926,Stage IIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
6f6afd31-b5dd-48ab-b18f-6390ba18a5f0,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
39cde586-df95-435f-b9a6-73b0c0ee5e92,female,Alive,1942,Stage IIB,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
1f8f87cb-8a0b-474c-97fb-c71b4fd88d97,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
316e021c-5175-4ab3-bdb6-2bf9683f657a,female,Alive,1981,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
da286247-e8bb-4941-a2af-2453fe61cd02,female,Alive,1955,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
08306ede-e74b-4be9-b768-7fd98647b6ac,female,Alive,1959,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
f6ed684f-ee7a-496c-80d5-6eacd494d16a,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
d81594d9-dd6a-45c3-8bad-61960611d78d,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
1285eb55-415c-494a-aa58-936f0427cdd0,female,Alive,1934,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
ebc460c2-df88-4dc0-a2c0-aca8072b75ad,female,Alive,1955,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
74f31744-0aed-4633-beec-4e203315f0b7,female,Alive,1966,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
fec0da58-1047-44d2-b6d1-c18cceed43dc,female,Alive,1940,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
e9a12df9-024e-4cbc-b6bf-e4e87485fa90,female,Alive,1924,Stage IIIB,Paget disease and infiltrating duct carcinoma of breast,"Radiation Therapy, NOS",2012,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
a20fa2c4-a502-47e3-bfaa-2ec4cce3a859,female,Alive,1936,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
93ed6066-b567-4e1c-ab81-23370f9d3452,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
22b35927-1c3f-4f98-ba42-deafc56b677a,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
a851ca14-7bbf-455b-a054-ec03979a4247,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
71626753-cc34-4731-abc0-ae188b0964e7,female,Alive,1963,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
7f0bbba1-9bc3-45db-bdda-eb3319bb15d2,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
36d77496-99f8-4911-ba7c-89fae32662aa,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
bb026999-0aab-4232-96d7-2c93b6c9691d,female,Alive,1963,Stage IIIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
0ed9ad26-7fdc-4d75-93f9-d029eee94993,female,Alive,1945,Stage IIB,Intraductal micropapillary carcinoma,"Pharmaceutical Therapy, NOS",2006,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
452672e8-b6d9-45b5-bb02-e88e03e2dd66,female,Alive,1937,Stage IIIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
6439621e-da61-4723-91cc-c5d87d0a4abc,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
eadf8482-e60e-4307-adb7-d5c3b9fa6cae,female,Alive,1971,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
e89a9deb-6321-4e61-b412-b4993d4277dd,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a2efe7e1-aca3-440f-825f-ed621edca69f,female,Alive,1972,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
e9002f4e-ba0b-4738-9368-dd9614a5da8a,female,Alive,1952,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
195b6731-6ae6-416e-a345-0eb8874a0ca2,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
d6f911b5-e895-43f8-8f86-0ac2f1bc6fae,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
e3935ce4-64d3-4a66-ba11-d308b844b410,female,Alive,1947,Stage IIB,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
303a1d77-a37a-4966-a4a4-9981d99ba1b4,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
01f50abf-fc15-446e-9d07-edeecc545a32,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb,female,Alive,1946,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
7d9d3522-ec3b-4efe-8c8e-c0e675276ef5,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
9ba11ea8-97d3-464a-90a4-ec1151be9088,female,Alive,1983,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
3828b534-908e-4953-a3fb-07d01cf49c7d,female,Alive,1951,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
99927651-34be-4795-893a-128d8a1fdb30,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
295cf595-4a29-46a3-a0c5-e5f08f947031,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
8631969d-4ac6-4fe1-9db3-d47db604494a,female,Alive,1960,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
cdd8c046-fd97-482a-a11f-2217b321c4d1,female,Alive,1964,Stage IB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
95873e61-afdb-496c-9f77-3f9beb008cda,female,Alive,1963,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
23f438bd-1dbb-4d46-972f-1e8e74ddbd37,female,Alive,1944,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
f0787165-6f58-4d67-b510-928eea2c4882,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
17c1d42c-cb84-4655-a4cd-b54bae17ecaf,female,Alive,1952,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
ec461eaf-f5cb-4225-a9a0-59d8e6c17ea6,female,Alive,1984,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
58090433-d8d1-4499-a235-810c3e9d5b74,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
3c275152-d04b-440c-9621-2fc05ea977b6,female,Alive,1957,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
f31c21b6-0f7f-435b-9e24-97c909755c36,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
e9f4f373-37a5-48ad-a1a0-b0d47820111a,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
084c6aec-94f7-4090-8f3f-59fa9e89721a,female,Alive,1932,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
9087585f-e792-4f33-baaa-56ffe0f745be,female,Alive,1984,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
0f7ab21b-1fd0-45e0-9a47-17c4691eb84f,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
02bf5203-f9cd-4c5a-97b4-e5584dc22325,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
4d120899-9a80-4736-b097-285e9e261bcb,female,Alive,1926,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
cc348a26-ee11-47a4-8b51-de922967e175,female,Alive,1958,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
78582fbc-dcc7-48ae-9f95-5271c9bc5b72,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
3e775c99-ceda-4246-8d6f-0f58ca5097c8,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
d9a1c06f-7b50-46b0-878e-89e8c31863ae,female,Alive,1965,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
4f04bd10-9902-4a23-b15d-4f4409d79499,female,Alive,1945,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
4922cddc-575c-4b8a-8245-ce5f6876760c,female,Alive,1940,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
8db69f1d-72e2-40ba-ad8a-cf228499840d,female,Alive,1954,Stage IIIA,"Metaplastic carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
4aacbc42-5ac5-4339-b9fa-c6e812084837,female,Alive,1937,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
24046547-d038-4616-b190-52ac93f4965f,female,Alive,1937,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
3828b534-908e-4953-a3fb-07d01cf49c7d,female,Alive,1951,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
1347c23d-8d6e-4c15-9461-640249838c96,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
fa176764-a76f-44c7-b97a-cd6d21e052be,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
124b693c-77dc-4fa8-b703-54e8b5054a92,female,Alive,,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
c72cb184-462d-4009-9cdb-848782ff8a76,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
5ea18514-51ad-4844-abea-15e82f0b10c9,female,Alive,1969,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
058dcb78-bed1-40c3-a6c2-a0cc40065531,female,Alive,1972,Stage IB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
5c9d8163-a68e-43ce-9cba-effb7405761e,female,Alive,1922,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
214a4507-d974-4b3e-8525-7408fccc6a0f,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
8cf54607-01ce-42b0-9bd9-8627edd9f3b7,female,Alive,1958,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
0a2a3529-f645-4967-9a58-89ee20b8bb62,female,Alive,1969,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
90ff48c3-b14b-4a8b-94a1-98c0bab0d27b,female,Alive,1947,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
6e126b73-d3e8-4641-a128-306f3b313e40,female,Alive,1927,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4,female,Alive,1960,Stage IIA,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2008,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
f130f376-5801-40f9-975d-a7e2f7b5670d,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
67c8dc41-edcb-4563-96b3-3f93f9edcbe9,female,Alive,1948,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
195b6731-6ae6-416e-a345-0eb8874a0ca2,female,Alive,1951,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
fbee40f1-d6d8-4156-8d42-36e09bb9f095,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
fb356957-f620-4d99-b675-1355a1d9f932,female,Alive,1932,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
0adf59c6-581a-475d-a2f4-40aa40060b5b,female,Alive,1941,--,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
43029932-feb0-4658-97fa-645c1e775009,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
632984bd-dc81-42b6-b024-476cfd0bb2ae,female,Alive,1950,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
a272171b-44f5-47a5-89be-7520413c01ad,female,Alive,1923,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
6623fc5e-00be-4476-967a-cbd55f676ea6,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
97862b8e-9f76-4b19-a865-156a9c00fb1e,female,Alive,1952,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
3e9f93c0-aa79-4b4c-bd6c-b3325912362a,female,Alive,1969,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
be9bf36a-12e1-4386-addf-1686dc8b49de,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
e112b452-8850-4353-bfed-0dbdc243290b,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
e98b69bc-766a-485f-b5e8-9166b8d457b3,female,Alive,1933,Stage X,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
3e25056d-d137-49f5-abaa-f68509426600,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
7eea2b6e-771f-44c0-9350-38f45c8dbe87,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
8159ff7b-89f4-411a-9b9c-491f1cb3eb34,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
36449392-de76-4ee9-bc09-627a07e18727,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
8240c4ae-f878-4882-aa07-7857c7ac52cf,female,Alive,1965,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
1a679332-30a3-4495-a2e5-39d299e14333,female,Alive,1942,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
8183f0fb-2303-4d7b-bccd-55e5031fc7df,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
aaea5f9c-b35b-47f8-93cb-bdc7b81844ff,female,Alive,1959,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2003,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
42e47f3a-dff7-41e4-8f84-146d97e8ab72,female,Alive,1930,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
67526f5a-3a30-45b2-aeab-2b21a855063e,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
38dc3e09-0b0e-4a29-b318-cc0352013dae,female,Alive,1968,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
807b62ed-d3f7-4211-83be-754386ff2c96,female,Alive,1962,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
e0929c47-cff3-4518-a188-8764af01073a,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
a381275f-8858-4793-a8a2-0ca9db7274c8,female,Alive,1960,--,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
452672e8-b6d9-45b5-bb02-e88e03e2dd66,female,Alive,1937,Stage IIIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
e5aae05a-478e-4a55-a27c-12b2b4be302a,female,Alive,1972,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
b2aac45b-2073-4c7a-adb9-769a4fdcc111,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
9857be0c-aeca-4a43-90b1-0535bd08e086,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",1998,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
13b860c3-8048-4dc9-9eb0-7480bc660837,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
70ab4f23-23c4-409f-a5cc-18a010c3a24e,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
d6f7afc0-1558-43ad-acb1-2b5311ed2264,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
96b9c7db-1be1-4b60-b47c-26b654c3d64c,female,Alive,1953,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
5fc7ff35-d3f7-4687-8759-3542bd58e988,female,Alive,1966,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2009,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
01b9f68b-4de4-4374-b4f2-8a0685e18153,female,Alive,1924,Stage IB,"Phyllodes tumor, malignant","Radiation Therapy, NOS",2012,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
a2434f47-2168-47d0-9bbb-981071597843,female,Alive,1962,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
cd7fb75e-1c2e-4201-86d3-b3ba21f476bf,female,Alive,1953,Stage II,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
d67cd793-2931-429a-9084-2f3c4c8be7ad,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
3afa1e93-1df8-4e4c-aaa4-557463f4bb77,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
f801aeed-dc43-49d7-a319-84c8851979d9,female,Alive,1940,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
79126e88-9cf8-45ff-bf91-a98da3b304d7,female,Alive,1961,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
1ff85ada-3cdd-4afb-b311-2c7befb52702,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
b4e4fea2-b802-4a86-923e-3fcbd3c708fe,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
6a186809-3422-41d0-83d2-867145830936,female,Alive,1954,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
ccb22ecc-6e18-44b8-ad48-6ab51314b16e,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
a855c228-a263-44df-87a0-cbc32187e3f5,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
02bed00f-bef7-4fb7-b243-540354990e45,female,Alive,1954,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
ec0ab947-9341-4fff-bda4-fdfb9434d508,female,Alive,1950,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
7c2a8440-0206-4039-8474-8d62f6c7de0c,female,Alive,1940,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
4a032bad-e726-48f2-8f39-e3acc109cc91,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
0dd8dbc1-c48b-4e7c-b401-57101f724967,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a851ca14-7bbf-455b-a054-ec03979a4247,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
dfd0b7ba-c7d3-498e-b455-346301865452,female,Alive,1948,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
ebc460c2-df88-4dc0-a2c0-aca8072b75ad,female,Alive,1955,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
a12fd22a-7f84-4b6e-b6d8-012e38eb73d7,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
b0f8d698-a30e-4d8d-b0a2-a5a01fac8406,female,Alive,1947,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
182c4bdf-2c58-4303-b034-459da86b9d90,female,Alive,1949,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
77e25ae8-82ec-4dea-8e62-1176f27e47ba,female,Alive,1957,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
15ff4b02-bb69-4d24-8a07-b82f428e428d,female,Alive,1949,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
86c6f993-327f-4525-9983-29c55625593a,female,Alive,1968,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
174850b4-5ec2-462b-a890-89bd1716b3c2,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
5cdae21d-eee5-478f-932a-0f51fcf5f031,female,Alive,1951,Stage IIIC,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2007,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
a991644b-3ee6-4cda-acf0-e37de48a49fc,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
5a5f0f48-2b13-4e78-b130-901b85d9a7f3,female,Alive,1981,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d,female,Alive,1941,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
a2453bcb-90f2-4505-949d-a89cf4bfc9b8,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
298a1710-deb4-4064-a0f2-da32d43aa217,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
115bc72c-116f-40c1-be9b-e3dd7650efae,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
92654f8d-5137-4ffd-aaa3-5ae38eb88226,female,Alive,1958,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
0bc5744c-5fa3-45bb-87d0-70a02068b392,female,Alive,1977,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
5a17dcd9-5ced-4a69-8069-23c7fd0649d1,female,Alive,1959,--,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
2e8e70f2-c781-44c2-8f12-1f8c2f536aa3,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
5580b21a-2cdb-4777-ad79-6e06654144f5,female,Alive,1971,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
59bf0ce4-715a-4017-bccb-c59916e78324,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
ce887e90-0660-4f44-a3a4-b3b894cb7eda,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
8d9b50d1-139b-4447-ae9c-e54764d9e2a7,female,Alive,1968,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
db62d9c7-8343-4771-84fc-146d2e307bb8,female,Alive,1961,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
9d95a65b-e41d-4f93-92d4-99dce29ff40d,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
726c6892-0dce-4869-a7a7-cc44c26fe843,female,Alive,1964,Stage IIB,Infiltrating lobular mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2013,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
7861a5f2-8910-4bcb-9c34-f79c5acd6e21,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
4ac693e9-10f3-46b3-9d46-df3af7b0d259,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
69a68fbc-e43d-4652-85ee-693211bded47,female,Alive,1969,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
1f99e4d4-4e8b-4cc1-a129-227a2a82780e,female,Alive,1946,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
ef4cbd38-bc79-4d60-a715-647edd2ebe9e,female,Alive,1960,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
c6086936-7544-4da0-8c0c-114166848483,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
a6e5f869-1182-4f81-b4bb-cf55261c8f3f,female,Alive,1955,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
e1119732-3e97-4259-bc69-dc4269d9496d,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
36220587-1c1c-4f92-b177-3b2155e7e273,female,Alive,1968,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
9e3de467-fb0d-4021-89f8-b34968a7c7bc,female,Alive,1960,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
0f7ab21b-1fd0-45e0-9a47-17c4691eb84f,female,Alive,1976,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c,female,Alive,1944,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
f6ed684f-ee7a-496c-80d5-6eacd494d16a,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
8183f0fb-2303-4d7b-bccd-55e5031fc7df,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
b304302a-f2b9-4cd7-ab14-c21edf7778ea,female,Alive,1952,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
78e1da41-127c-4e9c-aaaa-77a0d94c31d0,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
4922cddc-575c-4b8a-8245-ce5f6876760c,female,Alive,1940,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
c462e422-eb8d-4daf-9897-2a9c6cbd783a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
8360cec6-daf6-41c9-9a4f-7fc03c958dcc,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
7455d832-ad66-40df-85d7-3a7051c4498d,female,Alive,1942,Stage IB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
24334ac1-28a3-4b61-b590-3f51e375b247,female,Alive,1929,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
2fd36838-5a83-433e-ac80-b1f77448e5aa,female,Alive,1961,Stage IIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2013,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
81e7a3d3-be70-4834-8018-4d2cc077a4e6,female,Alive,1925,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
afb9418e-91eb-4db1-aacf-12bd946c9ba0,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
70f34c5c-3671-44c8-9469-99f9786efec1,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
08da7c4c-3067-4bcf-9d7a-78566df72e69,female,Alive,1928,Stage X,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1989,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
8785012f-f73e-4d68-87cf-1d804af32782,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
8577ffcb-242e-40e2-98d4-2831d952be34,female,Alive,1930,Stage IIA,"Papillary carcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
d13fb44b-291b-4ea4-920c-142daa8d1989,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
6397d7bc-9cb1-4a84-81ad-76954e0a8cee,female,Alive,1940,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
53ff5893-7d5e-4bcb-be9c-665fa34b7824,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
5e4187c9-98f8-4bdb-a8da-6a914e96f47a,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
0cf0d67c-2f7f-42a6-94f3-407d0ec46c88,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
52c35691-efca-42f5-a03e-02c9f872275c,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
39cda4c9-e1c8-44c2-bab7-f5849c12f879,female,Alive,1928,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
752ad011-79e0-494f-9868-98bf6feb28f8,female,Alive,1970,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
6b923e30-2ddc-407f-91b1-c202f1373fbb,female,Alive,1930,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
78e1da41-127c-4e9c-aaaa-77a0d94c31d0,female,Alive,1943,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
8785012f-f73e-4d68-87cf-1d804af32782,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
e74aea7c-ca14-49df-b5cf-dacb839ac27a,female,Alive,1950,Stage IIB,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
738e1acc-1f0c-4a96-9c8a-222727ef5af8,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
9d95a65b-e41d-4f93-92d4-99dce29ff40d,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
b6c286c6-2755-419b-87d3-59c7feda9653,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
81e7a3d3-be70-4834-8018-4d2cc077a4e6,female,Alive,1925,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
0ec70e40-07df-461d-8ff9-351240a0d454,female,Alive,1950,Stage IIA,"Carcinoma, NOS","Radiation Therapy, NOS",2012,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
f5539207-6534-4edc-a5a5-7666b5d16ba4,female,Alive,1964,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
9646160a-f1f9-437b-8c7d-efb0b57bfb97,female,Alive,1931,Stage IIB,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
7c2a8440-0206-4039-8474-8d62f6c7de0c,female,Alive,1940,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
c744fc13-3aca-4245-9e24-abd368cc8bef,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
1a18974d-967c-4727-b42e-12ae7be66589,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1988,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
606fbc6a-b41b-441d-9401-51e54912bf5e,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
f89588e9-ca73-4465-a7fb-7246edb45e3a,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
495f9eda-b9be-4eef-bae1-766a4bfbd68e,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
86c6f993-327f-4525-9983-29c55625593a,female,Alive,1968,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
89e867de-d30e-4bfc-a453-0a76309dabd5,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
d6f911b5-e895-43f8-8f86-0ac2f1bc6fae,female,Alive,1967,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
aa30ac3d-4216-45dd-a314-1ae192fafcb2,female,Alive,1967,Stage IIIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2005,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
98e0b4de-52fc-4945-9bf5-11e29368f939,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
34d5a193-85e5-4399-8a9b-e92858eafdfe,female,Alive,1943,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
fbee40f1-d6d8-4156-8d42-36e09bb9f095,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
45c3975c-d333-4237-93f7-e12dc2451c38,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
cd0c96a4-6414-4efb-879b-7408b62ed5b6,female,Alive,1936,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
75f6e476-233a-409c-a3ef-0240be569813,female,Alive,1965,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
dcd5860c-7e3a-44f3-a732-fe92fe3fe300,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
8577ffcb-242e-40e2-98d4-2831d952be34,female,Alive,1930,Stage IIA,"Papillary carcinoma, NOS","Radiation Therapy, NOS",2002,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
9087585f-e792-4f33-baaa-56ffe0f745be,female,Alive,1984,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
6d4860b2-21c6-4b7b-9093-2f32700d0612,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
3558dec7-eae3-4a41-a217-266c6a4535fb,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
c2aeee6c-ba10-4cf9-b560-c739580f7bf3,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0b23b5fe-6c7e-4297-bc55-f93fcb830ac4,female,Alive,1970,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
8e159b50-8136-42d4-b9c7-d579a74e4931,female,Alive,1961,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
719082cc-1ebe-4a51-a659-85a59db1d77d,female,Alive,1968,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
523e24a2-51b9-4658-be2f-42e5fccebb17,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
baf2afc8-f16c-488f-947c-efc9083c6bef,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
27c1c094-690b-4973-8900-a797ad88f98c,female,Alive,1958,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
39cda4c9-e1c8-44c2-bab7-f5849c12f879,female,Alive,1928,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
0772cdbe-8b0d-452b-8df1-bd70d1306363,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
125b0a9a-6cbe-4207-9178-e7ff03487e87,female,Alive,1962,Stage IIIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2005,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
58959e88-54e2-4558-9664-2effda7403dc,female,Alive,1960,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
9435447e-d65f-408b-863b-6576b1d652dd,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
c364e81c-eb1e-4870-ab37-9c661f5f2e3d,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
6412854a-f874-469e-9d1f-8bd3ae5bd41d,female,Alive,1956,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
d111c4ab-b39a-4a7c-8d8e-cb342bc10627,female,Alive,1945,Stage IIA,"Metaplastic carcinoma, NOS","Radiation Therapy, NOS",2012,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
ce9e0309-9756-42d2-ae94-d91264a79498,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
e37ae674-a107-4eb3-94d8-b86b0035a9f7,female,Alive,1924,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
0f64edec-0f1f-4025-8a53-75f9534f7828,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
09c2bc35-c21f-4aa4-ac30-0d8db02ad811,female,Alive,1925,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
1c40b84e-a0e3-429f-a48c-21566cf881c0,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
0bf6e772-1aa1-4f54-9a50-c1414e2f22f3,female,Alive,1958,Stage II,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
9b13927c-7357-44fd-8385-92ae6a656b7d,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1991,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
4fba3deb-db94-44b5-a0f2-a575d270779e,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
86a18ae0-dfb1-49c3-b5c4-67ec331d6e40,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
cc0902fd-a2fc-4327-929e-d4219e32e1d7,female,Alive,1963,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2002,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
418c11e8-2670-48d5-bbf5-95b46bff1201,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
ad7fcc89-82a3-48aa-8461-581c1a857677,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
28911b97-42bf-4189-9961-522fc0aeebc6,female,Alive,1930,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
72e486b8-a866-4916-b2e4-8b4bb5dcd92d,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
a6502f17-6bee-4d5a-8520-06364593d39c,female,Alive,1961,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ad0fa961-c085-4f38-b3db-5fc0cbf6b64f,female,Alive,1964,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
996bd3f0-d767-4eff-9c82-99fcb5a3006a,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
4b620966-b4c7-4615-bf58-ca9d3226b9bd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
796b593f-5886-4a27-bf94-7ea8df325e1a,female,Alive,1971,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
f3cb557d-23e4-4fd1-81ca-db1a3f56d56e,female,Alive,1978,Stage IIA,"Medullary carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
cf9db1af-17f0-490e-8139-142bd704763a,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
12d31787-e54d-4729-ace8-9141043c92b8,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
602083f0-18d9-48b6-a529-31e165c54b37,female,Alive,1953,Stage IIB,Intraductal papillary adenocarcinoma with invasion,"Pharmaceutical Therapy, NOS",2009,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
d8d7a6c2-6427-4f47-968c-6c3affba4617,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
0b172e29-6166-4863-803d-a0a010887c11,female,Alive,1922,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",1993,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a8a33ba9-0976-4e19-b0e9-fa5ba4d4eaa8,female,Alive,1961,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
cd7fb75e-1c2e-4201-86d3-b3ba21f476bf,female,Alive,1953,Stage II,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
05af737d-89aa-49b6-97b2-28b8ac8bd2cf,female,Alive,1933,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
8624354c-af25-423c-9c71-48a5dd821097,female,Alive,1948,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
a82d0a57-4383-473d-b334-d13b278404b1,female,Alive,1970,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
5c59028f-b8fa-4811-8314-be3eaed5f364,female,Alive,1950,Stage II,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
5c8983f2-9788-4dfa-971c-3ec457b6166e,female,Alive,1969,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
523e24a2-51b9-4658-be2f-42e5fccebb17,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
57af5c72-0d60-4a6b-b1b4-ec6dab90f80f,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
a53dd490-e0ba-419a-90c6-b905e241a8e5,female,Alive,1935,Stage IIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2012,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
27ba717a-5cd8-440a-9345-4ae086f6efca,female,Alive,1946,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
3927f736-3b5c-48c8-9d9e-83669ec44770,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
08740d7f-5a5e-4dfa-bd48-7fbf228a7a28,female,Alive,1946,Stage II,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1996,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
4b54e06e-a280-4981-a4e1-9aea154341b4,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
a53dd490-e0ba-419a-90c6-b905e241a8e5,female,Alive,1935,Stage IIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2012,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
c694615c-b1c6-499c-8058-995633ebf948,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
87e09544-eddb-473b-8617-212407ce644e,female,Alive,1972,Stage IB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
566792ae-f853-4a47-856d-f02cdcfcb18a,female,Alive,1940,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
89128dba-403f-4a96-bb3b-23ed0d5e2147,female,Alive,1941,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
cb0a2055-2168-4454-8755-47dd613db36f,female,Alive,1927,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
dd43ffd9-da18-4ad3-abe7-6f443c76a717,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
8624354c-af25-423c-9c71-48a5dd821097,female,Alive,1948,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
fc18d029-9be2-4fa0-9aef-6d647dc55f0b,female,Alive,1965,--,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
c85f080a-1075-41df-959f-1b514a11b3c4,female,Alive,1962,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
6020d1b4-ee20-4cc9-82a3-340b5e3122f1,female,Alive,1962,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
db8d38ab-cc61-49ee-863d-40060112f2af,female,Alive,1941,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
4b0d295c-e185-4b52-9752-178e5bc1d47d,female,Alive,1945,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
1502c7d7-1535-4e56-9f34-30623acd50d5,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
da9c10ea-c13f-4d88-8b94-a0cbc106d036,female,Alive,1931,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
72e486b8-a866-4916-b2e4-8b4bb5dcd92d,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
6d4860b2-21c6-4b7b-9093-2f32700d0612,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
71626753-cc34-4731-abc0-ae188b0964e7,female,Alive,1963,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
c57835be-77ab-4cf5-9b23-62c11a7b2eaf,female,Alive,1935,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
95c53f69-0f05-4348-822a-571f3d757001,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
182c4bdf-2c58-4303-b034-459da86b9d90,female,Alive,1949,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
8c09f413-e938-4f2e-a414-84f0e7fcfe41,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
b8a615f9-d19b-4b09-8ec8-0674e5c648cd,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a,female,Alive,1962,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
0a229f95-0ea1-4d63-953e-74f5ec2f3028,female,Alive,1946,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
98e0b4de-52fc-4945-9bf5-11e29368f939,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
a721dac6-0126-476c-b2d4-2dbf7406454b,female,Alive,1930,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
316625b8-a217-4829-90d1-dfd9cb7e4bc3,female,Alive,1974,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
2b22db1d-54a1-4b9e-a86e-a174cf51d95c,female,Alive,1952,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
4958c36f-1dc7-4f14-9dec-36e14107dbe3,female,Alive,1930,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
f947d67f-4aa2-4eb9-977e-21a5ae563613,female,Alive,1938,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
da70cf7e-0e61-4c72-b4c5-c408569d11b8,female,Alive,1949,Stage IIA,Mucinous adenocarcinoma,"Pharmaceutical Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
22eaba28-be67-4730-9846-860bc1fca29a,female,Alive,1955,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
e1786e78-ac46-46fd-8ce0-8f7456e46082,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
3144f1fb-4342-4079-bfe8-940da4bfd88e,female,Alive,1955,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
fc18d029-9be2-4fa0-9aef-6d647dc55f0b,female,Alive,1965,--,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
5c59028f-b8fa-4811-8314-be3eaed5f364,female,Alive,1950,Stage II,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
23c31c2e-336c-4878-a476-cf8d811b4875,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
b35fbe19-0e6d-427e-b9be-ee3527b5fca6,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
d9627184-b972-4e00-8c11-b0b946ac357a,female,Alive,1938,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
174850b4-5ec2-462b-a890-89bd1716b3c2,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
c4699748-f01d-4b30-9c74-1ca77fb84ac1,female,Alive,1974,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
4aacbc42-5ac5-4339-b9fa-c6e812084837,female,Alive,1937,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
b6b932ce-6856-4d94-9e6c-16dfbe51906f,female,Alive,1950,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
f2e28af9-c40e-41c4-9e82-205cca38f26a,female,Alive,1940,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
b63391a0-73f8-4544-9e94-f6529245ca2a,female,Alive,1931,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
66072c06-f251-4f0b-b6ae-12b407c52cc6,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
a6e11b30-3ae8-4dd1-b04c-a730c6a79746,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
0dc337fa-da8b-42c4-b9a7-fb76d81c161f,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
029ce650-5e5a-4100-8596-cd94300e7ef5,female,Alive,1967,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
c70ee5e1-4703-4996-bb5c-f4cca0fb53ba,female,Alive,1973,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2002,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
48ff0420-0f19-4e9d-a75d-6c54949a461a,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
13ca97a1-75bb-4a49-b8c3-181e5b2c9e86,female,Alive,1953,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
01263518-5f7c-49dc-8d7e-84b0c03a6a63,female,Alive,1933,Stage IV,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
becedbfd-b2aa-4dde-b7f4-29e6f59ec32c,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
4958c36f-1dc7-4f14-9dec-36e14107dbe3,female,Alive,1930,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
853456d8-2367-404e-abc9-020fe8bbd209,female,Alive,1927,Stage X,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
98e709e7-e195-4b37-9537-f6081affb609,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2013,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
5aca16ca-4516-4e27-8249-6914029a7ebf,female,Alive,1941,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2001,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
28e9048a-e540-42de-a1f4-4ef894fccc4c,female,Alive,1957,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
98e709e7-e195-4b37-9537-f6081affb609,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
56bbd282-b88d-4730-9242-ab97d08dc83a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
2c6adb12-380d-4710-a7e6-93d5a0e53289,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
36fe6152-f61e-4948-9ccc-23ac01a9d77d,female,Alive,1952,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
aa4244a8-0454-4247-a1c3-357fd51746fa,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
86b7b206-8e69-432d-acc9-bccce710955e,female,Alive,1973,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
9de678e5-67ed-4453-a98b-7ac351d5d0f1,female,Alive,1930,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
cf0a3f38-5850-44e1-8574-808bd37d84a3,female,Alive,1973,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
45c3975c-d333-4237-93f7-e12dc2451c38,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
a4c59287-1ad5-46a5-8040-e591e6ce064f,female,Alive,1957,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
e8ea576b-eb16-44f7-b241-daefc1375388,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
bef7b135-a727-45e8-850a-cc4cd56c49aa,female,Alive,1952,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2006,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
ab89bb2e-da84-4116-a8cd-49aad7bbfd4d,female,Alive,1960,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2003,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
c6086936-7544-4da0-8c0c-114166848483,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
f45210d3-9e66-4f5e-bef1-5ee5547cc893,female,Alive,1945,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
427d0648-3f77-4ffc-b52c-89855426d647,female,Alive,1949,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
f7ab565c-83b5-4988-b9be-8a46f65dca8c,female,Alive,1956,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
27c1c094-690b-4973-8900-a797ad88f98c,female,Alive,1958,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
8f912a40-3251-4e1f-ae65-1f93d71f9881,female,Alive,1952,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
1b4cfad1-e353-4411-97b6-2b7b9309e95e,female,Alive,1922,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
cc510968-fe52-4109-a79f-74f216b48c78,female,Alive,1934,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Radiation Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
f3b86c02-09a5-4e97-aa7a-86f13f7cda4b,female,Alive,1955,Stage IIA,Intraductal micropapillary carcinoma,"Radiation Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
96f02be7-f2df-483c-8968-a5bd2d887206,female,Alive,1924,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
518f231c-f5f9-4a39-a97b-7fd5666d3e50,female,Alive,1961,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
0a2a3529-f645-4967-9a58-89ee20b8bb62,female,Alive,1969,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
b3354b72-2637-4edc-9a95-e55801d3ac13,female,Alive,1976,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
96312510-c126-485d-8109-ed81844a1dc3,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
6adca853-1b09-47ff-814c-47b732a76d96,female,Alive,1961,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
08de63a2-7b76-43c3-80dc-df748b1d81bc,female,Alive,1962,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
2e243f0e-9d7d-4cb0-9678-70607f90430a,female,Alive,1949,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
05506f4c-e701-4a9d-ae06-97f066aade43,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
a076f135-be82-40fa-8516-285ed355c965,female,Alive,1945,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
cc348a26-ee11-47a4-8b51-de922967e175,female,Alive,1958,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
4fba3deb-db94-44b5-a0f2-a575d270779e,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
d7308344-5bab-4073-bb4f-4d8cd8d7bd17,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
993103b1-e5a1-4c33-8629-be53ebc41d64,female,Alive,1934,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
38a4e9bd-93e9-432d-a756-3b1055b823bd,female,Alive,1934,Stage IIIC,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2013,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
23dabeef-8e3c-44bc-9a12-a9522d17be5c,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
93ed6066-b567-4e1c-ab81-23370f9d3452,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
17d9e646-6ab3-40b3-a0bc-2c834d3c3213,female,Alive,1968,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2004,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
f2622cdb-ac92-42b3-a1ca-67e133c3dd4a,female,Alive,1943,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
ca76c6fc-ff30-4833-884d-3a94fe53ff17,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
6af6d256-a753-46d2-b611-e4094ff265aa,female,Alive,1944,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
4649dee3-b668-44cd-ab97-3834de3ef8f8,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
03da7a65-fa2f-42cb-a709-5fe8736f21d3,female,Alive,1953,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
34126cd5-cc38-4198-8582-c14fb5db7acb,female,Alive,1963,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
ba80db4e-d899-4da4-ae49-5263d98e1530,female,Alive,1964,Stage IIIC,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
23f438bd-1dbb-4d46-972f-1e8e74ddbd37,female,Alive,1944,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2005,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4,female,Alive,1964,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
95873e61-afdb-496c-9f77-3f9beb008cda,female,Alive,1963,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
4f04bd10-9902-4a23-b15d-4f4409d79499,female,Alive,1945,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
f06f09f3-8133-4a92-ac86-fbe64295e0d8,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
86a18ae0-dfb1-49c3-b5c4-67ec331d6e40,female,Alive,1954,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
5e670fec-8992-44bf-8657-f7f9a272306b,female,Alive,1933,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2003,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
048549cf-d0a5-4743-a0a1-2004f7cc2b08,female,Alive,1965,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
d13fb44b-291b-4ea4-920c-142daa8d1989,female,Alive,1936,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
295cf595-4a29-46a3-a0c5-e5f08f947031,female,Alive,1960,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e,female,Alive,1958,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
32861b48-83f5-43a3-bb54-45215ad2c5d6,female,Alive,1964,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
af577366-0258-49e7-b6af-e70056c081a4,female,Alive,1953,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
36449392-de76-4ee9-bc09-627a07e18727,female,Alive,1960,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f,female,Alive,1959,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
f7064d01-29d8-49a2-ad60-1e0c5f148f3e,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
f7064d01-29d8-49a2-ad60-1e0c5f148f3e,female,Alive,1946,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
9ac44381-5d43-4f63-aa3f-7703bfc923c9,female,Alive,1954,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
e68ebfd4-3688-4caa-9e38-7764f9258c30,female,Alive,1945,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
9ddc014d-9a8b-407b-845f-452a73f08e5e,female,Alive,1950,Stage IIIA,Infiltrating lobular mixed with other types of carcinoma,"Radiation Therapy, NOS",2012,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
298d33da-15af-48cb-b30f-eaf54e7baa43,female,Alive,1956,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
805bfe39-3695-43c2-93e4-d66d0559b89f,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
9da462b0-93c2-4305-89f6-7199a30399a7,female,Alive,1967,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
e6f527a2-38eb-457e-bb39-3c5b9c0bcbec,female,Alive,1959,Stage IIA,Intraductal papillary adenocarcinoma with invasion,"Radiation Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
5aca16ca-4516-4e27-8249-6914029a7ebf,female,Alive,1941,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2001,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
eebad74f-5961-4e91-b0eb-157a2f6f952b,female,Alive,1956,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
eff2360e-399a-4167-ab2b-798e27bef739,female,Alive,1954,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
ba80db4e-d899-4da4-ae49-5263d98e1530,female,Alive,1964,Stage IIIC,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
75113445-d2d6-44a0-866c-c9175e6d214b,female,Alive,1972,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
6439621e-da61-4723-91cc-c5d87d0a4abc,female,Alive,1939,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2005,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
1b4cfad1-e353-4411-97b6-2b7b9309e95e,female,Alive,1922,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
5d688049-f271-40ef-813a-d37240ffe21c,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
27dfb9d4-3a2c-44bc-9acf-8f638d3f3004,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
4bf50455-9ab7-4521-a791-089f66d3b877,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1996,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
baf1207d-7d1a-4cad-ba58-62c26be2415e,female,Alive,1948,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
9938ce5c-e74e-446e-a932-f096f85cc3b1,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
491d5ebb-e9ab-4b17-acb8-630ff9fef0f2,female,Alive,1954,Stage IIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2006,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
8d9b50d1-139b-4447-ae9c-e54764d9e2a7,female,Alive,1968,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
cc510968-fe52-4109-a79f-74f216b48c78,female,Alive,1934,Stage IIIA,Infiltrating duct mixed with other types of carcinoma,"Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
89c128b9-1c6b-4c04-a4af-7066772e783c,female,Alive,1966,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2007,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
baf5e81f-2322-41ec-9053-b9559a7993bc,female,Alive,1947,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
95e949d3-b1f3-46c6-9451-8fe92c99e4cf,female,Alive,1947,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
8332806e-f547-4aae-89af-6d5bec831fd2,female,Alive,1961,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
dcb68327-1537-4ca6-81de-3910d0663cb8,female,Alive,1964,Stage IIIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2013,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
2d29a4ac-98e7-4663-9dd6-5681bc32ac2e,female,Alive,1956,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
5f5964a8-8e07-4620-98f0-93d162dbc31e,female,Alive,1963,Stage IV,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
dd6b64a8-d546-4fd1-bbbd-ac9703791cae,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
161917b8-88ad-407b-ade6-d6b98478b359,female,Alive,1969,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
64089c20-939f-48b4-ae8b-904ad0597145,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
39de7761-e762-4811-b95c-8216b79ae06b,female,Alive,1974,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
4e509f73-99c7-48eb-a3a4-d34e3bface33,female,Alive,1948,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea,female,Alive,1935,Stage IIIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
757df7b0-4774-4493-98bf-999ded9ac86e,female,Alive,1943,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
b43e41af-1d82-4b5f-b8f1-add0510e6b86,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
32efa6e8-6b19-480a-9d04-ace02e93318a,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
d7cac141-9269-4733-83ce-e1bc0b503254,female,Alive,1936,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
f954de05-1b44-4087-8933-6cc72d81028d,female,Alive,1965,Stage IIB,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
bac4b268-c781-4408-96d8-43a48fec7418,female,Alive,1966,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
189e1f27-7738-413a-a4d4-97d41d592a13,female,Alive,1965,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
f30eb65f-fb44-4062-ac39-a38d072f655f,female,Alive,1930,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",1998,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
ca76c6fc-ff30-4833-884d-3a94fe53ff17,female,Alive,1939,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
4cf0f639-7940-48b6-8ea1-2a3494097cdb,female,Alive,1950,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2004,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
3d676bba-154b-4d22-ab59-d4d4da051b94,female,Alive,1983,Stage IIB,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
dd3bfb26-b534-4917-9c4d-9fe7b6477762,female,Alive,1968,Stage IIIA,Infiltrating duct and lobular carcinoma,"Radiation Therapy, NOS",2011,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
6e6b7742-a562-490b-bb72-04a5653852e4,female,Alive,1944,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
2cb8c866-9296-4c70-a3ea-f9a9b707895c,female,Alive,1936,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
546248b0-22a0-4b70-a437-76fb0a238a0d,female,Alive,1951,Stage IV,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
3c275152-d04b-440c-9621-2fc05ea977b6,female,Alive,1957,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d,female,Alive,1941,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
2e1e3bf0-1708-4b65-936c-48b89eb8966a,female,Alive,1946,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
dd6b64a8-d546-4fd1-bbbd-ac9703791cae,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
16fc3677-0393-4ed1-ad3f-c8355f056369,female,Alive,1947,Stage IV,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1,female,Alive,1944,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
ac68d219-5670-4ddd-8df6-8aa7ad59e5c7,female,Alive,1953,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
6e126b73-d3e8-4641-a128-306f3b313e40,female,Alive,1927,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
491d5ebb-e9ab-4b17-acb8-630ff9fef0f2,female,Alive,1954,Stage IIA,Infiltrating duct and lobular carcinoma,"Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
33fe5833-d7a0-43d7-a03d-56985ea448a6,female,Alive,1941,Stage IIIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
0930e97a-72ea-4bd5-b2f0-50c76af695f3,female,Alive,1963,Stage IIIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
9c895825-d6f6-4d14-a662-23212200f6e5,female,Alive,1946,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
b63391a0-73f8-4544-9e94-f6529245ca2a,female,Alive,1931,Stage IIA,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
3927f736-3b5c-48c8-9d9e-83669ec44770,female,Alive,1929,Stage IIIC,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4,female,Alive,1965,Stage IIB,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
3ea9412b-429e-4dcf-90cd-c53be06885a1,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
91da548b-5c64-49c3-a44a-1ef115f53311,female,Alive,1928,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
b6633c36-7ce4-4b69-9bf6-30b64d46c66f,female,Alive,1951,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
c632675e-e8af-43cd-8744-5be3754c1c14,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
08306ede-e74b-4be9-b768-7fd98647b6ac,female,Alive,1959,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
90ff48c3-b14b-4a8b-94a1-98c0bab0d27b,female,Alive,1947,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
b43e41af-1d82-4b5f-b8f1-add0510e6b86,female,Alive,1938,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
56203436-8634-4fd0-96b5-ba6be9d87857,female,Alive,1920,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
da70cf7e-0e61-4c72-b4c5-c408569d11b8,female,Alive,1949,Stage IIA,Mucinous adenocarcinoma,"Radiation Therapy, NOS",2011,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
6f959c92-b79f-4f84-9ee5-d07d3212d52d,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
3e775c99-ceda-4246-8d6f-0f58ca5097c8,female,Alive,1951,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
49717f75-0f2d-4e1c-9a12-f1cd7877b80a,female,Alive,1950,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
c7d7a770-23c0-4310-ab48-1f6152dc2849,female,Alive,1940,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
34126cd5-cc38-4198-8582-c14fb5db7acb,female,Alive,1963,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
ec0ab947-9341-4fff-bda4-fdfb9434d508,female,Alive,1950,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2012,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
303a1d77-a37a-4966-a4a4-9981d99ba1b4,female,Alive,1958,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
4da7abaf-ac7a-41c0-8033-5780a398545c,female,Alive,1966,Stage IIB,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
ac18b3a3-8d52-4e35-8625-673171a7fd92,female,Alive,1943,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
4a032bad-e726-48f2-8f39-e3acc109cc91,female,Alive,1948,Stage IIIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
03565036-b6d3-432f-8d9a-7099818e0788,female,Alive,1942,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2006,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
75f6e476-233a-409c-a3ef-0240be569813,female,Alive,1965,Stage IIA,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
76ace6aa-0505-442c-978a-f889cf2d44bb,female,Alive,1953,Stage IIB,"Lobular carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
9fefbe7c-f66a-4940-843e-285cb7b392c1,female,Alive,1949,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
56033839-35d5-4d72-8b8c-400cb345263d,female,Alive,1964,Stage IIA,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
c0892598-1f7b-4f23-9cd8-731f797753d5,female,Alive,1946,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
01b9f68b-4de4-4374-b4f2-8a0685e18153,female,Alive,1924,Stage IB,"Phyllodes tumor, malignant","Pharmaceutical Therapy, NOS",2012,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
1d38d356-d126-4476-94d0-26616b9375b1,female,Alive,1968,Stage IIIC,"Infiltrating duct carcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
805bfe39-3695-43c2-93e4-d66d0559b89f,female,Alive,1947,Stage IIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
3ea9412b-429e-4dcf-90cd-c53be06885a1,female,Alive,1957,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2007,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
602083f0-18d9-48b6-a529-31e165c54b37,female,Alive,1953,Stage IIB,Intraductal papillary adenocarcinoma with invasion,"Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
da286247-e8bb-4941-a2af-2453fe61cd02,female,Alive,1955,Stage IIB,"Lobular carcinoma, NOS","Radiation Therapy, NOS",2008,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
4e3699da-4367-4a43-9d66-a117d3ad460d,female,Alive,1942,Stage IIIA,"Infiltrating duct carcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0cbd2001-5067-5109-838d-3c053cfcfa55,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
72351cbb-af0d-50ae-b476-edbb6706eadc,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
cc57dcd7-5e85-5e52-b35b-4adf130b31d7,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
4c77a875-5eef-5480-b468-2ba87b6173ea,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
5a34c9fd-6e43-566b-8e12-af41e66ca002,female,Alive,1974,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
68eeb680-0c16-5cd2-ad66-077e1551696c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
0fe639d2-e36c-5dd9-bed0-8e11e1d36a61,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
3171801b-ead8-54fc-a7b9-481100dfe39d,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
6cb2b392-7f9d-56ff-951f-50fa1961540e,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
18454974-897b-5a0c-8f4e-a15d6a2da0f9,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
cb02881c-ab1f-5acf-ac66-56e28fae03c7,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
2f3cfe29-af4d-5dcd-84a6-304a3717051a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
3d97f2b9-778a-5826-8aa7-ddc7402c36c2,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
19a24b4b-1b54-5c06-ae56-8d3dde47aadd,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
608b1f93-afe7-5b95-bf1c-dfd43e6e96ae,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
ce8a91da-f81d-51b6-a2e5-82541798e6b9,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
68902cda-85a5-5b5d-8aa5-69a8fc3b7da5,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
dc97087e-e474-5a4a-ae55-9df2cd584547,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
1e9d614e-a709-5368-ad16-6a95d293e547,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
0926f2b4-a18a-531b-82a7-f798da65b318,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
a5a0d889-9d31-55c0-80a8-9c3eb31ed85d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
4a83af41-f0dd-5db8-a0bf-609e86d91d4a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
eb35520c-df45-5f2c-a0c9-e8edc9832a81,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
73986089-8e5f-5a89-8e84-674c67d66ce7,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d,female,Alive,1965,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
9f6ec603-0186-5e86-bd95-3ae3fe32682b,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
4d444b66-2a61-5097-8234-82701fa74420,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
909e5384-bc65-57da-a325-b3e37696288a,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
97fe2fbf-2085-5ffe-a6f9-5133af42f12d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
eb77bd79-bd4a-5ef4-a359-c918b069e1a3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
1e0b3a28-6504-56ef-80e0-7c9db03689ee,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
b6988514-2f1c-5264-b604-412054c5d4ec,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
fc98d37b-3159-5080-92f4-829f488879b6,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
f3f20b72-0419-5862-a8ab-db01ed67c608,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1995,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
34b18611-fa05-568a-8e4c-358e8525c1ef,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
46ee949e-91ac-585a-b287-023dda00ab3d,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
9234f877-58d0-540d-89b1-9666a42bbfc4,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
04f8eb46-e4c3-5074-ae25-c74e2facb1df,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
fdbce5bb-88bb-572b-8b58-e3f94a340c33,female,Alive,1957,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
2f20b9e2-817b-5e08-a486-b2009adaea1f,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1997,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
e0c51d2e-2739-5a27-ad54-25d14c00f90a,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
fc98d37b-3159-5080-92f4-829f488879b6,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
e6364172-46ac-520d-af07-f1d3d5bedeb9,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
42b773b4-de7e-563d-b394-022955a80a1b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
914f33d3-f471-5217-ab80-a340b1a61a93,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
877f9a19-9723-5331-bde9-2b6313f89de2,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
ad41e1ef-c12d-539c-936a-66be05ef82b6,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
0427721e-1969-585e-96ef-584f2d46f0fc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
992e1ed5-04f1-53ff-9084-e6594408070b,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
5a99a5f6-68c6-5de3-97e6-d1990afc1648,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
87e40b47-5597-599e-a9ae-34e77130cda2,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
9f6ec603-0186-5e86-bd95-3ae3fe32682b,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
d376f28e-2c9a-54ab-9426-adfa028674d4,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
725602a2-1229-515a-b401-94a1ead148af,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
4c77a875-5eef-5480-b468-2ba87b6173ea,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
692609e2-c553-550a-ac55-c875089ec9f1,female,Alive,1972,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
f8e5ff46-e164-5917-9a43-dcb119802be6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
540f6a1a-88ee-5303-8612-f84ac47bc183,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
8c2d24f1-cb1d-5b13-84a0-dcccefd1655c,female,Alive,1954,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
3c625a1d-559a-5c1f-a2ac-a798cda8da14,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
b77ca676-a31b-51be-bf22-fc4de05b5d1c,female,Alive,1944,--,"Carcinoma, undifferentiated, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a4323184-d6f7-50dc-85ae-1b9adbf70349,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
e5131de6-df58-5310-8f3f-9792154e2d41,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
12fbd795-9cb8-5b5b-9c91-533a3df57bfc,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
0b11fb4d-52a2-56e1-9cef-35568e1a2c19,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
7e3c3954-9e54-5294-be2e-0761ef69da77,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
5693261a-fc8a-5ba2-b87a-1fbb44a72372,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
c5e55511-7437-599c-9032-552b66dedc28,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
73986089-8e5f-5a89-8e84-674c67d66ce7,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
e00830e7-7afa-5262-95b1-9ec093cf6ff4,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
152431b8-e214-5341-b373-68135dc22afb,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
018043c6-bd82-5183-8d98-7b422d6d321c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
2861a82d-0e91-541e-b77d-c4585dc408e9,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
ed7b2087-cf0f-5360-be88-97a509a5dcbf,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
f3903f35-c35d-54f4-be3d-4c655da416f4,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
1db96901-2fe2-55cd-84fa-dc1d0da97ede,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
50c45796-e968-564d-9c4b-165c22625230,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
06154713-6fc5-589b-8799-e904a7d3ebd6,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
51289bbf-8cc2-5022-bfdd-b1377b17ce22,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
2a3c98a5-a5b9-56cc-9247-093e90862409,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
0ecef8f0-f148-5b31-8f6d-ea0e4f2440da,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
e6364172-46ac-520d-af07-f1d3d5bedeb9,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
2842e7d2-131b-560d-9b81-97d97647ff8a,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
5693261a-fc8a-5ba2-b87a-1fbb44a72372,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
33d6af45-80b9-546f-a040-7441d66a34d7,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
ed7b2087-cf0f-5360-be88-97a509a5dcbf,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
1f26523e-25cd-56bb-9040-3a6c41c9990a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
1e9d614e-a709-5368-ad16-6a95d293e547,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
157a0de8-9a60-547a-92df-8b04e55b9482,female,Alive,1920,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
cb02881c-ab1f-5acf-ac66-56e28fae03c7,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
b2815b75-c7ba-5b55-bcdc-21aabbed3b28,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
6014440f-b492-52dc-a262-f14f49e88341,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
d090c047-cf0d-569c-beb8-c5a933d12d42,female,Alive,1926,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
1974fb64-2bf1-5ae4-a1d3-549373310899,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
e5131de6-df58-5310-8f3f-9792154e2d41,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
21211a7f-bfde-54df-8a7d-c139cb0922c9,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
0599478f-7f76-560c-a1c0-93972e0d41da,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
c7999b4d-27ca-56c5-bf89-79ad97db1621,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
484728d0-24db-5eb6-af3c-0702a2907055,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
2f20b9e2-817b-5e08-a486-b2009adaea1f,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
ea34983c-8abf-5e0e-b795-731c3baf565e,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
558de49a-8e14-51dd-8df2-fca36ddbcf3d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
a7d688f5-0410-5408-8e94-f4d5621df1df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
48c62578-8e2e-5d1a-a37a-f971a6d5b7f2,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
16d35689-c5a4-50b8-b9ee-af408c742373,female,Alive,1940,--,Serous surface papillary carcinoma,"Pharmaceutical Therapy, NOS",2013,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
932b5f34-279f-58a1-b7ea-5ac264c68f39,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
f558be12-2a1f-5506-b7a5-39ae58109415,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
3505f603-e5fb-5a9e-8824-99e97c974956,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
2b099a95-8a5f-51ce-ace7-57107a9affab,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
255807e2-d413-5f0e-8244-0047a41ee5fe,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
c049a25f-94b1-5f01-a13c-0ec35b371750,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
20432a64-7226-55a6-bc3f-2c6dd69a4572,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
dde39d8c-7e4a-5965-852b-cd6904b2e99e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
0c86e026-26be-5c46-b41c-fa8aaaf5668b,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
58b46677-323d-533b-980b-5a724af621af,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
f3e4184b-0452-5930-98c5-ac8023f647f4,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
3eb25b7a-aeb5-5adc-b873-2ff37b59675f,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
b2b94f43-6ae2-5741-a03e-9bd5b9d71433,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
190653c3-b629-5caf-8cad-8a6dfc4b62f9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
0cc93255-8851-55bd-a9eb-0619ad5f924b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
628a9231-6a6f-58ee-bb03-77194c4e2534,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
9a587a49-7e43-57b6-9599-0dfd29696ad7,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
dac92b16-78e8-5599-94e2-bf73feae8378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
6576c375-63ee-5f39-8eba-d41859b9dc27,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
92763274-a8e2-5612-a776-b334b6ae5dbe,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
5b89e6af-bc94-5d29-9aae-508edc9f7ae2,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
eb35520c-df45-5f2c-a0c9-e8edc9832a81,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
dbd03450-1805-5569-9589-3d0455324e64,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
a761f58b-17f5-5a95-9d10-299a4fbf98e7,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
4d5a76c9-3887-5675-bb43-b0fb50bc0d49,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
32f9bc7f-6bbe-55fb-8c70-28e7cd114d27,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
8f20f1ea-97c6-5bcf-8305-b4b7451de028,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
ce0d78ee-e0db-55d8-88b5-227de3fbf4d2,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
8802988a-0d68-5a09-bdc4-3b21e28f31f8,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
1bcc5a0d-6671-5861-b26d-b67afa80d667,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
3706c952-17d0-5829-9624-26ed35ce61c6,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
316d7ad8-9075-5bbb-b4b3-a38a05ae77c3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
a725b8c8-1661-5ee3-8187-e4cb2286b6ed,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
42256e3f-852f-5914-8b38-744378ef0cac,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
157a0de8-9a60-547a-92df-8b04e55b9482,female,Alive,1920,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
5c40ea92-1293-5e14-96bf-5e39c5875c25,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
9a587a49-7e43-57b6-9599-0dfd29696ad7,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
ea1129e7-d64f-5806-8611-03a0818e92fc,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
5155c521-35ee-5ea9-be34-9912fa0d736b,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
ffaff7f1-1d96-5720-9231-587e03833f53,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
59388de5-fd85-5e5e-9f59-87345330429b,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
c24bb733-c129-5932-bba5-c197ac5b1bef,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
6a80fd66-a580-51bd-b9f9-c954eb173de6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
2861a82d-0e91-541e-b77d-c4585dc408e9,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
94dfa136-8422-58f4-a7c3-0856703cb127,female,Alive,1919,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
0cbf6c30-6909-56ac-9390-67b1bba5eaac,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
c4dacc00-24ae-5643-ba9f-f81668f7fc01,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
af950860-01d9-57e3-a223-7ae401b8c798,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
96e572fd-b222-549c-969e-fd4cc8e894d3,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ce0d78ee-e0db-55d8-88b5-227de3fbf4d2,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
d45a801b-a1cd-51a8-abd6-5b5f4ad4f091,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
2842e7d2-131b-560d-9b81-97d97647ff8a,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
eb111509-466e-5511-a767-c881fb9375e6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
95fd1298-1173-577a-ad75-1755f2ea7291,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
f4b4d94a-2b7d-53bd-8d10-811b893eed5d,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
f3e4184b-0452-5930-98c5-ac8023f647f4,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
2892198e-6c40-564b-b111-52a3797e9f8c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
3814abc2-97c0-50d9-9f26-8ef2db2993f8,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
6f899329-75a0-56df-99c2-e4cc79c2a1c4,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
de77fb9d-02b5-5d16-994a-46fa5a3e323b,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1995,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
694e78fe-7a46-5958-8551-9345298fe4ba,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
15d4e11d-5881-5dc0-b3ab-6deca92452a2,female,Alive,1923,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
f7a149e5-b25a-58e3-8ad4-4457ffb83a89,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
ce12f12d-6909-5e15-b949-98cea3d19440,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
ffc30aed-dee2-51e6-b47a-6040fd685f9e,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
c0fa632c-0f09-59bd-9e43-fb1211bd54cb,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
4507d83f-2738-5679-abb2-92367a2ac213,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
adc48981-fe38-5f10-b8d5-97a058523a5c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
253415bb-94cc-5a4a-8235-d20cb0ee900e,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
196b8cc4-bb1e-5790-9ba1-218e0a0309a2,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
97f38906-f4fd-584b-9a15-679d55409e68,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
d090c047-cf0d-569c-beb8-c5a933d12d42,female,Alive,1926,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
23755925-6968-50a9-b660-040e517fa61c,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
f7a149e5-b25a-58e3-8ad4-4457ffb83a89,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
4a83af41-f0dd-5db8-a0bf-609e86d91d4a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
8edb6f51-93e3-5ff9-88f6-e970cb486bb6,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
558de49a-8e14-51dd-8df2-fca36ddbcf3d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
c3177194-2df1-5361-a8c2-9a181bc27742,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
2c8ee06f-8361-510d-816f-c0e4550cdbd7,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
255807e2-d413-5f0e-8244-0047a41ee5fe,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
13527a4f-c30d-54d3-87c3-f2e6883445da,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
c37ab2c0-3978-59ee-a387-6e4a98de35ec,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
5671514e-c9d4-5f07-b12a-568226f20275,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
93778d19-dd7a-5e27-8b67-4fba294de047,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
83619ed1-a7ed-5029-ae2d-608ce3dcbf3f,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
d5ecc0c8-b648-567c-bef5-093fbf06a6cf,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
4cf21d71-f8d6-515e-ab34-b6ce4a4126db,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
3fccce6d-e7af-5ff7-9246-31b7c387040d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
ce96d3e6-6f9d-54ec-8173-e7af52159c07,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
5a34c9fd-6e43-566b-8e12-af41e66ca002,female,Alive,1974,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
847fa83d-736f-5a87-a0db-2dfbe7973176,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
96e572fd-b222-549c-969e-fd4cc8e894d3,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
489ef6fd-7a84-59ac-966e-51af8f004b77,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
82aaf7e3-9a30-5061-b417-624d521b0883,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
3b813f30-d519-5c0e-9aa7-ce07c2780822,female,Alive,1968,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
9d386311-6715-5417-a3fb-06d248c6e813,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
ee1002c1-689a-5594-a725-effa8b8af1dc,female,Alive,1975,--,"Endometrioid adenocarcinoma, secretory variant","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
6ce087d0-d4e5-5568-a73d-d12df1aba4d9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
fdbce5bb-88bb-572b-8b58-e3f94a340c33,female,Alive,1957,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
27d1bde4-7227-5326-82a1-ce3dcf173f2d,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
a0452fbc-d834-54b0-a7af-54217646f706,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
b18085fa-a9fc-591d-97c2-4ca241b9bc92,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
b2b94f43-6ae2-5741-a03e-9bd5b9d71433,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
d4e997f3-b77d-5c7b-8e71-f598cfd8f14a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
bffaa34a-37f1-5822-ab31-7d17a1aca9e4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
932b5f34-279f-58a1-b7ea-5ac264c68f39,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
50b47db9-0041-58d4-b3a7-b028b78418ec,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d,female,Alive,1965,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
358c1776-769f-553f-9b5b-edaa92da5a9a,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
16d35689-c5a4-50b8-b9ee-af408c742373,female,Alive,1940,--,Serous surface papillary carcinoma,"Radiation Therapy, NOS",2013,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
c5e55511-7437-599c-9032-552b66dedc28,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
ac45a829-3a9a-5711-953f-829b2fec2583,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
d0725cda-50ff-56dc-a9bd-64f4ae186931,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
519905a6-d464-5f72-bbe1-83bc661c1821,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
fe1253ff-6372-59d4-95d5-b7799dd58660,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
93c550da-55b4-5bf1-be9c-bbc05ba86643,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
bb77659e-237f-5a94-8538-2fb5d2a1797f,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
52e346ab-59e4-5cfc-97c1-ea275e8769a6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
b66db2b7-1f4f-5998-bc30-50af2b0a5309,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
eada4ab5-d648-5c4f-9f46-ea31cebd6457,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
dc97087e-e474-5a4a-ae55-9df2cd584547,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
0dc5ba75-646a-5fac-be58-86ae178ea9a3,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
f2d6d9b4-f88a-5830-a5d4-499a571ee71f,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
2a3c98a5-a5b9-56cc-9247-093e90862409,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
50c45796-e968-564d-9c4b-165c22625230,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
400b2e1e-7ebf-56da-a404-7bc683ec14ce,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
e6a8c88e-d05a-5bd9-9167-6afdcb41699d,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
ae46540d-b520-585f-941d-5492c9ae03bb,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
deb86788-08c6-59ba-9c5d-5637dd170b6e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
603ef2c1-6a1b-5889-926a-2cb5e9eaaba8,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
3fccce6d-e7af-5ff7-9246-31b7c387040d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
628a9231-6a6f-58ee-bb03-77194c4e2534,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
5adae4ab-9d4c-5380-ba44-2fc49810993d,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
eb111509-466e-5511-a767-c881fb9375e6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
606473b1-aaf5-50b5-9b3f-fd2fe9945ded,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
f0d1ed71-a6fc-526b-9a5a-8183ccd0229d,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
ab0425be-3d1c-5564-b557-614a4080be6a,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
5130114a-f1c7-5f3d-ae99-e5202537213c,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
097a59d7-4cf0-51e6-b86b-bdf1052dd68b,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
ab0425be-3d1c-5564-b557-614a4080be6a,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
f2d6d9b4-f88a-5830-a5d4-499a571ee71f,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
b18085fa-a9fc-591d-97c2-4ca241b9bc92,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
e8d75a74-9bea-5427-ac4c-e20566531835,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
e5720da2-a49b-5fb5-abcc-a6160a9f1e5b,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
dd1d384b-f3e5-53cb-b3e1-cff1a4d84850,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
3814abc2-97c0-50d9-9f26-8ef2db2993f8,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
94e5d21e-5343-553f-80b3-79fb4e38d0ba,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
e75c880e-40b7-5369-8760-575774b83938,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
7dd5c05e-762f-5589-8195-2e1094cbb70d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
2b099a95-8a5f-51ce-ace7-57107a9affab,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
8802988a-0d68-5a09-bdc4-3b21e28f31f8,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
6a80fd66-a580-51bd-b9f9-c954eb173de6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
ea1129e7-d64f-5806-8611-03a0818e92fc,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
30f06462-90ed-5004-81de-422d8ce9b270,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5f17d402-31f5-519a-8045-d4092aead279,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
715f8a44-a741-5bf0-977f-2d443c2c098d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
ad5dab9e-da95-57a2-aee7-1d0708b16f05,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
e1dc80db-4a53-5b1c-9d21-5577d2a116db,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
bfa17d93-143b-53bf-953e-b442f40b66da,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
f0036ae7-4205-5040-8e3e-a693f85e34ec,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
a0172345-d345-5bd2-b785-7f054781a0fe,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
7150706f-be8d-5f53-8882-93c479869817,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
524b3bcd-5407-5806-9e56-c91529f85f1e,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
90e1163b-6080-5f74-b548-83420da90baf,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
b0e6de39-ab28-5b60-90a2-2ae8485c99d9,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
921580f9-9167-5eb6-86ee-2c4f16954e7c,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
8a10a03b-4e16-529a-9ea8-d36aa532aad9,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
f0e29733-ab34-52ea-8d38-1c603eda8865,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
ae46540d-b520-585f-941d-5492c9ae03bb,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
55b042ff-89d8-5610-8f99-d3f469e6edd4,female,Alive,1921,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
105fd313-edc4-545d-b653-07fd87c0f017,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
561d660f-959e-5ee1-8989-14eebe9c71a9,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
1bcc5a0d-6671-5861-b26d-b67afa80d667,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
ab7c810e-febe-5caa-a6c2-35ad0f421909,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
c24bb733-c129-5932-bba5-c197ac5b1bef,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
847fa83d-736f-5a87-a0db-2dfbe7973176,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
9bc7569c-897a-5443-a8f7-f160ecba3605,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
9e21e02c-b227-5e1f-8ed6-c145c7713145,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
5155c521-35ee-5ea9-be34-9912fa0d736b,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
95491576-be63-50fd-a69a-453ec41714bb,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
e0c51d2e-2739-5a27-ad54-25d14c00f90a,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
e46162a7-b38d-5473-ba17-81b4e62c5c17,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
5e8f2da5-7f61-5140-9364-25325bf20cad,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
a3d8b15e-c949-5b84-8dfa-e04e6ef92814,female,Alive,1925,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
6890a0be-464d-57fe-a1e4-40299008de2c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
06154713-6fc5-589b-8799-e904a7d3ebd6,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
129632b7-438f-510e-9eab-1d43fc365cc0,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
62496790-a6d7-551d-98e3-2cccd01e73d2,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
e7a98c2c-539d-501e-8a18-f269636399ec,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
dcfe6a13-0521-5b95-bb52-c2c413703643,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
d8c4248b-3e80-5a02-bf28-aff20c54f0dc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
e7a98c2c-539d-501e-8a18-f269636399ec,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
e636331b-e748-57b6-8d24-32106af64cdf,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
3fecafa2-72e6-51c6-83b4-ad54786e9d2b,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
803b97ad-544f-5652-a79b-7dc4f1df6e1c,female,Alive,1920,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2004,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
ca39bf6f-6549-5d17-ae60-15dde3f5a32d,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
fd594d66-0c40-5b02-9262-afbc6549a207,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
68902cda-85a5-5b5d-8aa5-69a8fc3b7da5,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
b13e3c60-a675-5a8c-a335-12e65a23a310,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
04f8eb46-e4c3-5074-ae25-c74e2facb1df,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
9e21e02c-b227-5e1f-8ed6-c145c7713145,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4,female,Alive,1966,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
909e5384-bc65-57da-a325-b3e37696288a,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
215f190d-5fd9-57db-9461-d00abcfae4e0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
8c2d24f1-cb1d-5b13-84a0-dcccefd1655c,female,Alive,1954,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
a7d5fa96-a744-5b60-90ae-aecdafa90d04,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
f4b4d94a-2b7d-53bd-8d10-811b893eed5d,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
deb86788-08c6-59ba-9c5d-5637dd170b6e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
9234f877-58d0-540d-89b1-9666a42bbfc4,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
95fd1298-1173-577a-ad75-1755f2ea7291,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
f51e0306-5841-5740-83d5-43755b0b9f1e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
6fd6df70-ae97-57fd-97f6-997004450695,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
15dac957-20b9-50f8-8f86-a1d216f696d3,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a5a0d889-9d31-55c0-80a8-9c3eb31ed85d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
20432a64-7226-55a6-bc3f-2c6dd69a4572,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
2d640521-fd23-5176-bb37-d5e66cbca59a,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
26a37a66-829e-5cad-b2d4-c18ad2b5d28f,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
803b97ad-544f-5652-a79b-7dc4f1df6e1c,female,Alive,1920,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
c3177194-2df1-5361-a8c2-9a181bc27742,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
89dd9b5b-71a2-599c-b86a-9631ef174de5,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
62e5753a-c900-5b22-b3ab-7d11afe47bdf,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
44ebf565-e6c0-59c5-a3d6-7e355683c90a,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
6576c375-63ee-5f39-8eba-d41859b9dc27,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
9414ed5c-c3bf-5195-b220-09297a960ba8,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
7a2e57b2-e19b-5407-967c-2f076d5ee7fc,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
6fd6df70-ae97-57fd-97f6-997004450695,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4,female,Alive,1966,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
0ac0360f-5df5-52b5-a219-49f145a7e2ba,female,Alive,1951,--,"Endometrioid adenocarcinoma, secretory variant","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
f51e0306-5841-5740-83d5-43755b0b9f1e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
4bb8f00c-d398-5777-8070-31fa84085acd,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
e331981e-7b68-53b7-95c2-5cf15949c2ea,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
9f7d00ec-c32d-54a4-b535-29f67966f7b6,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
a9871d31-b21f-58cf-99c9-c43961029a80,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
13527a4f-c30d-54d3-87c3-f2e6883445da,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
32525c21-d012-5d48-add2-322fb2132125,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
d762555b-0370-5081-905f-16fa84728790,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
f3f20b72-0419-5862-a8ab-db01ed67c608,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",1995,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
11bbbb3d-ec5c-5cb7-885c-50576834f378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
65b14ddc-7ed2-577d-b70b-affa93ccebdd,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
9c7ebc91-28c8-5947-adb5-8a59ce7a93c4,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
0926f2b4-a18a-531b-82a7-f798da65b318,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
337f449f-972e-5bc5-a434-fe6dfca3d407,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
05c600f7-24d5-5768-9a0b-9c03dc374335,female,Alive,1930,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2001,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
f34a2659-0257-5109-8d37-63fd9d62af15,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
ef38b762-6e65-5a5f-985e-ae40bec376aa,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
0740835f-f4ed-5dc5-8ff0-d9df87dbd640,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
83619ed1-a7ed-5029-ae2d-608ce3dcbf3f,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
75adb354-65dc-56e8-a9bb-d01ff7b9ec15,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
23aad101-4296-5c7d-9bd5-05f34d2cba6f,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
ee1002c1-689a-5594-a725-effa8b8af1dc,female,Alive,1975,--,"Endometrioid adenocarcinoma, secretory variant","Pharmaceutical Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
a44ec5e7-b90f-5892-bdaa-19fe891d1b50,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
adc48981-fe38-5f10-b8d5-97a058523a5c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
e62a79ee-848d-50f1-a4e5-e32f4eb1605b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
4197c40d-f4d9-5603-8712-f15525e88cf4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
b85bd397-ef0d-53ff-a97e-1078fd412234,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
fe1253ff-6372-59d4-95d5-b7799dd58660,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
ce96d3e6-6f9d-54ec-8173-e7af52159c07,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
94140e88-a9fa-5519-947c-1960dd16a2cd,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
5af7b769-4f26-5003-8b0c-835175118797,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
92af23e2-41c0-5f21-ad67-cd16091385df,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
992e1ed5-04f1-53ff-9084-e6594408070b,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
5f17d402-31f5-519a-8045-d4092aead279,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
5130114a-f1c7-5f3d-ae99-e5202537213c,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
4483f9f3-4e11-52f5-bdd7-074f47cde40d,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8,female,Alive,1918,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
7d93421a-71dc-502a-9c1a-8d3d30104edf,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
9251d9f1-be21-5e38-9822-eede8d5cc51c,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
4d444b66-2a61-5097-8234-82701fa74420,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
877f9a19-9723-5331-bde9-2b6313f89de2,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
d762555b-0370-5081-905f-16fa84728790,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
e994a2fd-e48e-59d3-8f79-518983164bf1,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
fbe59fad-77f1-5a5c-be08-9129ca24a265,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
c172bc97-df3f-59ab-b64c-63529d29ba3d,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
344d426f-68fd-5ffe-8808-4716cab3c3c5,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0feea406-ba2e-5a9f-b989-213d6a3964aa,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
5c40ea92-1293-5e14-96bf-5e39c5875c25,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
4bed5f1e-e85b-5763-bb8b-ea0029cf902d,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
d45a801b-a1cd-51a8-abd6-5b5f4ad4f091,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
baa2500b-d4c9-5e0f-bc4a-41390e221f01,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
e6a8c88e-d05a-5bd9-9167-6afdcb41699d,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
abe07506-82c6-5605-8235-f6792943c654,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
ce12f12d-6909-5e15-b949-98cea3d19440,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
d0725cda-50ff-56dc-a9bd-64f4ae186931,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
fbd9da68-0278-5568-957d-94cbc2f6de8a,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
4b4e030a-6c7f-5469-9180-3d974b5900d2,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
bac1495d-3338-556a-b9d6-93239b967de8,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
f3903f35-c35d-54f4-be3d-4c655da416f4,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
d8c4248b-3e80-5a02-bf28-aff20c54f0dc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
a86dfa2e-5d13-51d3-bf8e-cad075653a3d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
c2e76a4c-ddb2-55de-baa7-c7067c1259f4,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
e5720da2-a49b-5fb5-abcc-a6160a9f1e5b,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
ee2f47ac-33f2-5a9e-8205-33f5961263b8,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
f42df73b-0462-5a66-b2da-39969fa1bcb0,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2001,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
ab7c810e-febe-5caa-a6c2-35ad0f421909,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
07f2d324-0079-5388-a28a-e7b6a3c00f3d,female,Alive,1955,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
f4785965-fb92-5876-80dc-48eba5d1a988,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
cd6ec347-4caf-5ff7-a22e-34c0c62a99b3,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
42256e3f-852f-5914-8b38-744378ef0cac,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
2d640521-fd23-5176-bb37-d5e66cbca59a,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
afd12a04-a61b-56c0-b7fc-bd90db975abb,female,Alive,1958,--,"Carcinoma, undifferentiated, NOS","Pharmaceutical Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
823c38c3-da83-5448-a724-54b825439b21,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
484728d0-24db-5eb6-af3c-0702a2907055,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
913d2af6-77a5-5410-a188-fe74d2567774,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
0309ac57-a9e4-5985-afaa-1c22c3de13d7,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
9c7ebc91-28c8-5947-adb5-8a59ce7a93c4,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
489ef6fd-7a84-59ac-966e-51af8f004b77,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
b9d31f87-628e-584a-b7ad-d7a6d69e6f91,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
400b2e1e-7ebf-56da-a404-7bc683ec14ce,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
9bc7569c-897a-5443-a8f7-f160ecba3605,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
823c38c3-da83-5448-a724-54b825439b21,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
af4a58b5-00b5-54cb-9916-1f23f97edda9,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
921580f9-9167-5eb6-86ee-2c4f16954e7c,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
d5d00d70-77b9-5443-bd30-112211cf1f36,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
30f06462-90ed-5004-81de-422d8ce9b270,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
be5b9e06-57b9-58e8-b0f2-c984c40219a7,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
e1dc80db-4a53-5b1c-9d21-5577d2a116db,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
d1af4708-62fe-5624-9a61-f1542621ba4b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
a79cde1d-b7cb-5f8f-9bfd-be728e18f270,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
b9fe82c2-4fea-502e-9d7d-7bd0b98acde3,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
94e5d21e-5343-553f-80b3-79fb4e38d0ba,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
0f4a1aa0-c451-5604-8efd-ca457cdff74c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
2c8ee06f-8361-510d-816f-c0e4550cdbd7,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
5bdd67ed-7c28-56a7-84b4-89f703283c5c,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
24d81207-6d0e-56d6-9cff-9d05306baef1,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
07c36ef4-9831-5e46-a1af-0458dd1703c6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
c8b4918b-961a-55ee-930c-51304d95033f,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
efdecf34-f346-53d8-9aab-eefc419d4463,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
0cbd2001-5067-5109-838d-3c053cfcfa55,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
75c88efc-df2b-5dc9-8f26-0a8826fc80c5,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
f8f23111-a666-52f4-aab4-9640dcf8e425,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
3085459e-dcc9-5589-b8de-cd5e8529769b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
e0765893-2c2e-50ce-a4c7-ac3526a8746e,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
6014440f-b492-52dc-a262-f14f49e88341,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
5af7b769-4f26-5003-8b0c-835175118797,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
a4c89303-0bac-562f-bd1a-207d4fd60680,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
dcfe6a13-0521-5b95-bb52-c2c413703643,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
e331981e-7b68-53b7-95c2-5cf15949c2ea,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
a968b7ee-1a75-5678-b036-8721f572b4d3,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
554b34de-9690-5845-a36e-4302ca06a99b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a0b12635-e4b8-5c98-8598-5d12f61f0f2a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
8edb6f51-93e3-5ff9-88f6-e970cb486bb6,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
2892198e-6c40-564b-b111-52a3797e9f8c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
7d93421a-71dc-502a-9c1a-8d3d30104edf,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
b0e6de39-ab28-5b60-90a2-2ae8485c99d9,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
0ac0360f-5df5-52b5-a219-49f145a7e2ba,female,Alive,1951,--,"Endometrioid adenocarcinoma, secretory variant","Radiation Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
ee615383-004f-552b-b4bb-3ec74433dfa9,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5bdd67ed-7c28-56a7-84b4-89f703283c5c,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
42b3c01b-def5-5cb2-be54-586665f83089,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
58b46677-323d-533b-980b-5a724af621af,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
59388de5-fd85-5e5e-9f59-87345330429b,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
2c8a958c-50b3-5c17-ad90-42e58160c400,female,Alive,1928,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
267743ea-2830-5b40-b683-f5e00d34c6c2,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
e00830e7-7afa-5262-95b1-9ec093cf6ff4,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
a3d8b15e-c949-5b84-8dfa-e04e6ef92814,female,Alive,1925,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
ee82158d-3054-55ab-a9f7-25cc3d32151e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d93c3f44-61a7-53ce-9bd8-a934eb81d151,female,Alive,1922,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
fbe59fad-77f1-5a5c-be08-9129ca24a265,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
4483f9f3-4e11-52f5-bdd7-074f47cde40d,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
1cfbb428-8eb0-51c0-ab30-92967445c79e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
7593a65f-93eb-5143-a5a6-8e4c144e0880,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
176c0a99-0302-5a6a-b9ad-30ff04e3360c,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
519905a6-d464-5f72-bbe1-83bc661c1821,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
22d6ec5d-0d1f-56e3-babd-8ee6d909622c,female,Alive,1977,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
33a85b3a-5efc-559a-958b-e7cc12adaff4,female,Alive,1973,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
f0036ae7-4205-5040-8e3e-a693f85e34ec,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
f34a2659-0257-5109-8d37-63fd9d62af15,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
33d6af45-80b9-546f-a040-7441d66a34d7,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
8ab5b506-712f-54cc-95f5-082df9ea6660,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
92af23e2-41c0-5f21-ad67-cd16091385df,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
d2b3ab8b-b070-588b-b574-8ee86e7eff94,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
42b773b4-de7e-563d-b394-022955a80a1b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
3eafb5fd-b307-50ba-838d-d8a4921cce6d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
92763274-a8e2-5612-a776-b334b6ae5dbe,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
913d2af6-77a5-5410-a188-fe74d2567774,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
e8476897-909b-57ac-abe1-14a9f79e2a3a,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
a9871d31-b21f-58cf-99c9-c43961029a80,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
51e0a502-6a75-5175-89d6-43421041fff7,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
92a5ea75-6ced-568e-928f-d1aef0646988,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
71e171de-4fbc-5396-8a52-e362331a8fd9,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
1e0b3a28-6504-56ef-80e0-7c9db03689ee,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
a0452fbc-d834-54b0-a7af-54217646f706,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
afd12a04-a61b-56c0-b7fc-bd90db975abb,female,Alive,1958,--,"Carcinoma, undifferentiated, NOS","Radiation Therapy, NOS",2008,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
118bb2cb-a544-5ce7-9eba-f989bd4f48f0,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
d1af4708-62fe-5624-9a61-f1542621ba4b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
bbb417a3-02c2-56b4-b115-92346aa6216f,female,Alive,1940,--,"Adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
f42df73b-0462-5a66-b2da-39969fa1bcb0,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
0599478f-7f76-560c-a1c0-93972e0d41da,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
1919a3a7-a04e-5f06-bbe2-d190bee937e0,female,Alive,1946,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
79264be9-ce83-5574-b4de-74e520602570,female,Alive,1923,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
3fecafa2-72e6-51c6-83b4-ad54786e9d2b,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
46ee949e-91ac-585a-b287-023dda00ab3d,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
018043c6-bd82-5183-8d98-7b422d6d321c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
5adae4ab-9d4c-5380-ba44-2fc49810993d,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
abe07506-82c6-5605-8235-f6792943c654,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
55b042ff-89d8-5610-8f99-d3f469e6edd4,female,Alive,1921,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
ce8a91da-f81d-51b6-a2e5-82541798e6b9,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
202ea12b-b0a4-5b04-be06-d9780a653387,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
124d1f29-524a-57e0-b4eb-6ed018678122,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
344d426f-68fd-5ffe-8808-4716cab3c3c5,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
0dc5ba75-646a-5fac-be58-86ae178ea9a3,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
914f33d3-f471-5217-ab80-a340b1a61a93,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
a1f289cf-dd76-53da-85d7-8289e9f6d3fa,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
97f38906-f4fd-584b-9a15-679d55409e68,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
eb14ffb2-f120-5873-8146-038dadc0fba8,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
a79cde1d-b7cb-5f8f-9bfd-be728e18f270,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
ca39bf6f-6549-5d17-ae60-15dde3f5a32d,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
07c36ef4-9831-5e46-a1af-0458dd1703c6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
0cbf6c30-6909-56ac-9390-67b1bba5eaac,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
15d4e11d-5881-5dc0-b3ab-6deca92452a2,female,Alive,1923,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
0c86e026-26be-5c46-b41c-fa8aaaf5668b,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
7d424c52-15ea-5d54-9fc8-3bdfb035d686,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
399576fd-07c2-54de-bfad-53f280417976,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
68eeb680-0c16-5cd2-ad66-077e1551696c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
90e1163b-6080-5f74-b548-83420da90baf,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
3b813f30-d519-5c0e-9aa7-ce07c2780822,female,Alive,1968,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
0ecef8f0-f148-5b31-8f6d-ea0e4f2440da,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
ee9641f4-f36d-5742-be0c-130144f39240,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
8a10a03b-4e16-529a-9ea8-d36aa532aad9,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
34b18611-fa05-568a-8e4c-358e8525c1ef,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d376f28e-2c9a-54ab-9426-adfa028674d4,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
f6beb124-7592-52b5-9440-69a20be0004e,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
73f1bca1-fc2b-5767-899a-8ff467a68d62,female,Alive,1933,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
7e3c3954-9e54-5294-be2e-0761ef69da77,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
51289bbf-8cc2-5022-bfdd-b1377b17ce22,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
606473b1-aaf5-50b5-9b3f-fd2fe9945ded,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
1c25671b-2d5d-5bb4-b022-6c8571ccc85f,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
608b1f93-afe7-5b95-bf1c-dfd43e6e96ae,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
3eafb5fd-b307-50ba-838d-d8a4921cce6d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
bb65e3c6-0979-5f98-a76c-dc2b773cc795,female,Alive,1959,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
af4a58b5-00b5-54cb-9916-1f23f97edda9,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
7593a65f-93eb-5143-a5a6-8e4c144e0880,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
05c600f7-24d5-5768-9a0b-9c03dc374335,female,Alive,1930,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
aa2b17e8-1a85-503a-b7ba-7847433aafaf,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
27868555-f3af-59fb-ba00-4da9c14176e1,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
b2815b75-c7ba-5b55-bcdc-21aabbed3b28,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
820573ea-7bc9-59dd-aca0-e4e712597461,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
d5d00d70-77b9-5443-bd30-112211cf1f36,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
dbc9ef72-8377-52a7-b0cc-6a29c0c1c174,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
2a8d54bd-2634-51fc-86cf-c8e882f98f3b,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
694e78fe-7a46-5958-8551-9345298fe4ba,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
a0d7577a-1868-535e-b229-e0ea205cd267,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
1b1c4e7b-2386-52da-929c-fc293a8cbad3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
2a8d54bd-2634-51fc-86cf-c8e882f98f3b,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",1997,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
07f2d324-0079-5388-a28a-e7b6a3c00f3d,female,Alive,1955,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
18454974-897b-5a0c-8f4e-a15d6a2da0f9,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
4cf21d71-f8d6-515e-ab34-b6ce4a4126db,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
071110ba-b63c-5157-8a7a-12db64b4c1fd,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
65b14ddc-7ed2-577d-b70b-affa93ccebdd,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
540f6a1a-88ee-5303-8612-f84ac47bc183,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
b9d31f87-628e-584a-b7ad-d7a6d69e6f91,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
17832a39-9b9c-59f2-a313-ab23798e31fa,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
1974fb64-2bf1-5ae4-a1d3-549373310899,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
8bd8505e-e3b3-5167-adc2-d6abce781dc6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
a0d7577a-1868-535e-b229-e0ea205cd267,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
a0172345-d345-5bd2-b785-7f054781a0fe,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
7fe5583a-aa8c-5ce8-896a-0397ead74a1a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
75adb354-65dc-56e8-a9bb-d01ff7b9ec15,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
cc57dcd7-5e85-5e52-b35b-4adf130b31d7,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
a4c89303-0bac-562f-bd1a-207d4fd60680,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
8de932fa-c5e3-5a52-b36c-7989aee3737b,female,Alive,1935,--,"Clear cell adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
ac45a829-3a9a-5711-953f-829b2fec2583,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
dac92b16-78e8-5599-94e2-bf73feae8378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
0f4a1aa0-c451-5604-8efd-ca457cdff74c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
692609e2-c553-550a-ac55-c875089ec9f1,female,Alive,1972,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
89dd9b5b-71a2-599c-b86a-9631ef174de5,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
e8d75a74-9bea-5427-ac4c-e20566531835,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
5b89e6af-bc94-5d29-9aae-508edc9f7ae2,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
51e0a502-6a75-5175-89d6-43421041fff7,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
34a4b0c0-cafa-5ade-9250-9a33891abdf0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
6ce087d0-d4e5-5568-a73d-d12df1aba4d9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
bb65e3c6-0979-5f98-a76c-dc2b773cc795,female,Alive,1959,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
34a4b0c0-cafa-5ade-9250-9a33891abdf0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
7fa24ac1-267b-525f-8deb-3a2b9b0e64a9,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
8a10febd-d599-50a1-a42c-6dee0e428a6a,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
253415bb-94cc-5a4a-8235-d20cb0ee900e,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
ad41e1ef-c12d-539c-936a-66be05ef82b6,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
6890a0be-464d-57fe-a1e4-40299008de2c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
0cc93255-8851-55bd-a9eb-0619ad5f924b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
202ea12b-b0a4-5b04-be06-d9780a653387,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
22ddbd13-3b49-5a2d-a251-a5cbe4b96c39,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
358c1776-769f-553f-9b5b-edaa92da5a9a,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
e2e24506-9147-5af7-abf8-8e974293db26,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
93c550da-55b4-5bf1-be9c-bbc05ba86643,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
15dac957-20b9-50f8-8f86-a1d216f696d3,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
32525c21-d012-5d48-add2-322fb2132125,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
0fe639d2-e36c-5dd9-bed0-8e11e1d36a61,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
877d24ed-dd52-5247-95aa-d023b682a6dd,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
ffc30aed-dee2-51e6-b47a-6040fd685f9e,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
8de932fa-c5e3-5a52-b36c-7989aee3737b,female,Alive,1935,--,"Clear cell adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
8dc88809-3a23-5cdf-8f5a-97e7747200b9,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
75c88efc-df2b-5dc9-8f26-0a8826fc80c5,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
e62a79ee-848d-50f1-a4e5-e32f4eb1605b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
196b8cc4-bb1e-5790-9ba1-218e0a0309a2,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ee615383-004f-552b-b4bb-3ec74433dfa9,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
97fe2fbf-2085-5ffe-a6f9-5133af42f12d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
11bbbb3d-ec5c-5cb7-885c-50576834f378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
6cb2b392-7f9d-56ff-951f-50fa1961540e,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
50b47db9-0041-58d4-b3a7-b028b78418ec,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
b6988514-2f1c-5264-b604-412054c5d4ec,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
eb14ffb2-f120-5873-8146-038dadc0fba8,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
a1f289cf-dd76-53da-85d7-8289e9f6d3fa,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
d6a3f6e0-9fcc-5add-a7b0-77050a978c56,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2013,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
152431b8-e214-5341-b373-68135dc22afb,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
86dca230-c669-54c6-b78d-74b1fa5a7b19,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
129632b7-438f-510e-9eab-1d43fc365cc0,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
92a5ea75-6ced-568e-928f-d1aef0646988,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
94dfa136-8422-58f4-a7c3-0856703cb127,female,Alive,1919,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
6f899329-75a0-56df-99c2-e4cc79c2a1c4,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
877d24ed-dd52-5247-95aa-d023b682a6dd,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
dde39d8c-7e4a-5965-852b-cd6904b2e99e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
105fd313-edc4-545d-b653-07fd87c0f017,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
aa2b17e8-1a85-503a-b7ba-7847433aafaf,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
c8b4918b-961a-55ee-930c-51304d95033f,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
81b84182-932d-5e2e-9d97-0000ec2b42db,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
62e5753a-c900-5b22-b3ab-7d11afe47bdf,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
22ddbd13-3b49-5a2d-a251-a5cbe4b96c39,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
fa79ab3e-3e6a-53f8-8f85-fe4c34052427,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
b66db2b7-1f4f-5998-bc30-50af2b0a5309,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
af758c42-36b7-5be1-b6ac-87916ca117fb,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
7a1bcab4-1dc6-5dff-bebc-6d77458d082e,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
27d1bde4-7227-5326-82a1-ce3dcf173f2d,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2013,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
dd1d384b-f3e5-53cb-b3e1-cff1a4d84850,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
7847ae82-f710-579e-a09d-765bec5e27a0,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
eb77bd79-bd4a-5ef4-a359-c918b069e1a3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
3171801b-ead8-54fc-a7b9-481100dfe39d,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
1cfbb428-8eb0-51c0-ab30-92967445c79e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
eada4ab5-d648-5c4f-9f46-ea31cebd6457,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
52e346ab-59e4-5cfc-97c1-ea275e8769a6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
dbd03450-1805-5569-9589-3d0455324e64,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
29722ebf-3505-5430-ab99-d9f747ae451e,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0427721e-1969-585e-96ef-584f2d46f0fc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
031b9275-feab-5a98-ab1d-ea8def8bce56,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
03dbbfce-a850-50b1-a52b-10a4bda28aaa,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
3b6442dc-a44c-5d6d-91f4-9aabb0781977,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
d6a3f6e0-9fcc-5add-a7b0-77050a978c56,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
1c25671b-2d5d-5bb4-b022-6c8571ccc85f,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
78723c73-98b3-5130-8a7b-d983311f213b,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
a725b8c8-1661-5ee3-8187-e4cb2286b6ed,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
a1684e59-c0e1-56da-b466-e8365faf08b9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
f6beb124-7592-52b5-9440-69a20be0004e,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
32f9bc7f-6bbe-55fb-8c70-28e7cd114d27,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
a4323184-d6f7-50dc-85ae-1b9adbf70349,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
bac1495d-3338-556a-b9d6-93239b967de8,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
bb77659e-237f-5a94-8538-2fb5d2a1797f,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
3d97f2b9-778a-5826-8aa7-ddc7402c36c2,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
d62cdfef-4a5d-51b3-90a0-369c60216423,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
f0d1ed71-a6fc-526b-9a5a-8183ccd0229d,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
e994a2fd-e48e-59d3-8f79-518983164bf1,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
3505f603-e5fb-5a9e-8824-99e97c974956,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
b77ca676-a31b-51be-bf22-fc4de05b5d1c,female,Alive,1944,--,"Carcinoma, undifferentiated, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
ee82158d-3054-55ab-a9f7-25cc3d32151e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
4d5a76c9-3887-5675-bb43-b0fb50bc0d49,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
4507d83f-2738-5679-abb2-92367a2ac213,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
7fa24ac1-267b-525f-8deb-3a2b9b0e64a9,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
1b0c592e-7c31-555e-bf54-a9b7dc83eaa5,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
0feea406-ba2e-5a9f-b989-213d6a3964aa,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
561d660f-959e-5ee1-8989-14eebe9c71a9,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
5e0b5d34-f9df-502e-94e6-7bfeeb92a539,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
071110ba-b63c-5157-8a7a-12db64b4c1fd,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
f0e29733-ab34-52ea-8d38-1c603eda8865,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
22d6ec5d-0d1f-56e3-babd-8ee6d909622c,female,Alive,1977,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
6e7bc132-cc3f-5675-b3bf-252c8a970841,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
a1684e59-c0e1-56da-b466-e8365faf08b9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
cd6ec347-4caf-5ff7-a22e-34c0c62a99b3,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
036e7831-79a7-520f-9b55-d3fa32a88c71,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
63c1a62a-724b-537a-ae88-6845143841c9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
81b84182-932d-5e2e-9d97-0000ec2b42db,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
d2b3ab8b-b070-588b-b574-8ee86e7eff94,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
29722ebf-3505-5430-ab99-d9f747ae451e,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
5e8f2da5-7f61-5140-9364-25325bf20cad,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
118bb2cb-a544-5ce7-9eba-f989bd4f48f0,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
7dd5c05e-762f-5589-8195-2e1094cbb70d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
4bb8f00c-d398-5777-8070-31fa84085acd,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
94140e88-a9fa-5519-947c-1960dd16a2cd,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
9f7d00ec-c32d-54a4-b535-29f67966f7b6,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
8dc88809-3a23-5cdf-8f5a-97e7747200b9,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
7150706f-be8d-5f53-8882-93c479869817,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
93b52e42-bee1-5a84-973a-5dec59c6e5ed,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
7a1bcab4-1dc6-5dff-bebc-6d77458d082e,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
316d7ad8-9075-5bbb-b4b3-a38a05ae77c3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
12fbd795-9cb8-5b5b-9c91-533a3df57bfc,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
3eb25b7a-aeb5-5adc-b873-2ff37b59675f,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8,female,Alive,1918,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
176c0a99-0302-5a6a-b9ad-30ff04e3360c,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
79264be9-ce83-5574-b4de-74e520602570,female,Alive,1923,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
1f26523e-25cd-56bb-9040-3a6c41c9990a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
ef38b762-6e65-5a5f-985e-ae40bec376aa,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
7fe5583a-aa8c-5ce8-896a-0397ead74a1a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
efdecf34-f346-53d8-9aab-eefc419d4463,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
d4e997f3-b77d-5c7b-8e71-f598cfd8f14a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
65351b19-481f-5a72-9867-f1b3c0fad92d,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
b346824d-c961-5a69-978a-f04452f8b1f0,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
5b4a1e6c-e831-5826-949b-e548534065f8,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
9414ed5c-c3bf-5195-b220-09297a960ba8,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
42272efd-0292-5bdf-b4cc-8a767f9dfc7f,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
9251d9f1-be21-5e38-9822-eede8d5cc51c,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
267743ea-2830-5b40-b683-f5e00d34c6c2,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5ac7cfe5-25b4-5521-8ed4-023f2afa3d42,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
7c2e2f5f-ce78-504d-817b-73a479cd09f9,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
be5b9e06-57b9-58e8-b0f2-c984c40219a7,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
4b4e030a-6c7f-5469-9180-3d974b5900d2,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
c172bc97-df3f-59ab-b64c-63529d29ba3d,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
5e0b5d34-f9df-502e-94e6-7bfeeb92a539,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
c37ab2c0-3978-59ee-a387-6e4a98de35ec,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
190653c3-b629-5caf-8cad-8a6dfc4b62f9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
8a10febd-d599-50a1-a42c-6dee0e428a6a,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
3c625a1d-559a-5c1f-a2ac-a798cda8da14,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
399576fd-07c2-54de-bfad-53f280417976,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
a86dfa2e-5d13-51d3-bf8e-cad075653a3d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
725602a2-1229-515a-b401-94a1ead148af,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
23aad101-4296-5c7d-9bd5-05f34d2cba6f,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
bffaa34a-37f1-5822-ab31-7d17a1aca9e4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
e2b366b5-54d4-52ab-9057-e2a3f7755781,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
86dca230-c669-54c6-b78d-74b1fa5a7b19,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
a761f58b-17f5-5a95-9d10-299a4fbf98e7,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
87e40b47-5597-599e-a9ae-34e77130cda2,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
1b0c592e-7c31-555e-bf54-a9b7dc83eaa5,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
95491576-be63-50fd-a69a-453ec41714bb,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
036e7831-79a7-520f-9b55-d3fa32a88c71,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
dbc9ef72-8377-52a7-b0cc-6a29c0c1c174,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
031b9275-feab-5a98-ab1d-ea8def8bce56,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
7013e283-d503-51f1-b15e-14770b692036,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
17832a39-9b9c-59f2-a313-ab23798e31fa,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
bfa17d93-143b-53bf-953e-b442f40b66da,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
0309ac57-a9e4-5985-afaa-1c22c3de13d7,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
8bd8505e-e3b3-5167-adc2-d6abce781dc6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
ee9641f4-f36d-5742-be0c-130144f39240,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
af758c42-36b7-5be1-b6ac-87916ca117fb,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
5ac7cfe5-25b4-5521-8ed4-023f2afa3d42,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
ad5dab9e-da95-57a2-aee7-1d0708b16f05,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
b346824d-c961-5a69-978a-f04452f8b1f0,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
215f190d-5fd9-57db-9461-d00abcfae4e0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
65351b19-481f-5a72-9867-f1b3c0fad92d,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
4bed5f1e-e85b-5763-bb8b-ea0029cf902d,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
f558be12-2a1f-5506-b7a5-39ae58109415,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
afb64fd6-7906-5bd8-87a9-03b43fb69900,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
e8476897-909b-57ac-abe1-14a9f79e2a3a,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
0740835f-f4ed-5dc5-8ff0-d9df87dbd640,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
5671514e-c9d4-5f07-b12a-568226f20275,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
26a37a66-829e-5cad-b2d4-c18ad2b5d28f,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
3706c952-17d0-5829-9624-26ed35ce61c6,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
2c9e2f40-5433-5194-ab7d-730d982de2f5,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
337f449f-972e-5bc5-a434-fe6dfca3d407,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
2e4bcad2-f344-56f7-888b-3fca2afe52df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
93b52e42-bee1-5a84-973a-5dec59c6e5ed,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
af950860-01d9-57e3-a223-7ae401b8c798,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
a7d688f5-0410-5408-8e94-f4d5621df1df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
2e5d8b2d-f3a4-5ebd-a612-2fd511f12455,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
097a59d7-4cf0-51e6-b86b-bdf1052dd68b,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
e2e24506-9147-5af7-abf8-8e974293db26,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
63c1a62a-724b-537a-ae88-6845143841c9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
9d386311-6715-5417-a3fb-06d248c6e813,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
fbd9da68-0278-5568-957d-94cbc2f6de8a,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
3085459e-dcc9-5589-b8de-cd5e8529769b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
e636331b-e748-57b6-8d24-32106af64cdf,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
fa79ab3e-3e6a-53f8-8f85-fe4c34052427,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
c2e76a4c-ddb2-55de-baa7-c7067c1259f4,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
03dbbfce-a850-50b1-a52b-10a4bda28aaa,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
e2b366b5-54d4-52ab-9057-e2a3f7755781,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
f9768205-d7e5-5d5e-bf59-37e064d73669,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
b85bd397-ef0d-53ff-a97e-1078fd412234,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
27868555-f3af-59fb-ba00-4da9c14176e1,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
715f8a44-a741-5bf0-977f-2d443c2c098d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
820573ea-7bc9-59dd-aca0-e4e712597461,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
e46162a7-b38d-5473-ba17-81b4e62c5c17,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
2c8a958c-50b3-5c17-ad90-42e58160c400,female,Alive,1928,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
0b11fb4d-52a2-56e1-9cef-35568e1a2c19,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
524b3bcd-5407-5806-9e56-c91529f85f1e,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
21211a7f-bfde-54df-8a7d-c139cb0922c9,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
23755925-6968-50a9-b660-040e517fa61c,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
3b6442dc-a44c-5d6d-91f4-9aabb0781977,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
ea34983c-8abf-5e0e-b795-731c3baf565e,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
71e171de-4fbc-5396-8a52-e362331a8fd9,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
24d81207-6d0e-56d6-9cff-9d05306baef1,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
b13e3c60-a675-5a8c-a335-12e65a23a310,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
fd594d66-0c40-5b02-9262-afbc6549a207,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
2e5d8b2d-f3a4-5ebd-a612-2fd511f12455,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
f8f23111-a666-52f4-aab4-9640dcf8e425,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
e0765893-2c2e-50ce-a4c7-ac3526a8746e,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
554b34de-9690-5845-a36e-4302ca06a99b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
7d424c52-15ea-5d54-9fc8-3bdfb035d686,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
2c9e2f40-5433-5194-ab7d-730d982de2f5,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
1919a3a7-a04e-5f06-bbe2-d190bee937e0,female,Alive,1946,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
44ebf565-e6c0-59c5-a3d6-7e355683c90a,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
c7999b4d-27ca-56c5-bf89-79ad97db1621,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
4197c40d-f4d9-5603-8712-f15525e88cf4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
78723c73-98b3-5130-8a7b-d983311f213b,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
c4dacc00-24ae-5643-ba9f-f81668f7fc01,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
42b3c01b-def5-5cb2-be54-586665f83089,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
7a2e57b2-e19b-5407-967c-2f076d5ee7fc,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
e75c880e-40b7-5369-8760-575774b83938,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
a968b7ee-1a75-5678-b036-8721f572b4d3,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
a44ec5e7-b90f-5892-bdaa-19fe891d1b50,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
33a85b3a-5efc-559a-958b-e7cc12adaff4,female,Alive,1973,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
124d1f29-524a-57e0-b4eb-6ed018678122,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
15b9957d-8c31-5525-b249-cb4e25a082fd,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
baa2500b-d4c9-5e0f-bc4a-41390e221f01,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
f4785965-fb92-5876-80dc-48eba5d1a988,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
603ef2c1-6a1b-5889-926a-2cb5e9eaaba8,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
19a24b4b-1b54-5c06-ae56-8d3dde47aadd,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
73f1bca1-fc2b-5767-899a-8ff467a68d62,female,Alive,1933,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
2f3cfe29-af4d-5dcd-84a6-304a3717051a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
93778d19-dd7a-5e27-8b67-4fba294de047,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
de77fb9d-02b5-5d16-994a-46fa5a3e323b,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",1995,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
1b1c4e7b-2386-52da-929c-fc293a8cbad3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
7c2e2f5f-ce78-504d-817b-73a479cd09f9,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
62496790-a6d7-551d-98e3-2cccd01e73d2,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
1db96901-2fe2-55cd-84fa-dc1d0da97ede,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
d62cdfef-4a5d-51b3-90a0-369c60216423,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
b9fe82c2-4fea-502e-9d7d-7bd0b98acde3,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
afb64fd6-7906-5bd8-87a9-03b43fb69900,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
d93c3f44-61a7-53ce-9bd8-a934eb81d151,female,Alive,1922,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
6e7bc132-cc3f-5675-b3bf-252c8a970841,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
c0fa632c-0f09-59bd-9e43-fb1211bd54cb,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
82aaf7e3-9a30-5061-b417-624d521b0883,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
72351cbb-af0d-50ae-b476-edbb6706eadc,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
8f20f1ea-97c6-5bcf-8305-b4b7451de028,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
48c62578-8e2e-5d1a-a37a-f971a6d5b7f2,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
a0b12635-e4b8-5c98-8598-5d12f61f0f2a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
2e4bcad2-f344-56f7-888b-3fca2afe52df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
7847ae82-f710-579e-a09d-765bec5e27a0,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
7013e283-d503-51f1-b15e-14770b692036,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
42272efd-0292-5bdf-b4cc-8a767f9dfc7f,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
ee2f47ac-33f2-5a9e-8205-33f5961263b8,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
c049a25f-94b1-5f01-a13c-0ec35b371750,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
d5ecc0c8-b648-567c-bef5-093fbf06a6cf,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
f8e5ff46-e164-5917-9a43-dcb119802be6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
ffaff7f1-1d96-5720-9231-587e03833f53,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
5b4a1e6c-e831-5826-949b-e548534065f8,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
a7d5fa96-a744-5b60-90ae-aecdafa90d04,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
8ab5b506-712f-54cc-95f5-082df9ea6660,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
5a99a5f6-68c6-5de3-97e6-d1990afc1648,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
f9768205-d7e5-5d5e-bf59-37e064d73669,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
15b9957d-8c31-5525-b249-cb4e25a082fd,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
bbb417a3-02c2-56b4-b115-92346aa6216f,female,Alive,1940,--,"Adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
018043c6-bd82-5183-8d98-7b422d6d321c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
018043c6-bd82-5183-8d98-7b422d6d321c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
0309ac57-a9e4-5985-afaa-1c22c3de13d7,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
0309ac57-a9e4-5985-afaa-1c22c3de13d7,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
031b9275-feab-5a98-ab1d-ea8def8bce56,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
031b9275-feab-5a98-ab1d-ea8def8bce56,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
036e7831-79a7-520f-9b55-d3fa32a88c71,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
036e7831-79a7-520f-9b55-d3fa32a88c71,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
03dbbfce-a850-50b1-a52b-10a4bda28aaa,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
03dbbfce-a850-50b1-a52b-10a4bda28aaa,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
0427721e-1969-585e-96ef-584f2d46f0fc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
0427721e-1969-585e-96ef-584f2d46f0fc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
04f8eb46-e4c3-5074-ae25-c74e2facb1df,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
04f8eb46-e4c3-5074-ae25-c74e2facb1df,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
0599478f-7f76-560c-a1c0-93972e0d41da,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
0599478f-7f76-560c-a1c0-93972e0d41da,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
05c600f7-24d5-5768-9a0b-9c03dc374335,female,Alive,1930,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2001,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
05c600f7-24d5-5768-9a0b-9c03dc374335,female,Alive,1930,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2001,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
06154713-6fc5-589b-8799-e904a7d3ebd6,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
06154713-6fc5-589b-8799-e904a7d3ebd6,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
071110ba-b63c-5157-8a7a-12db64b4c1fd,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
071110ba-b63c-5157-8a7a-12db64b4c1fd,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
0740835f-f4ed-5dc5-8ff0-d9df87dbd640,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
0740835f-f4ed-5dc5-8ff0-d9df87dbd640,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
07c36ef4-9831-5e46-a1af-0458dd1703c6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
07c36ef4-9831-5e46-a1af-0458dd1703c6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
07f2d324-0079-5388-a28a-e7b6a3c00f3d,female,Alive,1955,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
07f2d324-0079-5388-a28a-e7b6a3c00f3d,female,Alive,1955,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
0926f2b4-a18a-531b-82a7-f798da65b318,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
0926f2b4-a18a-531b-82a7-f798da65b318,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
097a59d7-4cf0-51e6-b86b-bdf1052dd68b,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
097a59d7-4cf0-51e6-b86b-bdf1052dd68b,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
0ac0360f-5df5-52b5-a219-49f145a7e2ba,female,Alive,1951,--,"Endometrioid adenocarcinoma, secretory variant","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
0ac0360f-5df5-52b5-a219-49f145a7e2ba,female,Alive,1951,--,"Endometrioid adenocarcinoma, secretory variant","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
0b11fb4d-52a2-56e1-9cef-35568e1a2c19,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
0b11fb4d-52a2-56e1-9cef-35568e1a2c19,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
0c86e026-26be-5c46-b41c-fa8aaaf5668b,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
0c86e026-26be-5c46-b41c-fa8aaaf5668b,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
0cbd2001-5067-5109-838d-3c053cfcfa55,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
0cbd2001-5067-5109-838d-3c053cfcfa55,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
0cbf6c30-6909-56ac-9390-67b1bba5eaac,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
0cbf6c30-6909-56ac-9390-67b1bba5eaac,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
0cc93255-8851-55bd-a9eb-0619ad5f924b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
0cc93255-8851-55bd-a9eb-0619ad5f924b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
0dc5ba75-646a-5fac-be58-86ae178ea9a3,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
0dc5ba75-646a-5fac-be58-86ae178ea9a3,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
0ecef8f0-f148-5b31-8f6d-ea0e4f2440da,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
0ecef8f0-f148-5b31-8f6d-ea0e4f2440da,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
0f4a1aa0-c451-5604-8efd-ca457cdff74c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
0f4a1aa0-c451-5604-8efd-ca457cdff74c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
0fe639d2-e36c-5dd9-bed0-8e11e1d36a61,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
0fe639d2-e36c-5dd9-bed0-8e11e1d36a61,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
0feea406-ba2e-5a9f-b989-213d6a3964aa,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
0feea406-ba2e-5a9f-b989-213d6a3964aa,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
105fd313-edc4-545d-b653-07fd87c0f017,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
105fd313-edc4-545d-b653-07fd87c0f017,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
118bb2cb-a544-5ce7-9eba-f989bd4f48f0,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
118bb2cb-a544-5ce7-9eba-f989bd4f48f0,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
11bbbb3d-ec5c-5cb7-885c-50576834f378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
11bbbb3d-ec5c-5cb7-885c-50576834f378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
124d1f29-524a-57e0-b4eb-6ed018678122,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
124d1f29-524a-57e0-b4eb-6ed018678122,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
129632b7-438f-510e-9eab-1d43fc365cc0,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
129632b7-438f-510e-9eab-1d43fc365cc0,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
12fbd795-9cb8-5b5b-9c91-533a3df57bfc,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
12fbd795-9cb8-5b5b-9c91-533a3df57bfc,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
13527a4f-c30d-54d3-87c3-f2e6883445da,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
13527a4f-c30d-54d3-87c3-f2e6883445da,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
152431b8-e214-5341-b373-68135dc22afb,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
152431b8-e214-5341-b373-68135dc22afb,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
157a0de8-9a60-547a-92df-8b04e55b9482,female,Alive,1920,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
157a0de8-9a60-547a-92df-8b04e55b9482,female,Alive,1920,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
15b9957d-8c31-5525-b249-cb4e25a082fd,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
15b9957d-8c31-5525-b249-cb4e25a082fd,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
15d4e11d-5881-5dc0-b3ab-6deca92452a2,female,Alive,1923,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
15d4e11d-5881-5dc0-b3ab-6deca92452a2,female,Alive,1923,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
15dac957-20b9-50f8-8f86-a1d216f696d3,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
15dac957-20b9-50f8-8f86-a1d216f696d3,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
16d35689-c5a4-50b8-b9ee-af408c742373,female,Alive,1940,--,Serous surface papillary carcinoma,"Pharmaceutical Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
16d35689-c5a4-50b8-b9ee-af408c742373,female,Alive,1940,--,Serous surface papillary carcinoma,"Radiation Therapy, NOS",2013,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
176c0a99-0302-5a6a-b9ad-30ff04e3360c,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
176c0a99-0302-5a6a-b9ad-30ff04e3360c,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
17832a39-9b9c-59f2-a313-ab23798e31fa,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
17832a39-9b9c-59f2-a313-ab23798e31fa,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
18454974-897b-5a0c-8f4e-a15d6a2da0f9,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
18454974-897b-5a0c-8f4e-a15d6a2da0f9,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
190653c3-b629-5caf-8cad-8a6dfc4b62f9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
190653c3-b629-5caf-8cad-8a6dfc4b62f9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
1919a3a7-a04e-5f06-bbe2-d190bee937e0,female,Alive,1946,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
1919a3a7-a04e-5f06-bbe2-d190bee937e0,female,Alive,1946,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
196b8cc4-bb1e-5790-9ba1-218e0a0309a2,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
196b8cc4-bb1e-5790-9ba1-218e0a0309a2,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
1974fb64-2bf1-5ae4-a1d3-549373310899,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
1974fb64-2bf1-5ae4-a1d3-549373310899,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
19a24b4b-1b54-5c06-ae56-8d3dde47aadd,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
19a24b4b-1b54-5c06-ae56-8d3dde47aadd,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
1b0c592e-7c31-555e-bf54-a9b7dc83eaa5,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
1b0c592e-7c31-555e-bf54-a9b7dc83eaa5,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
1b1c4e7b-2386-52da-929c-fc293a8cbad3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
1b1c4e7b-2386-52da-929c-fc293a8cbad3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
1bcc5a0d-6671-5861-b26d-b67afa80d667,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
1bcc5a0d-6671-5861-b26d-b67afa80d667,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
1c25671b-2d5d-5bb4-b022-6c8571ccc85f,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
1c25671b-2d5d-5bb4-b022-6c8571ccc85f,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
1cfbb428-8eb0-51c0-ab30-92967445c79e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
1cfbb428-8eb0-51c0-ab30-92967445c79e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
1db96901-2fe2-55cd-84fa-dc1d0da97ede,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
1db96901-2fe2-55cd-84fa-dc1d0da97ede,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
1e0b3a28-6504-56ef-80e0-7c9db03689ee,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
1e0b3a28-6504-56ef-80e0-7c9db03689ee,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
1e9d614e-a709-5368-ad16-6a95d293e547,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
1e9d614e-a709-5368-ad16-6a95d293e547,female,Alive,1936,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
1f26523e-25cd-56bb-9040-3a6c41c9990a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
1f26523e-25cd-56bb-9040-3a6c41c9990a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
202ea12b-b0a4-5b04-be06-d9780a653387,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
202ea12b-b0a4-5b04-be06-d9780a653387,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
20432a64-7226-55a6-bc3f-2c6dd69a4572,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
20432a64-7226-55a6-bc3f-2c6dd69a4572,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
21211a7f-bfde-54df-8a7d-c139cb0922c9,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
21211a7f-bfde-54df-8a7d-c139cb0922c9,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
215f190d-5fd9-57db-9461-d00abcfae4e0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
215f190d-5fd9-57db-9461-d00abcfae4e0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
22d6ec5d-0d1f-56e3-babd-8ee6d909622c,female,Alive,1977,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
22d6ec5d-0d1f-56e3-babd-8ee6d909622c,female,Alive,1977,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
22ddbd13-3b49-5a2d-a251-a5cbe4b96c39,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
22ddbd13-3b49-5a2d-a251-a5cbe4b96c39,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
23755925-6968-50a9-b660-040e517fa61c,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
23755925-6968-50a9-b660-040e517fa61c,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
23aad101-4296-5c7d-9bd5-05f34d2cba6f,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
23aad101-4296-5c7d-9bd5-05f34d2cba6f,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2013,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
24d81207-6d0e-56d6-9cff-9d05306baef1,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
24d81207-6d0e-56d6-9cff-9d05306baef1,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
253415bb-94cc-5a4a-8235-d20cb0ee900e,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
253415bb-94cc-5a4a-8235-d20cb0ee900e,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
255807e2-d413-5f0e-8244-0047a41ee5fe,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
255807e2-d413-5f0e-8244-0047a41ee5fe,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
267743ea-2830-5b40-b683-f5e00d34c6c2,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
267743ea-2830-5b40-b683-f5e00d34c6c2,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
26a37a66-829e-5cad-b2d4-c18ad2b5d28f,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
26a37a66-829e-5cad-b2d4-c18ad2b5d28f,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
27868555-f3af-59fb-ba00-4da9c14176e1,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
27868555-f3af-59fb-ba00-4da9c14176e1,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
27d1bde4-7227-5326-82a1-ce3dcf173f2d,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
27d1bde4-7227-5326-82a1-ce3dcf173f2d,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
2842e7d2-131b-560d-9b81-97d97647ff8a,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
2842e7d2-131b-560d-9b81-97d97647ff8a,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
2861a82d-0e91-541e-b77d-c4585dc408e9,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
2861a82d-0e91-541e-b77d-c4585dc408e9,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
2892198e-6c40-564b-b111-52a3797e9f8c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
2892198e-6c40-564b-b111-52a3797e9f8c,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
29722ebf-3505-5430-ab99-d9f747ae451e,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
29722ebf-3505-5430-ab99-d9f747ae451e,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
2a3c98a5-a5b9-56cc-9247-093e90862409,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
2a3c98a5-a5b9-56cc-9247-093e90862409,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
2a8d54bd-2634-51fc-86cf-c8e882f98f3b,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
2a8d54bd-2634-51fc-86cf-c8e882f98f3b,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
2b099a95-8a5f-51ce-ace7-57107a9affab,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
2b099a95-8a5f-51ce-ace7-57107a9affab,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8,female,Alive,1918,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8,female,Alive,1918,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
2c8a958c-50b3-5c17-ad90-42e58160c400,female,Alive,1928,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
2c8a958c-50b3-5c17-ad90-42e58160c400,female,Alive,1928,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
2c8ee06f-8361-510d-816f-c0e4550cdbd7,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
2c8ee06f-8361-510d-816f-c0e4550cdbd7,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
2c9e2f40-5433-5194-ab7d-730d982de2f5,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
2c9e2f40-5433-5194-ab7d-730d982de2f5,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
2d640521-fd23-5176-bb37-d5e66cbca59a,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
2d640521-fd23-5176-bb37-d5e66cbca59a,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
2e4bcad2-f344-56f7-888b-3fca2afe52df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
2e4bcad2-f344-56f7-888b-3fca2afe52df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
2e5d8b2d-f3a4-5ebd-a612-2fd511f12455,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
2e5d8b2d-f3a4-5ebd-a612-2fd511f12455,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
2f20b9e2-817b-5e08-a486-b2009adaea1f,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
2f20b9e2-817b-5e08-a486-b2009adaea1f,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
2f3cfe29-af4d-5dcd-84a6-304a3717051a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
2f3cfe29-af4d-5dcd-84a6-304a3717051a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
3085459e-dcc9-5589-b8de-cd5e8529769b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
3085459e-dcc9-5589-b8de-cd5e8529769b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
30f06462-90ed-5004-81de-422d8ce9b270,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
30f06462-90ed-5004-81de-422d8ce9b270,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
316d7ad8-9075-5bbb-b4b3-a38a05ae77c3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
316d7ad8-9075-5bbb-b4b3-a38a05ae77c3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
3171801b-ead8-54fc-a7b9-481100dfe39d,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
3171801b-ead8-54fc-a7b9-481100dfe39d,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
32525c21-d012-5d48-add2-322fb2132125,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
32525c21-d012-5d48-add2-322fb2132125,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
32f9bc7f-6bbe-55fb-8c70-28e7cd114d27,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
32f9bc7f-6bbe-55fb-8c70-28e7cd114d27,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
337f449f-972e-5bc5-a434-fe6dfca3d407,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
337f449f-972e-5bc5-a434-fe6dfca3d407,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
33a85b3a-5efc-559a-958b-e7cc12adaff4,female,Alive,1973,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
33a85b3a-5efc-559a-958b-e7cc12adaff4,female,Alive,1973,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
33d6af45-80b9-546f-a040-7441d66a34d7,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
33d6af45-80b9-546f-a040-7441d66a34d7,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
344d426f-68fd-5ffe-8808-4716cab3c3c5,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
344d426f-68fd-5ffe-8808-4716cab3c3c5,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
34a4b0c0-cafa-5ade-9250-9a33891abdf0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
34a4b0c0-cafa-5ade-9250-9a33891abdf0,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
34b18611-fa05-568a-8e4c-358e8525c1ef,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
34b18611-fa05-568a-8e4c-358e8525c1ef,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
3505f603-e5fb-5a9e-8824-99e97c974956,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
3505f603-e5fb-5a9e-8824-99e97c974956,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
358c1776-769f-553f-9b5b-edaa92da5a9a,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
358c1776-769f-553f-9b5b-edaa92da5a9a,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
3706c952-17d0-5829-9624-26ed35ce61c6,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
3706c952-17d0-5829-9624-26ed35ce61c6,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
3814abc2-97c0-50d9-9f26-8ef2db2993f8,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
3814abc2-97c0-50d9-9f26-8ef2db2993f8,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
399576fd-07c2-54de-bfad-53f280417976,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
399576fd-07c2-54de-bfad-53f280417976,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
3b6442dc-a44c-5d6d-91f4-9aabb0781977,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
3b6442dc-a44c-5d6d-91f4-9aabb0781977,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
3b813f30-d519-5c0e-9aa7-ce07c2780822,female,Alive,1968,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
3b813f30-d519-5c0e-9aa7-ce07c2780822,female,Alive,1968,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
3c625a1d-559a-5c1f-a2ac-a798cda8da14,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
3c625a1d-559a-5c1f-a2ac-a798cda8da14,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
3d97f2b9-778a-5826-8aa7-ddc7402c36c2,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
3d97f2b9-778a-5826-8aa7-ddc7402c36c2,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
3eafb5fd-b307-50ba-838d-d8a4921cce6d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
3eafb5fd-b307-50ba-838d-d8a4921cce6d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
3eb25b7a-aeb5-5adc-b873-2ff37b59675f,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
3eb25b7a-aeb5-5adc-b873-2ff37b59675f,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
3fccce6d-e7af-5ff7-9246-31b7c387040d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
3fccce6d-e7af-5ff7-9246-31b7c387040d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
3fecafa2-72e6-51c6-83b4-ad54786e9d2b,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
3fecafa2-72e6-51c6-83b4-ad54786e9d2b,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
400b2e1e-7ebf-56da-a404-7bc683ec14ce,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
400b2e1e-7ebf-56da-a404-7bc683ec14ce,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
4197c40d-f4d9-5603-8712-f15525e88cf4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
4197c40d-f4d9-5603-8712-f15525e88cf4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
42256e3f-852f-5914-8b38-744378ef0cac,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
42256e3f-852f-5914-8b38-744378ef0cac,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
42272efd-0292-5bdf-b4cc-8a767f9dfc7f,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
42272efd-0292-5bdf-b4cc-8a767f9dfc7f,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
42b3c01b-def5-5cb2-be54-586665f83089,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
42b3c01b-def5-5cb2-be54-586665f83089,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
42b773b4-de7e-563d-b394-022955a80a1b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
42b773b4-de7e-563d-b394-022955a80a1b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
4483f9f3-4e11-52f5-bdd7-074f47cde40d,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
4483f9f3-4e11-52f5-bdd7-074f47cde40d,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
44ebf565-e6c0-59c5-a3d6-7e355683c90a,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
44ebf565-e6c0-59c5-a3d6-7e355683c90a,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
4507d83f-2738-5679-abb2-92367a2ac213,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
4507d83f-2738-5679-abb2-92367a2ac213,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
46ee949e-91ac-585a-b287-023dda00ab3d,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
46ee949e-91ac-585a-b287-023dda00ab3d,female,Alive,1932,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
484728d0-24db-5eb6-af3c-0702a2907055,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
484728d0-24db-5eb6-af3c-0702a2907055,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
489ef6fd-7a84-59ac-966e-51af8f004b77,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
489ef6fd-7a84-59ac-966e-51af8f004b77,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
48c62578-8e2e-5d1a-a37a-f971a6d5b7f2,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
48c62578-8e2e-5d1a-a37a-f971a6d5b7f2,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
4a83af41-f0dd-5db8-a0bf-609e86d91d4a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
4a83af41-f0dd-5db8-a0bf-609e86d91d4a,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
4b4e030a-6c7f-5469-9180-3d974b5900d2,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
4b4e030a-6c7f-5469-9180-3d974b5900d2,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
4bb8f00c-d398-5777-8070-31fa84085acd,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
4bb8f00c-d398-5777-8070-31fa84085acd,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
4bed5f1e-e85b-5763-bb8b-ea0029cf902d,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
4bed5f1e-e85b-5763-bb8b-ea0029cf902d,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
4c77a875-5eef-5480-b468-2ba87b6173ea,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
4c77a875-5eef-5480-b468-2ba87b6173ea,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
4cf21d71-f8d6-515e-ab34-b6ce4a4126db,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
4cf21d71-f8d6-515e-ab34-b6ce4a4126db,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
4d444b66-2a61-5097-8234-82701fa74420,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
4d444b66-2a61-5097-8234-82701fa74420,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
4d5a76c9-3887-5675-bb43-b0fb50bc0d49,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
4d5a76c9-3887-5675-bb43-b0fb50bc0d49,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
50b47db9-0041-58d4-b3a7-b028b78418ec,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
50b47db9-0041-58d4-b3a7-b028b78418ec,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
50c45796-e968-564d-9c4b-165c22625230,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
50c45796-e968-564d-9c4b-165c22625230,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
51289bbf-8cc2-5022-bfdd-b1377b17ce22,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
51289bbf-8cc2-5022-bfdd-b1377b17ce22,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
5130114a-f1c7-5f3d-ae99-e5202537213c,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
5130114a-f1c7-5f3d-ae99-e5202537213c,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
5155c521-35ee-5ea9-be34-9912fa0d736b,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
5155c521-35ee-5ea9-be34-9912fa0d736b,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
519905a6-d464-5f72-bbe1-83bc661c1821,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
519905a6-d464-5f72-bbe1-83bc661c1821,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
51e0a502-6a75-5175-89d6-43421041fff7,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
51e0a502-6a75-5175-89d6-43421041fff7,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
524b3bcd-5407-5806-9e56-c91529f85f1e,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
524b3bcd-5407-5806-9e56-c91529f85f1e,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
52e346ab-59e4-5cfc-97c1-ea275e8769a6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
52e346ab-59e4-5cfc-97c1-ea275e8769a6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
540f6a1a-88ee-5303-8612-f84ac47bc183,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
540f6a1a-88ee-5303-8612-f84ac47bc183,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
554b34de-9690-5845-a36e-4302ca06a99b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
554b34de-9690-5845-a36e-4302ca06a99b,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
558de49a-8e14-51dd-8df2-fca36ddbcf3d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
558de49a-8e14-51dd-8df2-fca36ddbcf3d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
55b042ff-89d8-5610-8f99-d3f469e6edd4,female,Alive,1921,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
55b042ff-89d8-5610-8f99-d3f469e6edd4,female,Alive,1921,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
561d660f-959e-5ee1-8989-14eebe9c71a9,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
561d660f-959e-5ee1-8989-14eebe9c71a9,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
5671514e-c9d4-5f07-b12a-568226f20275,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
5671514e-c9d4-5f07-b12a-568226f20275,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
5693261a-fc8a-5ba2-b87a-1fbb44a72372,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
5693261a-fc8a-5ba2-b87a-1fbb44a72372,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
58b46677-323d-533b-980b-5a724af621af,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
58b46677-323d-533b-980b-5a724af621af,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
59388de5-fd85-5e5e-9f59-87345330429b,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
59388de5-fd85-5e5e-9f59-87345330429b,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
5a34c9fd-6e43-566b-8e12-af41e66ca002,female,Alive,1974,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
5a34c9fd-6e43-566b-8e12-af41e66ca002,female,Alive,1974,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
5a99a5f6-68c6-5de3-97e6-d1990afc1648,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
5a99a5f6-68c6-5de3-97e6-d1990afc1648,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
5ac7cfe5-25b4-5521-8ed4-023f2afa3d42,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
5ac7cfe5-25b4-5521-8ed4-023f2afa3d42,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
5adae4ab-9d4c-5380-ba44-2fc49810993d,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
5adae4ab-9d4c-5380-ba44-2fc49810993d,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
5af7b769-4f26-5003-8b0c-835175118797,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
5af7b769-4f26-5003-8b0c-835175118797,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
5b4a1e6c-e831-5826-949b-e548534065f8,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
5b4a1e6c-e831-5826-949b-e548534065f8,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
5b89e6af-bc94-5d29-9aae-508edc9f7ae2,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
5b89e6af-bc94-5d29-9aae-508edc9f7ae2,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
5bdd67ed-7c28-56a7-84b4-89f703283c5c,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
5bdd67ed-7c28-56a7-84b4-89f703283c5c,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
5c40ea92-1293-5e14-96bf-5e39c5875c25,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
5c40ea92-1293-5e14-96bf-5e39c5875c25,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
5e0b5d34-f9df-502e-94e6-7bfeeb92a539,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
5e0b5d34-f9df-502e-94e6-7bfeeb92a539,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
5e8f2da5-7f61-5140-9364-25325bf20cad,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
5e8f2da5-7f61-5140-9364-25325bf20cad,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
5f17d402-31f5-519a-8045-d4092aead279,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
5f17d402-31f5-519a-8045-d4092aead279,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
6014440f-b492-52dc-a262-f14f49e88341,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
6014440f-b492-52dc-a262-f14f49e88341,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
603ef2c1-6a1b-5889-926a-2cb5e9eaaba8,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
603ef2c1-6a1b-5889-926a-2cb5e9eaaba8,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
606473b1-aaf5-50b5-9b3f-fd2fe9945ded,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
606473b1-aaf5-50b5-9b3f-fd2fe9945ded,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
608b1f93-afe7-5b95-bf1c-dfd43e6e96ae,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
608b1f93-afe7-5b95-bf1c-dfd43e6e96ae,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
62496790-a6d7-551d-98e3-2cccd01e73d2,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
62496790-a6d7-551d-98e3-2cccd01e73d2,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
628a9231-6a6f-58ee-bb03-77194c4e2534,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
628a9231-6a6f-58ee-bb03-77194c4e2534,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
62e5753a-c900-5b22-b3ab-7d11afe47bdf,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
62e5753a-c900-5b22-b3ab-7d11afe47bdf,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
63c1a62a-724b-537a-ae88-6845143841c9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
63c1a62a-724b-537a-ae88-6845143841c9,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
65351b19-481f-5a72-9867-f1b3c0fad92d,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
65351b19-481f-5a72-9867-f1b3c0fad92d,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
6576c375-63ee-5f39-8eba-d41859b9dc27,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
6576c375-63ee-5f39-8eba-d41859b9dc27,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
65b14ddc-7ed2-577d-b70b-affa93ccebdd,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
65b14ddc-7ed2-577d-b70b-affa93ccebdd,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
68902cda-85a5-5b5d-8aa5-69a8fc3b7da5,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
68902cda-85a5-5b5d-8aa5-69a8fc3b7da5,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
6890a0be-464d-57fe-a1e4-40299008de2c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
6890a0be-464d-57fe-a1e4-40299008de2c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
68eeb680-0c16-5cd2-ad66-077e1551696c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
68eeb680-0c16-5cd2-ad66-077e1551696c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
692609e2-c553-550a-ac55-c875089ec9f1,female,Alive,1972,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
692609e2-c553-550a-ac55-c875089ec9f1,female,Alive,1972,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
694e78fe-7a46-5958-8551-9345298fe4ba,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
694e78fe-7a46-5958-8551-9345298fe4ba,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
6a80fd66-a580-51bd-b9f9-c954eb173de6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
6a80fd66-a580-51bd-b9f9-c954eb173de6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
6cb2b392-7f9d-56ff-951f-50fa1961540e,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
6cb2b392-7f9d-56ff-951f-50fa1961540e,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
6ce087d0-d4e5-5568-a73d-d12df1aba4d9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
6ce087d0-d4e5-5568-a73d-d12df1aba4d9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
6e7bc132-cc3f-5675-b3bf-252c8a970841,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
6e7bc132-cc3f-5675-b3bf-252c8a970841,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
6f899329-75a0-56df-99c2-e4cc79c2a1c4,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
6f899329-75a0-56df-99c2-e4cc79c2a1c4,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
6fd6df70-ae97-57fd-97f6-997004450695,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
6fd6df70-ae97-57fd-97f6-997004450695,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
7013e283-d503-51f1-b15e-14770b692036,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
7013e283-d503-51f1-b15e-14770b692036,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
7150706f-be8d-5f53-8882-93c479869817,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
7150706f-be8d-5f53-8882-93c479869817,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
715f8a44-a741-5bf0-977f-2d443c2c098d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
715f8a44-a741-5bf0-977f-2d443c2c098d,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
71e171de-4fbc-5396-8a52-e362331a8fd9,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
71e171de-4fbc-5396-8a52-e362331a8fd9,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
72351cbb-af0d-50ae-b476-edbb6706eadc,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
72351cbb-af0d-50ae-b476-edbb6706eadc,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
725602a2-1229-515a-b401-94a1ead148af,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
725602a2-1229-515a-b401-94a1ead148af,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
73986089-8e5f-5a89-8e84-674c67d66ce7,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
73986089-8e5f-5a89-8e84-674c67d66ce7,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
73f1bca1-fc2b-5767-899a-8ff467a68d62,female,Alive,1933,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
73f1bca1-fc2b-5767-899a-8ff467a68d62,female,Alive,1933,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
7593a65f-93eb-5143-a5a6-8e4c144e0880,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
7593a65f-93eb-5143-a5a6-8e4c144e0880,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
75adb354-65dc-56e8-a9bb-d01ff7b9ec15,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
75adb354-65dc-56e8-a9bb-d01ff7b9ec15,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
75c88efc-df2b-5dc9-8f26-0a8826fc80c5,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
75c88efc-df2b-5dc9-8f26-0a8826fc80c5,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
7847ae82-f710-579e-a09d-765bec5e27a0,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
7847ae82-f710-579e-a09d-765bec5e27a0,female,Alive,1931,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
78723c73-98b3-5130-8a7b-d983311f213b,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
78723c73-98b3-5130-8a7b-d983311f213b,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
79264be9-ce83-5574-b4de-74e520602570,female,Alive,1923,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
79264be9-ce83-5574-b4de-74e520602570,female,Alive,1923,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
7a1bcab4-1dc6-5dff-bebc-6d77458d082e,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
7a1bcab4-1dc6-5dff-bebc-6d77458d082e,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
7a2e57b2-e19b-5407-967c-2f076d5ee7fc,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
7a2e57b2-e19b-5407-967c-2f076d5ee7fc,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
7c2e2f5f-ce78-504d-817b-73a479cd09f9,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
7c2e2f5f-ce78-504d-817b-73a479cd09f9,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d,female,Alive,1965,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d,female,Alive,1965,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
7d424c52-15ea-5d54-9fc8-3bdfb035d686,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
7d424c52-15ea-5d54-9fc8-3bdfb035d686,female,Alive,1934,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
7d93421a-71dc-502a-9c1a-8d3d30104edf,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
7d93421a-71dc-502a-9c1a-8d3d30104edf,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
7dd5c05e-762f-5589-8195-2e1094cbb70d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
7dd5c05e-762f-5589-8195-2e1094cbb70d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
7e3c3954-9e54-5294-be2e-0761ef69da77,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
7e3c3954-9e54-5294-be2e-0761ef69da77,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
7fa24ac1-267b-525f-8deb-3a2b9b0e64a9,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
7fa24ac1-267b-525f-8deb-3a2b9b0e64a9,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
7fe5583a-aa8c-5ce8-896a-0397ead74a1a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
7fe5583a-aa8c-5ce8-896a-0397ead74a1a,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
803b97ad-544f-5652-a79b-7dc4f1df6e1c,female,Alive,1920,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
803b97ad-544f-5652-a79b-7dc4f1df6e1c,female,Alive,1920,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
81b84182-932d-5e2e-9d97-0000ec2b42db,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
81b84182-932d-5e2e-9d97-0000ec2b42db,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
820573ea-7bc9-59dd-aca0-e4e712597461,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
820573ea-7bc9-59dd-aca0-e4e712597461,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
823c38c3-da83-5448-a724-54b825439b21,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
823c38c3-da83-5448-a724-54b825439b21,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
82aaf7e3-9a30-5061-b417-624d521b0883,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
82aaf7e3-9a30-5061-b417-624d521b0883,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
83619ed1-a7ed-5029-ae2d-608ce3dcbf3f,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
83619ed1-a7ed-5029-ae2d-608ce3dcbf3f,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
847fa83d-736f-5a87-a0db-2dfbe7973176,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
847fa83d-736f-5a87-a0db-2dfbe7973176,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
86dca230-c669-54c6-b78d-74b1fa5a7b19,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
86dca230-c669-54c6-b78d-74b1fa5a7b19,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
877d24ed-dd52-5247-95aa-d023b682a6dd,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
877d24ed-dd52-5247-95aa-d023b682a6dd,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
877f9a19-9723-5331-bde9-2b6313f89de2,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
877f9a19-9723-5331-bde9-2b6313f89de2,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
87e40b47-5597-599e-a9ae-34e77130cda2,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
87e40b47-5597-599e-a9ae-34e77130cda2,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
8802988a-0d68-5a09-bdc4-3b21e28f31f8,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
8802988a-0d68-5a09-bdc4-3b21e28f31f8,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
89dd9b5b-71a2-599c-b86a-9631ef174de5,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
89dd9b5b-71a2-599c-b86a-9631ef174de5,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
8a10a03b-4e16-529a-9ea8-d36aa532aad9,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
8a10a03b-4e16-529a-9ea8-d36aa532aad9,female,Alive,1969,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
8a10febd-d599-50a1-a42c-6dee0e428a6a,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
8a10febd-d599-50a1-a42c-6dee0e428a6a,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
8ab5b506-712f-54cc-95f5-082df9ea6660,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
8ab5b506-712f-54cc-95f5-082df9ea6660,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
8bd8505e-e3b3-5167-adc2-d6abce781dc6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
8bd8505e-e3b3-5167-adc2-d6abce781dc6,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
8c2d24f1-cb1d-5b13-84a0-dcccefd1655c,female,Alive,1954,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
8c2d24f1-cb1d-5b13-84a0-dcccefd1655c,female,Alive,1954,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
8dc88809-3a23-5cdf-8f5a-97e7747200b9,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
8dc88809-3a23-5cdf-8f5a-97e7747200b9,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
8de932fa-c5e3-5a52-b36c-7989aee3737b,female,Alive,1935,--,"Clear cell adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
8de932fa-c5e3-5a52-b36c-7989aee3737b,female,Alive,1935,--,"Clear cell adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
8edb6f51-93e3-5ff9-88f6-e970cb486bb6,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
8edb6f51-93e3-5ff9-88f6-e970cb486bb6,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
8f20f1ea-97c6-5bcf-8305-b4b7451de028,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
8f20f1ea-97c6-5bcf-8305-b4b7451de028,female,Alive,1954,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
909e5384-bc65-57da-a325-b3e37696288a,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
909e5384-bc65-57da-a325-b3e37696288a,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
90e1163b-6080-5f74-b548-83420da90baf,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
90e1163b-6080-5f74-b548-83420da90baf,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
913d2af6-77a5-5410-a188-fe74d2567774,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
913d2af6-77a5-5410-a188-fe74d2567774,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
914f33d3-f471-5217-ab80-a340b1a61a93,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
914f33d3-f471-5217-ab80-a340b1a61a93,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
921580f9-9167-5eb6-86ee-2c4f16954e7c,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
921580f9-9167-5eb6-86ee-2c4f16954e7c,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
9234f877-58d0-540d-89b1-9666a42bbfc4,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
9234f877-58d0-540d-89b1-9666a42bbfc4,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
9251d9f1-be21-5e38-9822-eede8d5cc51c,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
9251d9f1-be21-5e38-9822-eede8d5cc51c,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
92763274-a8e2-5612-a776-b334b6ae5dbe,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
92763274-a8e2-5612-a776-b334b6ae5dbe,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
92a5ea75-6ced-568e-928f-d1aef0646988,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
92a5ea75-6ced-568e-928f-d1aef0646988,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
92af23e2-41c0-5f21-ad67-cd16091385df,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
92af23e2-41c0-5f21-ad67-cd16091385df,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
932b5f34-279f-58a1-b7ea-5ac264c68f39,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
932b5f34-279f-58a1-b7ea-5ac264c68f39,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
93778d19-dd7a-5e27-8b67-4fba294de047,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
93778d19-dd7a-5e27-8b67-4fba294de047,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
93b52e42-bee1-5a84-973a-5dec59c6e5ed,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
93b52e42-bee1-5a84-973a-5dec59c6e5ed,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
93c550da-55b4-5bf1-be9c-bbc05ba86643,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
93c550da-55b4-5bf1-be9c-bbc05ba86643,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
94140e88-a9fa-5519-947c-1960dd16a2cd,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
94140e88-a9fa-5519-947c-1960dd16a2cd,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
9414ed5c-c3bf-5195-b220-09297a960ba8,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
9414ed5c-c3bf-5195-b220-09297a960ba8,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
94dfa136-8422-58f4-a7c3-0856703cb127,female,Alive,1919,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
94dfa136-8422-58f4-a7c3-0856703cb127,female,Alive,1919,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
94e5d21e-5343-553f-80b3-79fb4e38d0ba,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
94e5d21e-5343-553f-80b3-79fb4e38d0ba,female,Alive,1963,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
95491576-be63-50fd-a69a-453ec41714bb,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
95491576-be63-50fd-a69a-453ec41714bb,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
95fd1298-1173-577a-ad75-1755f2ea7291,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
95fd1298-1173-577a-ad75-1755f2ea7291,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
96e572fd-b222-549c-969e-fd4cc8e894d3,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
96e572fd-b222-549c-969e-fd4cc8e894d3,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
97f38906-f4fd-584b-9a15-679d55409e68,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
97f38906-f4fd-584b-9a15-679d55409e68,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
97fe2fbf-2085-5ffe-a6f9-5133af42f12d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
97fe2fbf-2085-5ffe-a6f9-5133af42f12d,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
992e1ed5-04f1-53ff-9084-e6594408070b,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
992e1ed5-04f1-53ff-9084-e6594408070b,female,Alive,1964,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
9a587a49-7e43-57b6-9599-0dfd29696ad7,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
9a587a49-7e43-57b6-9599-0dfd29696ad7,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
9bc7569c-897a-5443-a8f7-f160ecba3605,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
9bc7569c-897a-5443-a8f7-f160ecba3605,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4,female,Alive,1966,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4,female,Alive,1966,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
9c7ebc91-28c8-5947-adb5-8a59ce7a93c4,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
9c7ebc91-28c8-5947-adb5-8a59ce7a93c4,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1997,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",1997,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
9d386311-6715-5417-a3fb-06d248c6e813,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
9d386311-6715-5417-a3fb-06d248c6e813,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
9e21e02c-b227-5e1f-8ed6-c145c7713145,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
9e21e02c-b227-5e1f-8ed6-c145c7713145,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
9f6ec603-0186-5e86-bd95-3ae3fe32682b,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
9f6ec603-0186-5e86-bd95-3ae3fe32682b,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
9f7d00ec-c32d-54a4-b535-29f67966f7b6,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
9f7d00ec-c32d-54a4-b535-29f67966f7b6,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
a0172345-d345-5bd2-b785-7f054781a0fe,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
a0172345-d345-5bd2-b785-7f054781a0fe,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
a0452fbc-d834-54b0-a7af-54217646f706,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
a0452fbc-d834-54b0-a7af-54217646f706,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
a0b12635-e4b8-5c98-8598-5d12f61f0f2a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
a0b12635-e4b8-5c98-8598-5d12f61f0f2a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
a0d7577a-1868-535e-b229-e0ea205cd267,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
a0d7577a-1868-535e-b229-e0ea205cd267,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
a1684e59-c0e1-56da-b466-e8365faf08b9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
a1684e59-c0e1-56da-b466-e8365faf08b9,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
a1f289cf-dd76-53da-85d7-8289e9f6d3fa,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
a1f289cf-dd76-53da-85d7-8289e9f6d3fa,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
a3d8b15e-c949-5b84-8dfa-e04e6ef92814,female,Alive,1925,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
a3d8b15e-c949-5b84-8dfa-e04e6ef92814,female,Alive,1925,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
a4323184-d6f7-50dc-85ae-1b9adbf70349,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
a4323184-d6f7-50dc-85ae-1b9adbf70349,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
a44ec5e7-b90f-5892-bdaa-19fe891d1b50,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
a44ec5e7-b90f-5892-bdaa-19fe891d1b50,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
a4c89303-0bac-562f-bd1a-207d4fd60680,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
a4c89303-0bac-562f-bd1a-207d4fd60680,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
a5a0d889-9d31-55c0-80a8-9c3eb31ed85d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
a5a0d889-9d31-55c0-80a8-9c3eb31ed85d,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
a725b8c8-1661-5ee3-8187-e4cb2286b6ed,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
a725b8c8-1661-5ee3-8187-e4cb2286b6ed,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
a761f58b-17f5-5a95-9d10-299a4fbf98e7,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
a761f58b-17f5-5a95-9d10-299a4fbf98e7,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
a79cde1d-b7cb-5f8f-9bfd-be728e18f270,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
a79cde1d-b7cb-5f8f-9bfd-be728e18f270,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
a7d5fa96-a744-5b60-90ae-aecdafa90d04,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
a7d5fa96-a744-5b60-90ae-aecdafa90d04,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
a7d688f5-0410-5408-8e94-f4d5621df1df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
a7d688f5-0410-5408-8e94-f4d5621df1df,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
a86dfa2e-5d13-51d3-bf8e-cad075653a3d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
a86dfa2e-5d13-51d3-bf8e-cad075653a3d,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
a968b7ee-1a75-5678-b036-8721f572b4d3,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
a968b7ee-1a75-5678-b036-8721f572b4d3,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
a9871d31-b21f-58cf-99c9-c43961029a80,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
a9871d31-b21f-58cf-99c9-c43961029a80,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
aa2b17e8-1a85-503a-b7ba-7847433aafaf,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
aa2b17e8-1a85-503a-b7ba-7847433aafaf,female,Alive,1928,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
ab0425be-3d1c-5564-b557-614a4080be6a,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
ab0425be-3d1c-5564-b557-614a4080be6a,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
ab7c810e-febe-5caa-a6c2-35ad0f421909,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
ab7c810e-febe-5caa-a6c2-35ad0f421909,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
abe07506-82c6-5605-8235-f6792943c654,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
abe07506-82c6-5605-8235-f6792943c654,female,Alive,1942,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
ac45a829-3a9a-5711-953f-829b2fec2583,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
ac45a829-3a9a-5711-953f-829b2fec2583,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
ad41e1ef-c12d-539c-936a-66be05ef82b6,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
ad41e1ef-c12d-539c-936a-66be05ef82b6,female,Alive,1932,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
ad5dab9e-da95-57a2-aee7-1d0708b16f05,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
ad5dab9e-da95-57a2-aee7-1d0708b16f05,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
adc48981-fe38-5f10-b8d5-97a058523a5c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
adc48981-fe38-5f10-b8d5-97a058523a5c,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
ae46540d-b520-585f-941d-5492c9ae03bb,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
ae46540d-b520-585f-941d-5492c9ae03bb,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
af4a58b5-00b5-54cb-9916-1f23f97edda9,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
af4a58b5-00b5-54cb-9916-1f23f97edda9,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
af758c42-36b7-5be1-b6ac-87916ca117fb,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
af758c42-36b7-5be1-b6ac-87916ca117fb,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
af950860-01d9-57e3-a223-7ae401b8c798,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
af950860-01d9-57e3-a223-7ae401b8c798,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
afb64fd6-7906-5bd8-87a9-03b43fb69900,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
afb64fd6-7906-5bd8-87a9-03b43fb69900,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
afd12a04-a61b-56c0-b7fc-bd90db975abb,female,Alive,1958,--,"Carcinoma, undifferentiated, NOS","Pharmaceutical Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
afd12a04-a61b-56c0-b7fc-bd90db975abb,female,Alive,1958,--,"Carcinoma, undifferentiated, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
b0e6de39-ab28-5b60-90a2-2ae8485c99d9,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
b0e6de39-ab28-5b60-90a2-2ae8485c99d9,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
b13e3c60-a675-5a8c-a335-12e65a23a310,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
b13e3c60-a675-5a8c-a335-12e65a23a310,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
b18085fa-a9fc-591d-97c2-4ca241b9bc92,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
b18085fa-a9fc-591d-97c2-4ca241b9bc92,female,Alive,1949,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
b2815b75-c7ba-5b55-bcdc-21aabbed3b28,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
b2815b75-c7ba-5b55-bcdc-21aabbed3b28,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
b2b94f43-6ae2-5741-a03e-9bd5b9d71433,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
b2b94f43-6ae2-5741-a03e-9bd5b9d71433,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
b346824d-c961-5a69-978a-f04452f8b1f0,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
b346824d-c961-5a69-978a-f04452f8b1f0,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
b66db2b7-1f4f-5998-bc30-50af2b0a5309,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
b66db2b7-1f4f-5998-bc30-50af2b0a5309,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
b6988514-2f1c-5264-b604-412054c5d4ec,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
b6988514-2f1c-5264-b604-412054c5d4ec,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
b77ca676-a31b-51be-bf22-fc4de05b5d1c,female,Alive,1944,--,"Carcinoma, undifferentiated, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
b77ca676-a31b-51be-bf22-fc4de05b5d1c,female,Alive,1944,--,"Carcinoma, undifferentiated, NOS","Radiation Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
b85bd397-ef0d-53ff-a97e-1078fd412234,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
b85bd397-ef0d-53ff-a97e-1078fd412234,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
b9d31f87-628e-584a-b7ad-d7a6d69e6f91,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
b9d31f87-628e-584a-b7ad-d7a6d69e6f91,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
b9fe82c2-4fea-502e-9d7d-7bd0b98acde3,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
b9fe82c2-4fea-502e-9d7d-7bd0b98acde3,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
baa2500b-d4c9-5e0f-bc4a-41390e221f01,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
baa2500b-d4c9-5e0f-bc4a-41390e221f01,female,Alive,1953,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
bac1495d-3338-556a-b9d6-93239b967de8,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
bac1495d-3338-556a-b9d6-93239b967de8,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
bb65e3c6-0979-5f98-a76c-dc2b773cc795,female,Alive,1959,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
bb65e3c6-0979-5f98-a76c-dc2b773cc795,female,Alive,1959,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
bb77659e-237f-5a94-8538-2fb5d2a1797f,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
bb77659e-237f-5a94-8538-2fb5d2a1797f,female,Alive,1961,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
bbb417a3-02c2-56b4-b115-92346aa6216f,female,Alive,1940,--,"Adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
bbb417a3-02c2-56b4-b115-92346aa6216f,female,Alive,1940,--,"Adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
be5b9e06-57b9-58e8-b0f2-c984c40219a7,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
be5b9e06-57b9-58e8-b0f2-c984c40219a7,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
bfa17d93-143b-53bf-953e-b442f40b66da,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
bfa17d93-143b-53bf-953e-b442f40b66da,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
bffaa34a-37f1-5822-ab31-7d17a1aca9e4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
bffaa34a-37f1-5822-ab31-7d17a1aca9e4,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
c049a25f-94b1-5f01-a13c-0ec35b371750,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
c049a25f-94b1-5f01-a13c-0ec35b371750,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
c0fa632c-0f09-59bd-9e43-fb1211bd54cb,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
c0fa632c-0f09-59bd-9e43-fb1211bd54cb,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
c172bc97-df3f-59ab-b64c-63529d29ba3d,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
c172bc97-df3f-59ab-b64c-63529d29ba3d,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
c24bb733-c129-5932-bba5-c197ac5b1bef,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
c24bb733-c129-5932-bba5-c197ac5b1bef,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
c2e76a4c-ddb2-55de-baa7-c7067c1259f4,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
c2e76a4c-ddb2-55de-baa7-c7067c1259f4,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
c3177194-2df1-5361-a8c2-9a181bc27742,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
c3177194-2df1-5361-a8c2-9a181bc27742,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
c37ab2c0-3978-59ee-a387-6e4a98de35ec,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
c37ab2c0-3978-59ee-a387-6e4a98de35ec,female,Alive,1953,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
c4dacc00-24ae-5643-ba9f-f81668f7fc01,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
c4dacc00-24ae-5643-ba9f-f81668f7fc01,female,Alive,1960,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
c5e55511-7437-599c-9032-552b66dedc28,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
c5e55511-7437-599c-9032-552b66dedc28,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
c7999b4d-27ca-56c5-bf89-79ad97db1621,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
c7999b4d-27ca-56c5-bf89-79ad97db1621,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
c8b4918b-961a-55ee-930c-51304d95033f,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
c8b4918b-961a-55ee-930c-51304d95033f,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
ca39bf6f-6549-5d17-ae60-15dde3f5a32d,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
ca39bf6f-6549-5d17-ae60-15dde3f5a32d,female,Alive,1945,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
cb02881c-ab1f-5acf-ac66-56e28fae03c7,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
cb02881c-ab1f-5acf-ac66-56e28fae03c7,female,Alive,1955,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf,female,Alive,1950,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
cc57dcd7-5e85-5e52-b35b-4adf130b31d7,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
cc57dcd7-5e85-5e52-b35b-4adf130b31d7,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
cd6ec347-4caf-5ff7-a22e-34c0c62a99b3,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
cd6ec347-4caf-5ff7-a22e-34c0c62a99b3,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
ce0d78ee-e0db-55d8-88b5-227de3fbf4d2,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
ce0d78ee-e0db-55d8-88b5-227de3fbf4d2,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
ce12f12d-6909-5e15-b949-98cea3d19440,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
ce12f12d-6909-5e15-b949-98cea3d19440,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
ce8a91da-f81d-51b6-a2e5-82541798e6b9,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
ce8a91da-f81d-51b6-a2e5-82541798e6b9,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
ce96d3e6-6f9d-54ec-8173-e7af52159c07,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
ce96d3e6-6f9d-54ec-8173-e7af52159c07,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
d0725cda-50ff-56dc-a9bd-64f4ae186931,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
d0725cda-50ff-56dc-a9bd-64f4ae186931,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
d090c047-cf0d-569c-beb8-c5a933d12d42,female,Alive,1926,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
d090c047-cf0d-569c-beb8-c5a933d12d42,female,Alive,1926,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2003,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
d1af4708-62fe-5624-9a61-f1542621ba4b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
d1af4708-62fe-5624-9a61-f1542621ba4b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
d2b3ab8b-b070-588b-b574-8ee86e7eff94,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
d2b3ab8b-b070-588b-b574-8ee86e7eff94,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
d376f28e-2c9a-54ab-9426-adfa028674d4,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
d376f28e-2c9a-54ab-9426-adfa028674d4,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
d45a801b-a1cd-51a8-abd6-5b5f4ad4f091,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
d45a801b-a1cd-51a8-abd6-5b5f4ad4f091,female,Alive,1937,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
d4e997f3-b77d-5c7b-8e71-f598cfd8f14a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
d4e997f3-b77d-5c7b-8e71-f598cfd8f14a,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8,female,Alive,1933,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
d5d00d70-77b9-5443-bd30-112211cf1f36,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
d5d00d70-77b9-5443-bd30-112211cf1f36,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
d5ecc0c8-b648-567c-bef5-093fbf06a6cf,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
d5ecc0c8-b648-567c-bef5-093fbf06a6cf,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
d62cdfef-4a5d-51b3-90a0-369c60216423,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
d62cdfef-4a5d-51b3-90a0-369c60216423,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
d6a3f6e0-9fcc-5add-a7b0-77050a978c56,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
d6a3f6e0-9fcc-5add-a7b0-77050a978c56,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
d762555b-0370-5081-905f-16fa84728790,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
d762555b-0370-5081-905f-16fa84728790,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
d8c4248b-3e80-5a02-bf28-aff20c54f0dc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
d8c4248b-3e80-5a02-bf28-aff20c54f0dc,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
d93c3f44-61a7-53ce-9bd8-a934eb81d151,female,Alive,1922,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
d93c3f44-61a7-53ce-9bd8-a934eb81d151,female,Alive,1922,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
dac92b16-78e8-5599-94e2-bf73feae8378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
dac92b16-78e8-5599-94e2-bf73feae8378,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
dbc9ef72-8377-52a7-b0cc-6a29c0c1c174,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
dbc9ef72-8377-52a7-b0cc-6a29c0c1c174,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
dbd03450-1805-5569-9589-3d0455324e64,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
dbd03450-1805-5569-9589-3d0455324e64,female,Alive,1970,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
dc97087e-e474-5a4a-ae55-9df2cd584547,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2002,David H. Koch Institute for Integrative Cancer Research at MIT,42.362298,-71.089075,Cambridge,Massachusetts ,2139
dc97087e-e474-5a4a-ae55-9df2cd584547,female,Alive,1948,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2002,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
dcfe6a13-0521-5b95-bb52-c2c413703643,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
dcfe6a13-0521-5b95-bb52-c2c413703643,female,Alive,1936,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
dd1d384b-f3e5-53cb-b3e1-cff1a4d84850,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
dd1d384b-f3e5-53cb-b3e1-cff1a4d84850,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
dde39d8c-7e4a-5965-852b-cd6904b2e99e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
dde39d8c-7e4a-5965-852b-cd6904b2e99e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
de77fb9d-02b5-5d16-994a-46fa5a3e323b,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1995,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
de77fb9d-02b5-5d16-994a-46fa5a3e323b,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",1995,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
deb86788-08c6-59ba-9c5d-5637dd170b6e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
deb86788-08c6-59ba-9c5d-5637dd170b6e,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
e00830e7-7afa-5262-95b1-9ec093cf6ff4,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
e00830e7-7afa-5262-95b1-9ec093cf6ff4,female,Alive,1963,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
e0765893-2c2e-50ce-a4c7-ac3526a8746e,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
e0765893-2c2e-50ce-a4c7-ac3526a8746e,female,Alive,1938,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2005,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
e0c51d2e-2739-5a27-ad54-25d14c00f90a,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
e0c51d2e-2739-5a27-ad54-25d14c00f90a,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
e1dc80db-4a53-5b1c-9d21-5577d2a116db,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
e1dc80db-4a53-5b1c-9d21-5577d2a116db,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
e2b366b5-54d4-52ab-9057-e2a3f7755781,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
e2b366b5-54d4-52ab-9057-e2a3f7755781,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
e2e24506-9147-5af7-abf8-8e974293db26,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2013,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
e2e24506-9147-5af7-abf8-8e974293db26,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2013,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
e331981e-7b68-53b7-95c2-5cf15949c2ea,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
e331981e-7b68-53b7-95c2-5cf15949c2ea,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
e46162a7-b38d-5473-ba17-81b4e62c5c17,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
e46162a7-b38d-5473-ba17-81b4e62c5c17,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
e5131de6-df58-5310-8f3f-9792154e2d41,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
e5131de6-df58-5310-8f3f-9792154e2d41,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
e5720da2-a49b-5fb5-abcc-a6160a9f1e5b,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
e5720da2-a49b-5fb5-abcc-a6160a9f1e5b,female,Alive,1979,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
e62a79ee-848d-50f1-a4e5-e32f4eb1605b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
e62a79ee-848d-50f1-a4e5-e32f4eb1605b,female,Alive,1949,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
e636331b-e748-57b6-8d24-32106af64cdf,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
e636331b-e748-57b6-8d24-32106af64cdf,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
e6364172-46ac-520d-af07-f1d3d5bedeb9,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
e6364172-46ac-520d-af07-f1d3d5bedeb9,female,Alive,,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
e6a8c88e-d05a-5bd9-9167-6afdcb41699d,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
e6a8c88e-d05a-5bd9-9167-6afdcb41699d,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
e75c880e-40b7-5369-8760-575774b83938,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
e75c880e-40b7-5369-8760-575774b83938,female,Alive,1925,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
e7a98c2c-539d-501e-8a18-f269636399ec,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
e7a98c2c-539d-501e-8a18-f269636399ec,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
e8476897-909b-57ac-abe1-14a9f79e2a3a,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
e8476897-909b-57ac-abe1-14a9f79e2a3a,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a,female,Alive,1944,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
e8d75a74-9bea-5427-ac4c-e20566531835,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
e8d75a74-9bea-5427-ac4c-e20566531835,female,Alive,1926,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
e994a2fd-e48e-59d3-8f79-518983164bf1,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
e994a2fd-e48e-59d3-8f79-518983164bf1,female,Alive,1954,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
ea1129e7-d64f-5806-8611-03a0818e92fc,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
ea1129e7-d64f-5806-8611-03a0818e92fc,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
ea34983c-8abf-5e0e-b795-731c3baf565e,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
ea34983c-8abf-5e0e-b795-731c3baf565e,female,Alive,1939,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
eada4ab5-d648-5c4f-9f46-ea31cebd6457,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
eada4ab5-d648-5c4f-9f46-ea31cebd6457,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
eb111509-466e-5511-a767-c881fb9375e6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
eb111509-466e-5511-a767-c881fb9375e6,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
eb14ffb2-f120-5873-8146-038dadc0fba8,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
eb14ffb2-f120-5873-8146-038dadc0fba8,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
eb35520c-df45-5f2c-a0c9-e8edc9832a81,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
eb35520c-df45-5f2c-a0c9-e8edc9832a81,female,Alive,1937,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
eb77bd79-bd4a-5ef4-a359-c918b069e1a3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
eb77bd79-bd4a-5ef4-a359-c918b069e1a3,female,Alive,1943,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80,female,Alive,1940,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
ed7b2087-cf0f-5360-be88-97a509a5dcbf,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
ed7b2087-cf0f-5360-be88-97a509a5dcbf,female,Alive,1945,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ee1002c1-689a-5594-a725-effa8b8af1dc,female,Alive,1975,--,"Endometrioid adenocarcinoma, secretory variant","Pharmaceutical Therapy, NOS",2009,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
ee1002c1-689a-5594-a725-effa8b8af1dc,female,Alive,1975,--,"Endometrioid adenocarcinoma, secretory variant","Radiation Therapy, NOS",2009,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
ee2f47ac-33f2-5a9e-8205-33f5961263b8,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
ee2f47ac-33f2-5a9e-8205-33f5961263b8,female,Alive,1929,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
ee615383-004f-552b-b4bb-3ec74433dfa9,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
ee615383-004f-552b-b4bb-3ec74433dfa9,female,Alive,1935,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
ee82158d-3054-55ab-a9f7-25cc3d32151e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2005,Salk Institute Cancer Center,32.87017,-117.24235,La Jolla,California,92037
ee82158d-3054-55ab-a9f7-25cc3d32151e,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2005,Sanford Burnham Prebys Medical Discovery Institute,32.87017,-117.24235,La Jolla,California,92037
ee9641f4-f36d-5742-be0c-130144f39240,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,City of Hope Comprehensive Cancer Center,34.132229,-117.971619,Duarte,California,91010
ee9641f4-f36d-5742-be0c-130144f39240,female,Alive,1939,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Jonsson Comprehensive Cancer Center,34.06447,-118.44352,Los Angeles,California,90095
ef38b762-6e65-5a5f-985e-ae40bec376aa,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,USC Norris Comprehensive Cancer Center,34.06133,-118.20479,Los Angeles,California,90089
ef38b762-6e65-5a5f-985e-ae40bec376aa,female,Alive,1938,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2007,University of New Mexico Cancer Research and Treatment Center,35.089456,-106.619299,Albuquerque,New Mexico,87131
efdecf34-f346-53d8-9aab-eefc419d4463,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,University of Arizona Cancer Center,32.24067,-110.94409,Tucson,Arizona,85724
efdecf34-f346-53d8-9aab-eefc419d4463,female,Alive,1943,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,Huntsman Cancer Institute,40.772603,-111.834444,Salt Lake City,"Salt Lake City, Utah",84112
f0036ae7-4205-5040-8e3e-a693f85e34ec,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,University of Colorado Cancer Center,39.74176,-104.837601,Aurora,Colorado,80045
f0036ae7-4205-5040-8e3e-a693f85e34ec,female,Alive,1958,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Mays Cancer Center at UT Health San Antonio,29.512967,-98.580474,San Antonio,Texas,78229
f0d1ed71-a6fc-526b-9a5a-8183ccd0229d,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dan L Duncan Comprehensive Cancer Center,29.69861,-95.394253,Houston,Texas,77030
f0d1ed71-a6fc-526b-9a5a-8183ccd0229d,female,Alive,1944,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,The University of Texas MD Anderson Cancer Center,29.70717,-95.397626,Houston,Texas,77030
f0e29733-ab34-52ea-8d38-1c603eda8865,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Harold C. Simmons Comprehensive Cancer Center,32.812682,-96.839914,Dallas,Texas,75390
f0e29733-ab34-52ea-8d38-1c603eda8865,female,Alive,1951,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Stephenson Cancer Center,35.477582,-97.498413,Oklahoma City,Oklahoma,73104
f2d6d9b4-f88a-5830-a5d4-499a571ee71f,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Fred and Pamela Buffett Cancer Center,41.255282,-95.979999,Omaha,Nebraska,68198
f2d6d9b4-f88a-5830-a5d4-499a571ee71f,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,The University of Kansas Cancer Center,39.055031,-94.611778,Kansas City,Kansas,66160
f34a2659-0257-5109-8d37-63fd9d62af15,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Alvin J. Siteman Cancer Center,38.638224,-90.262815,St. Louis,Missouri,63110
f34a2659-0257-5109-8d37-63fd9d62af15,female,Alive,1952,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,The University of Chicago Comprehensive Cancer Center,41.7882,-87.604492,Chicago,Illinois,60637
f3903f35-c35d-54f4-be3d-4c655da416f4,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Robert H. Lurie Comprehensive Cancer Center,41.89477,-87.6228,Chicago,Illinois,60611
f3903f35-c35d-54f4-be3d-4c655da416f4,female,Alive,1941,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Mayo Clinic Cancer Center,44.022137,-92.466634,Rochester,Minnesota,55905
f3e4184b-0452-5930-98c5-ac8023f647f4,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Masonic Cancer Center,44.97066,-93.23118,Minneapolis,Minnesota,55455
f3e4184b-0452-5930-98c5-ac8023f647f4,female,Alive,1950,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,University of Wisconsin Carbone Cancer Center,43.068332,-89.428881,Madison,Wisconsin,53792
f3f20b72-0419-5862-a8ab-db01ed67c608,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",1995,Holden Comprehensive Cancer Center,41.661621,-91.549919,Iowa City,Iowa,52242
f3f20b72-0419-5862-a8ab-db01ed67c608,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",1995,The Barbara Ann Karmanos Cancer Institute,42.353149,-83.056778,Detroit,Miochigan,48201
f42df73b-0462-5a66-b2da-39969fa1bcb0,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2001,University of Michigan Rogel Cancer Center,42.28492,-83.728577,Ann Arbor,Miochigan,48109
f42df73b-0462-5a66-b2da-39969fa1bcb0,female,Alive,1930,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2001,Purdue University Center for Cancer Research,40.4267,-86.9173,West Lafayette,Indiana,47907
f4785965-fb92-5876-80dc-48eba5d1a988,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2007,Indiana University Melvin and Bren Simon Cancer Center,39.77517,-86.17812,Indianapolis,Indiana,46202
f4785965-fb92-5876-80dc-48eba5d1a988,female,Alive,1931,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2007,Case Comprehensive Cancer Center,41.503695,-81.607866,Cleveland,Ohio,44106
f4b4d94a-2b7d-53bd-8d10-811b893eed5d,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,The Ohio State University Comprehensive Cancer Center,39.994715,-83.019935,Columbus,Ohio,43202
f4b4d94a-2b7d-53bd-8d10-811b893eed5d,female,Alive,1946,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2011,Markey Cancer Center,38.032009,-84.508057,Lexington,Kentucky,40536
f51e0306-5841-5740-83d5-43755b0b9f1e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,St. Jude Children's Research Hospital,35.153267,-90.039147,Memphis,Tennessee,38105
f51e0306-5841-5740-83d5-43755b0b9f1e,female,Alive,1947,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2012,Vanderbilt-Ingram Cancer Center,36.140308,-86.802176,Nashville,Tennessee,37232
f558be12-2a1f-5506-b7a5-39ae58109415,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,O’Neal Comprehensive Cancer Center,34.1408,-85.65593,Birmingham, Alabama,35294
f558be12-2a1f-5506-b7a5-39ae58109415,female,Alive,1959,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Moffitt Cancer Center,33.58685,-101.891701,Tampa,Florida,33612
f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Sylvester Comprehensive Cancer Center,33.58637,33.58637, Miami,Florida,33136
f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3,female,Alive,1957,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2009,Winship Cancer Institute,23.25245,87.84344,Atlanta,Georgia,30322
f6beb124-7592-52b5-9440-69a20be0004e,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2009,Hollings Cancer Center,32.783205,-79.947562,Charleston,South Carolins,29425
f6beb124-7592-52b5-9440-69a20be0004e,female,Alive,1929,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2009,Duke Cancer Institute,36.004912,-78.936577, Durham,North Carolina,27710
f7a149e5-b25a-58e3-8ad4-4457ffb83a89,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,UNC Lineberger Comprehensive Cancer Center,35.905141,-79.050928,Chapel Hill,North Carolina,27599
f7a149e5-b25a-58e3-8ad4-4457ffb83a89,female,Alive,1935,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Wake Forest Baptist Comprehensive Cancer Center,36.089651,-80.271272,Winston-Salem,North Carolina,27157
f8e5ff46-e164-5917-9a43-dcb119802be6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2011,Massey Cancer Center,37.539469,-77.428802,Richmond,Virginia,23298
f8e5ff46-e164-5917-9a43-dcb119802be6,female,Alive,1940,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2011,University of Virginia Cancer Center,38.032644,-78.498263,Charlottesville,Virginia,22908
f8f23111-a666-52f4-aab4-9640dcf8e425,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2004,Sidney Kimmel Comprehensive Cancer Center,39.296738,-76.592735,Baltimore,Maryland,21231
f8f23111-a666-52f4-aab4-9640dcf8e425,female,Alive,1962,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2004,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,39.288689,-76.624153,Baltimore,Maryland,21201
f9768205-d7e5-5d5e-bf59-37e064d73669,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Georgetown Lombardi Comprehensive Cancer Center,33.58637,-101.89168,Washington,D.C.,20007
f9768205-d7e5-5d5e-bf59-37e064d73669,female,Alive,1971,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fox Chase Cancer Center,40.06875,-75.095937,Philadelphia,Pennsylvania,19111
fa79ab3e-3e6a-53f8-8f85-fe4c34052427,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Sidney Kimmel Cancer Center – Jefferson Health,39.947587,-75.156899,Philadelphia,Pennsylvania,19107
fa79ab3e-3e6a-53f8-8f85-fe4c34052427,female,Alive,1924,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Abramson Cancer Center,39.946341,-75.153895,Philadelphia,Pennsylvania,19104
fbd9da68-0278-5568-957d-94cbc2f6de8a,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,The Wistar Institute Cancer Center,39.951149,-75.196392,Philadelphia,Pennsylvania,19104
fbd9da68-0278-5568-957d-94cbc2f6de8a,female,Alive,1941,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,UPMC Hillman Cancer Center,40.455291,-79.942185,Pittsburg,Pennsylvania,15232
fbe59fad-77f1-5a5c-be08-9129ca24a265,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2006,Roswell Park Comprehensive Cancer Center,42.897939,-78.864965,Buffalo,New York,14263
fbe59fad-77f1-5a5c-be08-9129ca24a265,female,Alive,1951,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2006,Cold Spring Harbor Laboratory Cancer Center,40.864671,-73.472244,Cold Spring Harbor,New York,11724
fc98d37b-3159-5080-92f4-829f488879b6,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Albert Einstein Cancer Center,40.850861,-73.845384,The Bronx,New York,10461
fc98d37b-3159-5080-92f4-829f488879b6,female,Alive,1934,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2008,Memorial Sloan Kettering Cancer Center (MSK),40.764022,-73.956068,New York,New York,10065
fd594d66-0c40-5b02-9262-afbc6549a207,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Herbert Irving Comprehensive Cancer Center,40.839767,-73.939571,New York,New York,10032
fd594d66-0c40-5b02-9262-afbc6549a207,female,Alive,1947,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2010,Tisch Cancer Institute,40.79087,-73.952081,New York,New York,10029
fdbce5bb-88bb-572b-8b58-e3f94a340c33,female,Alive,1957,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2012,Laura and Isaac Perlmutter Cancer Center at NYU Langone Health,40.74729,-73.974948,New York,New York,10016
fdbce5bb-88bb-572b-8b58-e3f94a340c33,female,Alive,1957,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2012,Rutgers Cancer Institute of New Jersey,40.496391,-74.448694,New Brunswick,New Jersey,8903
fe1253ff-6372-59d4-95d5-b7799dd58660,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,Yale Cancer Center,41.30319,-72.93391,New Haven,Connecticut,6510
fe1253ff-6372-59d4-95d5-b7799dd58660,female,Alive,1948,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Norris Cotton Cancer Center at Dartmouth,42.990923,-71.473307,Manchester,New Hampshire,3756
fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2010,Dana-Farber/Harvard Cancer Center (DF/HCC),43.97871,-97.803497,Boston ,Massachusetts ,2215
fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed,female,Alive,1956,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2010,Fred Hutchinson/University of Washington Cancer Consortium,47.627347,-122.331221,Seattle,Washington,98109
ffaff7f1-1d96-5720-9231-587e03833f53,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2003,Knight Cancer Institute,45.498225,-122.67139,Portland,Oregon,97239
ffaff7f1-1d96-5720-9231-587e03833f53,female,Alive,1927,--,"Endometrioid adenocarcinoma, NOS","Radiation Therapy, NOS",2003,University of Hawaii Cancer Center,39.05253,-77.43906, Honolulu,Hawaii,96813
ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Pharmaceutical Therapy, NOS",2008,UC Davis Comprehensive Cancer Center,38.55532,-121.45279,Sacramento,California,95817
ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea,female,Alive,1942,--,"Serous cystadenocarcinoma, NOS","Radiation Therapy, NOS",2008,Stanford Cancer Institute (SCI),37.43725,-122.17727,Palo Alto,California,94305
ffc30aed-dee2-51e6-b47a-6040fd685f9e,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Pharmaceutical Therapy, NOS",2011,UCSF Helen Diller Family Comprehensive Cancer Center,37.784695,-122.439224,San Francisco,California,94115
ffc30aed-dee2-51e6-b47a-6040fd685f9e,female,Alive,1946,--,Papillary serous cystadenocarcinoma,"Radiation Therapy, NOS",2011,Moores Comprehensive Cancer Center,32.79746,-117.15656,La Jolla,California,92093
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,